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The prevailing dogma in structural genomics is the existence of a strong
correlation between protein sequence, structure, and biological function. Proteins with
high sequence similarity typically have a similar, if not the same, structure and function.
In many cases this logic can fail due to distantly related proteins having very low
sequence similarity, a lack of a representative structure, structural novelty, or the absence
of a characterized function. Further, the paradigm fails to account for dynamics, which
have a significant effect on structural stability and enzymatic efficacy.
Nuclear magnetic resonance (NMR) spectroscopy is uniquely capable of solving
the structure, assisting with annotation, and deriving the dynamics of previously
unstudied proteins. Historically, NMR has been used to calculate structures and dynamics
of small or disordered proteins, which could then be used with computational methods to
predict function. Predicted annotations are then confirmed by further experimentation
such as ligand screens or titrations. The combination of NMR and bioinformatics,
therefore, works synergistically to yield significant results, which has the ability to
characterize highly complex proteins and fill gaps in the sequence to structure to function
paradigm.
This dissertation begins with work accomplished using the Comparison of Active
Site Structures (CPASS) software to show the functional evolution of a class of cofactor
dependent enzymes and also expands on the utility of CPASS with the implementation of

a functional clustering of its database. Described next is an emphasis on protein and
peptide structure and the relationship between the experimentally derived ensembles and
biological function and dynamics. Recent improvements in the calculation of protein fasttimescale dynamics are then introduced before a final concluding chapter.
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Chapter 1
Introduction
1.1 The Application of Nuclear Magnetic Resonance Spectroscopy and
Bioinformatics in Structural Genomics
Upon completion of the human genome project and other genomics initiatives, it became
possible to find relationships between organisms using their whole genome sequences.1, 2
The relationships are leveraged to discover homologous proteins with similar functions.
However, an enormous amount of genomic data now exists which contains “gaps” where
genes are structurally and functionally uncharacterized. The field of structural genomics
has arisen to meet this exceptional challenge. Rather than solving the three-dimensional
structure of every protein encoded within a particular genome, the aim is to concentrate
on representative domain targets for each globular fold.2 The known structures can
subsequently be used in computational homology modeling to then predict the remainder
of the structures.
Thus far, structural genomics has greatly diversified the range of structural information
available for many different protein families.3 High-throughput methods have been used
to steadily produce structural representatives of previously uncharacterized genes.
Although the new structures have been deposited in the Protein Data Bank (PDB)4,
relatively few papers have been published by structural genomics centers and a distant
lack of novel folds have been discovered.3 In contrast, structural biology groups produce
fewer protein structures, but the structures typically contain novel folds and are deposited
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with a corresponding publication. The authors go further in their analysis and also add
detail pertaining to the protein’s function and physiological importance. Therefore, the
roles of individual structural biology groups and structural genomics centers are
synergistic. Structural genomics builds a comprehensive profile of the structural
landscape while structural biology characterizes protein function.
Protein structures are traditionally determined by X-ray crystallography or nuclear
magnetic resonance (NMR) spectroscopy.5 Most of the structures are determined by
crystallography, although not all protein targets are amenable to crystallization. Further,
crystal structures are static snapshots of the protein in a non-physiological environment,
which may contain structural elements that are not present in the native conformation.
For example, crystallization has the tendency to produce non-biological symmetry in
proteins.6 NMR complements X-ray crystallography in that it is capable of solving
structures in the solution state. The aqueous solution can be additionally adjusted to
mimic the physiologic conditions for the protein. Conditions can be matched to the pH,
ionic strength, and temperature of the physiological environment of the protein to be
studied. Rather than producing a single conformer, NMR structures are presented as an
ensemble of low-energy conformers. Therefore, the ensemble represents a set of
structures that the protein may transiently sample while in solution. A significant
limitation to NMR structure determination is the limitation to proteins less than 25kDa.7
Higher molecular weight proteins are possible, but require more advanced methods and
significantly more time to solve.7 Nonetheless, it has been estimated that at least 25% of
uncharacterized open reading frames (ORFs) are under the molecular weight cutoff for an
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NMR solution structure. This ensures that NMR will remain an essential tool in
structural genomics for years to come.
The insurmountable amount of genomic data that now exists cannot possibly be
completely analyzed using only experimentation. Bioinformatics, the study of complex
biological data using computational methods, can be employed to quickly determine
function and structure for uncharacterized genes. Many methods have been developed to
predict structure and function from amino acid sequences and function from structure.9-11
These tools have been essential to the field of structural genomics for annotating families
of proteins from very little preliminary information. As with most tools and methods,
there are limitations to what can be predicted and inferred. There is significant difficulty
and error associated with comparative studies involving proteins at or below 30%
sequence similarity.12 For sequence comparison methods, low similarity leads too poor
functional characterization and poor evolutionary relationship construction. It becomes
necessary to compare proteins at the structural level using their tertiary structure or active
sites to infer function and evolution.13 However, the problem is further compounded in de
novo structure prediction where low accuracy models are generated for proteins with less
than 30% similarity.14 This instance highlights the mutually beneficial relationship
between bioinformatics and structural biology. A representative protein from an
uncharacterized and ancient family can be structurally elucidated, and the resulting
structure can be used to model the remainder of the family.

4

1.2 Overview of Work
This dissertation describes a body of work focused on the application of bioinformatics
and structural biology towards the understanding of novel and physiologically relevant
proteins. It begins with an original way to phylogenetically model distantly related
proteins and describes the advantageousness of using active site structures to cluster
proteins. Next are practical applications of NMR toward the structure determination of
previously unsolved peptides and proteins. A deeper understanding of protein dynamics
is then developed in the subsequent chapters, which includes new methods in their
derivation.
Chapter 2 introduces the utility of the Comparison of Protein Active Sites Software
(CPASS)15, 16 in the discovery of evolutionary relationships between proteins.13 Typically
evolutionary relationships between proteins are inferred using sequence comparison
methods. These methods, however, fail for families of distantly related proteins due to
very low sequence identity. This further hinders functional annotation and
characterization of the protein family. Slowly evolving structural moieties of proteins,
such as an active site, are therefore valuable for annotating putative and distantly related
proteins. CPASS compares the similarity and geometry of active site residues and acts as
a sensitive measure of active site evolution. Similar methods compare putative cavities,17
local structures,18 active site shapes,19 and have been extensively reviewed.20 CPASS
differs from these other methods because it uniquely uses ligand-defined active sites. An
active site must have a known and bound ligand in its 3D structure file to be considered
for CPASS analysis. Thus, this is both an advantage and disadvantage of the software. It
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compares real ligand binding sites, rather than putative, but is also limited by the
necessity to have a bound ligand.
Pyridoxal-5’-phosphate (PLP) dependent enzymes are primordial enzymes that
diversified in the last universal ancestor. Molecular evolution efforts focusing on these
enzymes have been limited to small subgroups due to the low sequence identity within
the family.21-23 Using CPASS, we show that the active site structures of PLP-dependent
enzymes can be used to infer evolutionary relationships based on functional similarity.
The enzymes successfully clustered together based on substrate specificity, function, and
three-dimensional fold. This chapter reveals the first ever successful clustering of the
entire PLP-dependent enzyme family. Furthermore, it demonstrates the value of using
active site structures for functional evolutionary analysis and the effectiveness of CPASS.
Adam Caprez, Ashu Guru, and David Swanson assisted with the “all versus all”
comparison used in this project and were instrumental in the organization of the data.
Chapter 3 further expands upon the expediency of CPASS with the addition of an
improved active site comparison search. A standard CPASS search compares the query
active site to all members in the database. This search, although optimized, takes several
hours due to the enormity of the database (approximately 40,000 active sites), which will
continue to increase as the number of deposits in the Protein Data Bank (PDB) grows.
While an exhaustive search may produce the top result, the time required may be
detrimental when doing multiple queries. Therefore, a search against a representative
subset of the CPASS database, approximately 10% in size, would be advantageous and
would only become more optimized upon further addition to the PDB. Enzyme
classification (EC) numbers are generally used to group proteins and enzymes according
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to function. The application of these EC numbers to CPASS actives sites creates
functional clusters for each ligand, which can then be used for subset generation. Cluster
representatives are then found by applying principal component analysis (PCA) to the
CPASS distance matrix for each ligand where 95% confidence ellipses are calculated for
each EC number. The active site with the closest Euclidean distance to the center of each
confidence ellipse is chosen as the cluster representative. This chapter demonstrates the
effectiveness of using the CPASS representative subset, the effect it has on computational
time, and novelty of functional clustering based on active site structures. For this project,
Adam Caprez and David Swanson helped with the organization of the data and with the
implementation of the representative tree into the CPASS webserver.
Chapter 4 pivots to more biophysical and structural studies of peptides and the
relationship between the structural moieties and antibacterial properties. The rapid
emergence of multidrug resistant bacterial strains and the development of permanent
biofilms have made the search for new antibacterial agents of paramount importance.24
Newer approaches have been developed which employ existing antibiotics in
combination with other antibiotics, adjuvants, and other previously approved drugs.24
Nonetheless, the dire need still exists for the discovery of new antibiotics. Cationic
antimicrobial peptides (AMPs) are a class of agents that have received a lot of attention
lately due to an ability to eliminate resistant pathogens and to inhibit bacterial biofilms.25
The mechanism of action of AMPs differs from current antibiotics, which makes their
potential use appealing. In general, the AMPs act as detergents that are selective for
bacterial membranes and this mode of action greatly reduces the ability of infectious
bacterial to gain resistance. However, beyond gross cationic, helical and hydrophobic
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properties of AMPs little is known about the structural requirements for activity.
Citropin 1.1 is a helical AMP found on the skin of amphibians that exhibits both
antibacterial and anticancer activity.26 Previous studies suggested that Citropin 1.1 acts
through an α-helical agglomerative mechanism known as carpeting.25, 26 Employing
finely tuned analogs of Citropin 1.1, we explore how slight structural variations have a
remarkable influence on the AMP secondary structure and activity. Our study identified
the AMP regions responsible for essential interactions that also regulate antibacterial
activity and go beyond the “charge-only paradigm”. Projection of the residue side chains
was found to be essential to the activity of the peptides. Surprisingly, shortening the
lysine side chains by one carbon led to a significant decrease in antimicrobial activity.
Additionally, we found that the hydrogen bond network at the N-terminus of the peptides
was crucial in helix stabilization and in the subsequent monomer to aggregate
equilibrium. Active Citropin 1.1 analogs displayed a greater tendency to form α-helices
and to consequently dimerize when in contact with a negatively charged membrane. In
this regard, our results support the carpet-model mechanism of AMP biological activity.
AMPs may be used to augment conventional antibacterial therapeutics to overcome drug
resistance as part of a multidrug treatment. However, significant challenges must be
solved, such as in vivo stability and toxicity, before they can be approved for systemic or
topical use.27 This study considerably contributes to the understanding of the biophysical
properties of α-helical AMPs and will hopefully assist with future endeavors towards
producing a novel antibacterial therapy. Mehdi Bin Samad, Nathalia Rodrigues de
Almeida, and Martin Conda-Sheridan synthesized the peptides, performed the MIC
assays, and completed the microscopy experiments during this collaborative project.
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Sequence analysis was essential to the work done with Citropin 1.1. We compared
sequences of known peptides with high antimicrobial activity and were able to make
hypotheses about the effects of mutations or modifications. In the end, the sequence
analysis was the first, and probably most significant, step towards the synthesis of an
enhanced AMP. Protein function elucidation also relies heavily on amino acid sequence
analysis and other bioinformatics approaches. The reliance is extended to structure
homology modeling for ligand docking and protein-protein interaction mapping.
Structural genomics initiatives, such as the Northeast Structure Genomics Consortium
(NESG),28 identify protein families that are sequentially similar but lack functional
annotation and a representative structure. The NESG identified RPA3313, a putative
protein from Rhodopseudomonas palustris, as a potential target. Sequence analysis of
RPA3313 exposes a large, unannotated class of hypothetical proteins mostly from the
Rhizobiales order. In the absence of sequence and structure information, further
functional elucidation of this class of proteins has been significantly hindered. In chapter
5 we reveal the NMR structure of RPA3313, which adopts a novel split ββαβ fold with a
conserved ligand binding pocket between the first β-strand and the N-terminus of the αhelix.29 Conserved residue analysis and protein-protein interaction prediction analyses
reveal multiple protein binding sites and conserved functional residues. Results of a mass
spectrometry proteomic analysis strongly point toward interaction with the ribosome and
its subunits. The combined structural and proteomic analyses suggest that RPA3313 by
itself or in a larger complex may assist in the transportation of substrates to or from the
ribosome for further processing. Importantly, this analysis of RPA3313 can be further
extended to the remainder of the previously uncharacterized protein family identified by
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the NESG and aptly fulfills the core purpose of structural genomics. This work could
not have been done without the assistance of Austin Lowe and Ronald Cerny, who helped
with protein purification and mass spectrometry analysis, respectively.
Chapter 6 continues with structural biology in the analysis of the C-terminal domain
(CTD) of DnaG primase.30 Bacterial DNA replication initiates through a crucial
interaction between two highly conserved proteins, DnaG primase and DnaB helicase.
The interface between the DnaG primase C-terminal domain and the N-terminal domain
of DnaB helicase is essential for bacterial DNA replication because it allows coordinated
priming of DNA synthesis at the replication fork while the DNA is being unwound. Since
these two proteins are conserved in all bacteria and distinct from those in eukaryotes,
their interface is an attractive antibiotic target. To learn more about this interface, we
determined the solution structure and dynamics of the DnaG primase CTD from
Staphylococcus aureus, a medically important bacterial species. Comparison with the
known primase CTD structures shows there are two biologically relevant conformations
– an open conformation that likely binds to DnaB helicase and a closed conformation that
does not. The S. aureus primase CTD is in the closed conformation, but NMR dynamic
studies indicates there is considerable movement in the linker between the two
subdomains and that N564 is the most dynamic residue within the linker. A highthroughput NMR ligand-affinity screen identified potential binding compounds, among
which were acycloguanosine and myricetin. Although the affinity for these compounds
and adenosine was in the millimolar range, all three bind to a common pocket that is only
present on the closed conformation of CTD. This binding pocket is at the opposite end of
helices 6 and 7 from N564, the key hinge residue. The identification of this binding
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pocket should allow the development of stronger-binding ligands that can prevent
formation of the CTD open conformation that binds to DnaB helicase. Preventing the
interaction between the primase CTD and helicase would significantly hinder bacterial
DNA synthesis and, ultimately, reproduction. Although blocking this interaction would
not result in immediate cell death, in combination with another antibiotic the treatment
could potentially overcome multidrug resistance. This work was done in collaboration
with Jessica Periago and Mark Griep.
Proteins are inherently dynamic and adopt various conformations at physiological
conditions. The study of their dynamic behavior and discovering all of their hidden
conformations is, consequently, essential to completely understanding their function. This
was especially true for the primase CTD from S. aureus. From the dynamics study we
were able to identify a key hinge residue and binding site that may provide a novel
therapeutic target. Knowing firsthand the importance of dynamics relative to protein
function we accomplished a similar study on human protein DJ-1, which is presented in
chapter 7.
Various missense mutations in the cytoprotective protein DJ-1 (PARK7) cause rare forms
of inherited Parkinsonism. One such mutation, M26I, diminishes DJ-1 protein levels in
the cell but does not result in large changes in the three-dimensional structure or thermal
stability of the protein. Therefore, the molecular basis for M26I DJ-1 instability and
dysfunction is unknown. Chapter 7 reveals that by using NMR spectroscopy the
picosecond-nanosecond timescale dynamics of wild-type and M26I DJ-1 are similar, but
longer timescale (minutes to hours) dynamics are enhanced in M26I DJ-1 near
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physiological temperature. These slow conformational fluctuations transiently expose
part of the hydrophobic core of M26I DJ-1 to solvent and cause the protein to aggregate
in vitro at 37°C. Aggregation of the protein effectively diminishes its function and
removes the protein from the cellular composition. The non-pathogenic M26L mutation,
in contrast, does not aggregate at 37°C and is less dynamic than M26I at physiological
temperature. Therefore, M26I DJ-1 is an example of a pathogenic change in protein
conformational dynamics causing a temperature-dependent loss of stability in the cell.
Furthermore, the onset of M26I DJ-1 instability at physiological temperature illustrates
the pitfalls of characterizing proteins exclusively at room temperature or below, as key
aspects of their behavior may not be apparent. Given the prevalence of structurally
conservative disease-causing mutations in proteins, we suggest that disruption of protein
dynamics could be a more common pathogenic event than is currently appreciated.
Moving forward with the dynamics of DJ-1, chapter 8 introduces a methodological
development that expands on the amount of interpretable data that can be obtained from
an NMR experiment. NMR dynamics experiments have traditionally been collected using
1

H-15N HSQC R1, R2, and heteronuclear NOE experiments with the Carr-Purcell-

Meiboom-Gill (CPMG) relaxation dispersion approach.32 However, these approaches
take significant time to complete and often require are large amount of protein divided
over multiple samples. In the case of M26I DJ-1, the protein would aggregate at
physiological temperature and required a fresh sample for each experiment. Accordingly,
there is an immediate need for new methods that reduce experimental time or extract
additional information from existing datasets. Previous studies have shown that
relaxation parameters and fast protein dynamics can be quickly elucidated from 15N-
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CEST experiments. Longitudinal R1 and transverse R2 values were reliably derived
from fitting of CEST profiles. We show that 15N-CEST experiments and traditional
modelfree analysis provide the internal dynamics of three states of human protein DJ-1 at
physiological temperature. The chemical exchange profiles show the absence of a minor
state conformation and, in conjunction with 1H-15N NOEs, show increased mobility. R1
and R2 values remained relatively unchanged at the three naturally occurring oxidation
states of DJ-1, but exhibit striking NOE differences. The NOE data was, therefore,
essential in determining the internal motions of the DJ-1 proteins. To our knowledge, we
present the first study that combines 15N CEST data with traditional model-free analyses
in the study of a biological system and affirm that more ‘lean’ model-free approaches
should be used cautiously. The DJ-1 work was done in collaboration with Nicole
Milkovic, Mark Wilson, and Tessa Andrews.
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Chapter 2
Functional Evolution of PLP-dependent Enzymes Based on Active site
Structural Similarities
2.1 Introduction
Sequence comparison methods and structural homology models are often used to imply
evolutionary relationships between proteins in the same family or of the same function.1, 2
These analyses are additionally used to infer the function of uncharacterized proteins.3, 4
Enhancing our understanding of protein evolution furthers our insights into cellular
processes, enables the discovery of drug targets and disease markers, while validating or
establishing phylogenies of organisms, among numerous other beneficial impacts.5
However, evolutionary studies are limited for distantly related proteins in which sequence
and structural similarity may not be easily deduced. Sequence comparison methods
assume a constant rate of amino acid substitution and are not suitable for all phylogenetic
reconstructions of ancestral sequences. Correspondingly, for sequences with minimal
identity local conformations can vary greatly and may inhibit structural studies.6
It is understood that although the rate of sequence evolution is highly variable, residues
essential to function and active site chemistry will remain highly conserved over time.7
Slight changes in the position and identity of an active site residue can lead to changes in
both substrate and reaction specificity.1, 8 In fact, it has been proposed that catalytic
residues maintain their position and identity longer than the configuration of some
secondary structures.9 The importance of these residues has spawned many
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computational approaches to assist with the prediction of active site residues,

10-12

the

functional annotation of proteins based on active sites,13-15 as well as gene functional
annotation.16, 17 Additionally, the evolution of homologous proteins sharing low sequence
identities has been inferred using active site structure geometries.9, 18, 19 These
observations are consistent with the premise that molecular evolution and functional
evolution proceed through distinct processes. Molecular evolution is driven by random
mutational events where maintaining function is paramount.1, 2 Conversely, protein
functional evolution requires a new gene through duplication, acquisition or creation that
enables protein functional drift while avoiding a negative impact on cell fitness.20-22
Correspondingly, analyzing functional evolution may require a different approach from
the global sequence comparisons routinely used for molecular evolution.1, 2 In this
manner, active site structures may be a suitable alternative for inferring an evolutionary
relationship based on function.23
Some of the most diverse and versatile classes of enzymes are those that utilize
pyridoxal-5’-phosphate (PLP) as a cofactor.24 These enzymes are found in five of the six
classes defined by the Enzyme Commission and catalyze a multitude of different
reactions.25 The diversity of the reactions can be attributed to the electron sink properties
of the cofactor26 and the stereochemical restraints in the active site of the enzyme.27-29
PLP-dependent enzymes acting on amino acid substrates can be separated into four
families of paralogous proteins annotated as fold-types I-IV.26, 30 Interestingly, each of
the fold-types are highly promiscuous in terms of function, and multiple examples of
convergent evolution have been discovered.24 These observations have led to the
hypothesis that the four lineages of PLP-dependent enzymes developed in the last
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common universal ancestor.
Extensive work has been done with sequence-based methods to establish a phylogenetic
relationship among PLP-dependent enzymes.24, 31, 32 These studies, however, have been
limited to small subgroups due to the low sequence identity within each fold-type and
across all PLP-dependent enzymes. Remarkably, the functions of these enzymes are
highly dependent on the structure of their active sites. Although these enzymes lend
themselves to an evolutionary study based on active site structures, one has not yet been
undertaken.
Here, we use a novel method to compare the active site structures of 204 PLP-dependent
enzymes from the four different fold-types that are specifically involved in amino acid
metabolism. The Comparison of Protein Active Site Structures (CPASS) software and
database was developed to aid in the functional annotation of uncharacterized proteins by
comparing ligand defined active sites.15, 33 As a sensitive measure of active site geometry,
it was proposed that CPASS could also be used to model families of divergent proteins.
In this work we present the functional evolution of PLP-dependent enzymes based on
active site structures. To the authors’ knowledge, this is the first study of its kind that
models the functional evolution of a superfamily of proteins by active site comparisons,
and the first to model all PLP-dependent fold-types together on one network. Results
were compared to previous studies using both sequence and structure-guided methods.
We find that the active site comparisons successfully cluster the enzymes based on both
function and three-dimensional fold-type.
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2.2 Materials and Methods
2.2.1 Active Site Structure Comparison
Three-dimensional structures with ligand-defined active sites were gathered from the
Protein Data Bank on May 9, 2014.34 An all versus all comparison was carried out
between the active site structures using the Comparison of Protein Active Site Structures
(CPASS) software. CPASS finds the optimum structural alignment between two active
sites by maximizing a scoring function based on structure (C and C RMSD) and
sequence (BLOSUM62) similarity.35, 36 The scoring function is the summation of an ideal
pairing of residues between each of the active sites rather than a summation of all
possible pairings. Therefore, it is possible that active site residues remain unpaired during
analysis. Since the CPASS algorithm is dependent upon the size of the active site query,
an asymmetrical similarity matrix was generated from the all versus all comparison. The
lower score of the two pairwise comparisons was extracted and converted to a distance by
subtracting from 100% similarity. From the resulting distance matrix, only the PLP
bound proteins that acted on amino acid substrates were extracted. Redundancies in the
PLP-distance matrix were removed. A total of 204 X-ray crystal structures and
corresponding active sites were analyzed in this study.

2.2.2 Protein Annotation
A total of 204 PLP-dependent proteins were functionally annotated with Enzyme
Commission (EC) numbers using the UniProt database37 and in-house software. Enzymes
that did not have an EC number in the UniProt database were assigned manually using
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the PDB. For enzymes with more than one number or classification, only the first was
taken. Species, phylogenetic kingdom, and fold-type annotations were done manually
using the PDB and UniProt databases as well as literature sources.

2.2.3 Phylogenetic Analysis
A phylogenetic network using all of the PLP-dependent enzymes was generated with
Splitstree438 using the Neighbor-Net algorithm.39 The network represents a deterministic
model of the distances obtained from the CPASS algorithm and software. Identification
of the four fold-type clusters was accomplished by visual inspection of the network. Each
of the clusters is continuous and does not contain enzymes that are not of the same foldtype. Phylogenetic trees were created for each of the fold-types using Dendroscope,40
CPASS distances, and the Neighbor-join algorithm. Neighbor joining is an agglomerative
clustering method in which a tree is built from a distance matrix. Briefly, the two closest
taxa in the distance matrix are joined to create a new node. Distances from each of the
remaining taxa to the new node are recalculated and the matrix is updated. As this
process is repeated, the distance matrix shrinks until only a pair of nodes remains.

2.2.4 Sequence Identity
The PDB IDs for the 204 PLP-dependent enzymes in this study were submitted to the
UniProt database for primary sequence retrieval. The sequences were subsequently
submitted to Clustal Omega41 for multiple sequence alignment (MSA) using the default
parameters. The MSA and percent identity matrix were retrieved upon completion and
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visualized in the R software environment. A histogram was generated with intervals of
0.2 percent identity and represents the entire, non-condensed percent identity matrix. A
heat map of the entire matrix was also generated with a white to red gradient
corresponding to low and high percent identity. The ordering of the sequences in the heat
map corresponds to the ordering in Table S1.

2.2.5 Structure Alignment
The 204 PLP-dependent enzymes were further subjected to an all versus all structural
alignment using TM-align.42 Results from the pairwise comparisons were organized into
a matrix and were visualized in the R software environment. A histogram was generated
with TM-align score intervals of 0.001 and represents the entire symmetrical matrix.
Correspondingly, a heat map of the matrix was generated with a white to red gradient
representing low and high TM-align scores, respectively. Ordering of the heat map is the
same as the sequence identity ordering and follows the order in Table S1.

2.2.6 Comparison of Type-I Transaminase Active Sites
From the 204 PLP-dependent enzymes in the CPASS dataset, 4 enzymes were selected to
elucidate the active site differences that encode substrate specificity. An acetylornithine
(ACO) transaminase (PDB ID: 2ORD), a γ-aminobutyric acid (GABA) transaminase
(PDB ID: 1OHW), an aspartate (Asp) transaminase (PDB ID: 1ARG), and a tyrosine
(Tyr) transaminase (PDB ID: 3DYD) were selected from functional clusters 1, 1, 4b, and
4a, respectively. Active site residues for each of the enzymes were selected based on their
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proximity to the PLP ligand (6 Å) as defined by CPASS. Active sites were overlaid in
Chimera43 and visually inspected for the changes resulting in different substrate
specificity. Additional transaminases with the same function as the four in question were
subjected to individual multiple sequence alignments in Clustal Omega. The additional
enzymes were manually selected from the PDB and were not present in our original
dataset because a bound ligand was not present in the structure.

2.3 Results
2.3.1 Phylogenetic Network Analysis
Phylogenetic analyses were carried out on 204 PLP-dependent enzymes with bound
cofactor (Table S1) from each of the four fold-types previously defined in the literature.26
It is well known that each of the fold-types originated from separate evolutionary
lineages. Using sequence-based phylogenetic methods,24 each of the lineages has been
visualized with a molecular evolutionary tree structure. However, due to their low
sequence identity visualizing all of the fold-types together has not yet been accomplished.
Using active site similarity comparisons, it is possible to display all of the PLP-dependent
enzymes in one phylogenetic network that demonstrates an evolutionary relationship
based on function (Figure 1). Type-I enzymes make up the largest portion of the PLP
enzymes and encompasses most of the enzymes that act at the Cα position of the
substrate. Type-II enzymes catalyze reactions at the Cα and Cβ positions and contain
fewer members compared to Type-I. The final two folds, Types III and IV, have the
fewest members of PLP-dependent enzymes. The function-based phylogenetic network
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suggests that each of the fold-types originated from an independent lineage. The main
branches of the network all spawn from the center, indicating a universal organism
contained ancestral enzymes for each of the fold-types. Also evident are clear separations
within each of the groups that form function-specific clusters (numbered 1 through 13).

Figure 1: Active site network analysis of PLP-dependent enzymes. A phylogenetic
network analysis of 204 PLP-dependent enzymes with ligand defined active sites in the
PDB. The red, yellow, green and blue colored regions and protein structures correspond
to fold-types I, II, III and IV, respectively. Individual clusters found within each of the
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folds represent groups of function specific enzymes and are numbered 1-13. The
network was generated using CPASS similarity scores and the Neighbor-net method.

The functional network also highlights the advantages of using an enzyme’s active site to
elucidate an evolutionary relationship. Each of the PLP-dependent fold-types has a
defined active site geometry, and within each type, each function-specific cluster has a
unique variation in the active site geometry. However, the functional network only gives
a general overview of the relatedness between each of the functions in the fold-types and
between the fold-types. To make valid inferences of functional evolutions, further
analysis is still necessary.

2.3.2 Phylogenetic Analysis of Type-I Enzymes
Active site similarity scores from the enzymes in the Type-I fold-type were analyzed in
detail to find a phylogenetic relationship among functional clusters 1-7 (Figure 2). The
dominating function of fold-type I involves transaminase activity (EC 2.6.1), which is
found in clusters 1, 2, 4 and 7. Clusters 3, 5 and 6 are primarily comprised of carbonsulfur lyases (EC 4.4.1), decarboxylases (EC 4.1.1), and glycine
hydroxymethyltransferases (EC 2.1.2.1), respectively. Although clusters 1, 2, 4 and 7
share a broad transaminase activity, these clusters are punctuated in the phylogenetic tree
by the remaining functional clusters. This observation suggests multiple Type-I enzymes
existed in a common ancestor with specialized function. Conversely, a continuous
grouping of all the transaminases would have implied the existence of a single
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transaminase with broad substrate specificity. Previous studies have recognized similar
divisions within the Type-I fold using sequence homology methods and structural
alignment tools; and came to the same conclusion.44-46 The punctuation in the active site
similarity tree highlights the sensitivity of CPASS for comparing residues and geometries
of active sites; and supports its use as a phylogenetic tool.

Figure 2: Type-I PLP-dependent enzyme phylogenetic analysis. The phylogenetic tree
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of PLP-dependent enzymes belonging to the Type-I fold. Each leaf of the tree is
annotated with PDB ID, EC number and species. Branch lengths represent the
evolutionary distance between enzymes based on active site structure comparisons.
Functional clusters 1-7 correspond to the numbers in the network analysis of all PLPdependent enzymes (Figure 1). The tree was constructed using CPASS similarity scores
and the Neighbor-join algorithm.

There are multiple examples of bacterial and eukaryotic species with homologous
enzymes within the Type-I functional clusters (Table S1). A general idea of the extent of
enzyme divergence from a universal ancestor can be elucidated based on how these
homologous enzymes group within the Type-I functional clusters. In cluster 3, the
methionine gamma-lyases (EC 4.4.1.11) belonging to eukaryotic T. vaginalis and
bacterial P. putida were found to be closely related. Directly following in the phylogentic
tree are the cystathionine gamma-lyases (EC 4.4.1.1) for both eukaryotes and bacteria.
This indicates that a methionine gamma-lyase and a cystathionine gamma-lyase existed
in a universal ancestor. Similar examples are also found in clusters 2, 6, and 7 for
phosphoserine transaminases (EC 2.6.1.52), kynureninases (EC 3.7.1.3) and glycine
hydroxymethyltransferases (EC 2.1.2.1), respectively.
Aspartate transaminases are present in both clusters 4a and 4b, but a clear separation
between these two clusters is apparent in the phylogenetic tree shown in Figure 1. This is
due to the fact that eukaryotic aspartate transaminases are only found in cluster 4b, while
bacterial aspartate transaminases are found in both clusters 4a and 4b. The eukaryotic
enzymes in cluster 4a are comprised of carboxylate synthases (EC 4.4.1) from the
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kingdom Plantae, and tyrosine and alanine transaminases (EC 2.6.1.5 and 2.6.1.2)
from the kingdom Animalia. This finding does not support the idea that all Type-I
enzymes became highly specialized in the last universal ancestor. Instead, our results
suggest that a promiscuous aspartate transaminase was passed on to emergent species
and, through subsequent speciation and gene duplication events, the enzymes in clusters
4a and 4b became more functionally specialized and more substrate specific.

2.3.3 Phylogenetic Analysis of Type-II Enzymes
A detailed phylogenetic analysis was also carried out on the Type-II PLP-dependent
enzymes using CPASS similarity scores and the Neighbor-Join algorithm (Figure 3a).
Three functional clusters based on active site similarity were identified for this fold-type
and are labeled as clusters 8, 9 and 10. Enzymes catalyzing deaminase reactions on 1aminocyclopropane-1-carboxylate (EC 3.5.99.7) are found exclusively in cluster 8. These
enzymes belong to species in archaeal and eukaryal domains indicating that their function
was specialized in a common ancestor. The same observation was made for the enzymes
in cluster 10. Threonine synthase (EC 4.2.3.1), tryptophan synthase (EC 4.2.1.20), and
serine dehydratase/threonine deaminase (EC 4.3.1.17/4.3.1.19) enzymes from archaeal,
bacterial, and eukaryal species cluster by function rather than by domain. Cluster 9
contains cysteine synthases (EC 2.5.1.47) from the bacterial, archaeal, and eukaryal
domains and cystathionine -synthases (EC 4.2.1.22) from the eukaryal domain. The
clustering of the cysteine synthases by function rather than by domain once again
indicates specialization in a common ancestor; however, an insufficient number of
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cystathionine -synthases are represented in the dataset to elucidate its functional
evolution.

2.3.4 Phylogenetic Analysis of Type-III Enzymes
Phylogenetic analysis was also undertaken to explain the emergence of enzymes
belonging to the Type-III fold-type (Figure 3b). Clusters 11 and 12 were found to be
discernibly different from one another in the phylogenetic network (Figure 1) and,
correspondingly, separate from one another on the phylogenetic tree created with the
Neighbor-Join algorithm. Alanine racemases (EC 5.1.1.1) exclusively populate functional
cluster 12; whereas, functional cluster 11 is made up of three comparable decarboxylases.
Unlike most of the enzymes in fold-types I and II, it does not appear the Type-III
enzymes specialized in the last common ancestor.

Figure 3: Types-II, -III, and -IV PLP-dependent enzyme phylogenetic analysis.
Phylogenetic reconstructions of PLP-dependent enzymes from Types-II (A), -III (B), and
-IV (C) folds were built using CPASS similarity scores and the Neighbor-join algorithm.
Enzymes are labeled with their PDB ID, an EC number and organism. Tree branch
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lengths correspond to the evolutionary distance between the active sites of the
enzymes. Numbers 8-13 represent the functional clusters found in the network analysis
(Figure 1).

In our dataset, diaminopimelate decarboxylases (DAPDC, EC 4.1.1.20) and arginine
decarboxylases (ADC, EC 4.1.1.19) from bacterial and archaeal species are present while
ornithine decarboxylases (OCD, EC 4.1.1.17) appear only from eukaryal species.
However, function specific clustering of the enzymes in cluster 11 is not observed. It is
likely that a decarboxylase with a very generic active site existed in a common ancestor
due to the kingdom specific characteristics of the current enzymes.47, 48 Additionally,
ODCs for bacterial species can be found in functional cluster 5 of the Type-I enzymes.
This example of convergent evolution further supports the idea of a broad-based
decarboxylase belonging to the Type-III fold. A viral ADC (PDB ID: 2NV9) is also
present within functional cluster 11, but does not cluster with the bacterial ADCs. It was
previously hypothesized that this enzyme was acquired from a bacterial ornithine
decarboxylase and subsequently mutated toward arginine specificity.49 CPASS analysis
supports this proposal as the enzyme clusters with eukaryal ODCs and a bacterial
DAPDC instead of the bacterial ADCs. Specifically, this finding represents an example
of convergent evolution within the Type-III fold.

2.3.5 Phylogenetic Analysis of Type-IV Enzymes
Type-IV enzymes occupy the smallest portion of all PLP-dependent enzymes and form
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only one functional cluster (Figure 3c). Cluster 13 contains aminodeoxychorismate
lyases (EC 4.1.3.38), branched chain amino acid transaminases (EC 2.6.1.42) and a Damino acid transaminase (EC 2.6.1.21). Similar to the other three fold-types, the function
specific enzymes in this family group together. However, because there is only one Damino acid transaminase represented in the dataset, the enzyme is grouped with the
branched chain amino acid transaminases. Interestingly, D-amino acid transaminases
share similar active site characteristics with the Type-I transaminases.50 The geometry
and residue identity is different enough, however, to distinguish between Types I and IV
enzymes without having to look at the three-dimensional structure.

2.3.6 Sequence Identity and Structural Similarity
A heat map and corresponding histogram was generated from a multiple sequence
alignment (MSA) of the 204 PLP-dependent enzymes (Figure 4a-b). Values above 20%
identity belong to self-comparisons and comparisons of closely related homologous
enzymes within the same organism. This can be seen visually as the diagonal line in the
corresponding heat map. As expected, the histogram shows that the majority of the
pairwise comparisons are well-below 20% sequence identity. This is consistent with prior
observations that PLP-dependent enzymes have very low sequence identity.24, 31, 32
Importantly, establishing a protein function based solely on sequence homology
significantly decreases in reliability as sequence identity falls below 50%.51 Presumably,
a similar high level of uncertainty in establishing a functional evolutionary relationship
would occur for proteins with sequence identity well-below 20%.
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The 3D structures of PLP-dependent enzymes were also analyzed to ascertain the
reliability of using structures of distantly related proteins to generate a functional
evolutionary model. Figure 5a-b illustrates the resulting histogram and heat map of the
pairwise structural alignments of the 204 PLP-dependent enzymes. The histogram shows
a bimodal distribution of TM-align scores. TM-align scores greater than 0.5 are
consistent with two proteins sharing the same CATH or SCOP fold. Correspondingly, the
~0.6 TM-align scores occur for PLP-dependent enzymes within the same fold-type.
Conversely, the lower TM-align scores result from comparisons between fold-types.

Figure 4: Sequence identity histogram and heat map. (A) A histogram of the percent
similarity matrix representing 204 PLP-dependent protein sequences. The entire
similarity matrix was analyzed in 0.2% intervals to generate the plot. (B) A heat map of
the percent similarity matrix used in (A). The white to red coloring of the heat map
corresponds to the percent similarity and color gradient in (A). The order of the
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sequences is the same as in Table S1 and the associated network map is illustrated in
Figure S1.

Figure 5: Structural alignment histogram and heat map. (A) A histogram of the
pairwise TMalign scores for the 204 PLP-dependent proteins in the dataset. The entire
symmetrical score matrix was evaluated in 0.002 intervals to produce the plot. (B) A heat
map of the corresponding TMalign score matrix used in (A). The white to red coloring
scheme of the heat map corresponds to the score and gradient in the respective histogram.
The order of the sequences is the same as in Table S1 and the associated network map is
illustrated in Figure S2.

The associated heat map of TM-align scores clarifies this point; high TM-align scores are
clustered by fold-type. Although structural alignments are able to separate the fold-types
and determine proper PLP-dependent enzyme membership within a fold-type, the global
structural information is not sensitive enough to cluster the PLP-dependent enzymes
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based on function. In essence, the global structural similarity between enzymes within
a fold-type over-whelms any subtle differences related to functional divergence.
Similarly, the large structural differences between fold-types negate any local similarities
that may be present due to a common functional ancestor.

2.3.7 Comparison of Type-I Transaminase Active Sites
The evolutionary network based on active site similarity depicted in Figure 1 identified
acetylornithine (ACO) transaminase (EC 2.6.1.11, PDB ID: 2ORD) and a γ-aminobutyric
acid (GABA) transaminase (EC 2.6.1.19, PDB ID: 1OHW) as nearest neighbors in the
network. Both enzymes correspond to fold-type I and are located in cluster 1, but the
enzymes have different EC numbers and substrate specificity. Thus, the active sites were
compared in order to reveal structural change(s) that contribute to the different substrate
specificities that led to a functional divergence (Figures 6a-b). The goal was to further
explore the validity of the phylogenetic network based on CPASS similarity scores to
provide insights on the pathway of functional evolution. Further pairwise comparisons
were also made with enzymes from functional clusters 4a and 4b in order to show a
progressive, step-wise transition of one active site structure to the next. An aspartate
(Asp) transaminase belonging to functional cluster 4b (EC 2.6.1.1, PDB ID: 1ARG) was
overlaid with the GABA transaminase to show the active site structural change between
functional clusters (Figures 6b, d). The final comparison between the Asp transaminase
and a tyrosine (Tyr) transaminase (EC 2.6.1.5, PDB ID: 3DYD) was undertaken to show
the active site differences between functional clusters 4b and 4a as well as the structural
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changes necessary to accommodate the larger substrate (Figures 6c-d).

Figure 6: Side by side alignment of ACO, GABA, Asp, and Tyr transaminase active
sites. (A) The active site of 2ORD, an ACO transaminase. Circled in red is the threonine
residue that stabilizes the substrate (not shown) in the active site. (B) The active site of
1OHW, a GABA transaminase. The red circle indicates the position of the asparagine
residue relative to the position of the threonine residue from (A). (C) The active site of
3DYD, a Tyr transaminase. Indicated in the red triangle is the conserved tyrosine residue
relative to the position of the asparagine residue in (D). (D) The active site structure of
1ARG, an Asp transaminase. The red box indicates the addition of a tyrosine residue in
the active site relative to the GABA transaminase active site in (B).
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2.4 Discussion
Sequence and structural homology models are typically used to infer descent from a
common ancestor – molecular evolution. Many examples of protein evolution have been
constructed based solely on sequence information. The advent of computational
algorithms based on probability theory has provided a powerful means for inferring
sequence homology and evolutionary relationships.52, 53 However, these methods
encounter difficulties when dealing with very divergent sequences. At low sequence
identity, the incorporation of gaps for a suitable alignment may produce results that are
not genuine.54 The spatial arrangement of local structures begins to define the function of
a protein and represents an important, but distinct, evolutionary signal – functional
evolution.23 Several methods have been developed that use structural templates to help
guide and ultimately improve the alignment of divergent sequences.55, 56 Conversely,
when both sequence and structure are divergent these methods become less reliable.51
Critically, while molecular evolution and functional evolution are related, they proceed
through distinctly different mechanisms.1, 2, 20 Correspondingly, different approaches are
needed to measure the evolution of homologous proteins across multiple species
compared to investigating the evolutionary relationship of various protein functions.
Thus, instead of applying global sequence similarities to infer an evolutionary
relationship between distantly related proteins, investigating functional evolution requires
a targeted approach by analyzing the sequence and structural characteristics of functional
epitopes or protein active sites.
The CPASS software and database was initially designed to functionally annotate novel
proteins based on ligand defined active site structures and to act as a complement to drug
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15, 33

discovery programs.

CPASS finds the optimal sequence and structural alignment

between two active sites, exclusive of sequence connectivity, and returns a similarity
score. It was found that CPASS could effectively group and annotate proteins that bound
the same ligand based on specific function.15 Further analysis of the results led to the
hypothesis that CPASS may also infer an evolutionary relationship based on function
since active site structure and geometry is primarily functionally dependent. CPASS
does, however, have an inherent disadvantage since it requires a 3D structure of the
enzyme with a bound ligand.
PLP-dependent enzymes encompass a broad-range of catalytic functions and represent a
significant percentage of an organism’s genome.57 Correspondingly, PLP-dependent
enzymes are a common target for investigating protein evolution.24, 31, 32 Complicating
these analyses is the fact that PLP-dependent enzymes suffer from low sequence identity
within and between the four different fold-types.45, 58 For these very distantly related
proteins, any sequence similarity that still remains will only be found in the regions of the
proteins that evolve at a significantly slower rate (functionally important) rather than over
the entire sequence length. The incorporation of additional sequence information, which
is not associated with these functionally conserved regions, is likely to negatively impact
a global analysis. Instead, CPASS presents an alternative approach to investigate the
functional evolution of PLP-dependent enzymes by restricting the analysis to the
conserved, functionally relevant active site sequence and structure. A total of 204 PLPdependent enzymes had a structure deposited in the RCSB PDB34 that contained a bound
PLP and could be used for a CPASS analysis of functional evolution.
The results from the CPASS analysis of the PLP-dependent enzymes agree with previous
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findings that the enzymes developed from four different fold-types in the last universal
ancestor (Figure 1). CPASS further clustered the enzymes together by specific function
within each of the four fold-types. Again, this is consistent with the existing functional
annotation for the PLP-dependent enzymes. It is critical to point out that the CPASS
analysis did not utilize the fold-type classification or the available functional annotation
to generate the phylogenetic network depicted in Figure 1. The network was generated
strictly based on the CPASS active site similarity scores. The fold-type classification and
functional cluster labels were simply added to the network after the fact.
Correspondingly, these results demonstrate the reliability of using enzyme active sites for
comparing distantly related proteins to infer an evolutionary and functional relationship.
Conversely, it was not possible to generate a similar function-based network for PLPdependent enzymes for the four fold types using either global sequence or structure
similarity. A network generated from sequence alignment data results in an essentially
random, nonsensical map because of the extremely low sequence alignment within and
between the fold-types (Figure S1). Similarly, a network generated from structure
homology data groups the PLP-dependent enzymes into the four fold-types, which of
course is not surprising since the fold types were defined by structure homology (Figure
S2). But, any further refinement into functional clusters or any association between the
four fold-types is, again, essentially random and irrelevant.
In order to maintain function, the active site of a protein remains highly conserved.
Similarly, as the function of an enzyme evolves to accommodate a different substrate or
catalyze a different reaction, only subtle changes in the geometry of the active site or
moderate sequence substitutions, deletions or insertions are necessary. These active site
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changes are likely to occur in a slow and step-wise process utilizing the same
mechanisms that drive overall molecular evolution. Maintaining an active site change
will depend on how the new (if any) enzymatic activity is contributing to cell fitness. In
essence, a sequential path from one active site to another is expected where the observed
sequence and structural changes directly contribute to the functional differences between
the enzymes. This is exactly what was observed in the CPASS derived phylogenetic
network. Nearest neighbors identifies subtle differences in active site sequences and
structures that occur as the enzymatic activity and substrate specificity diverges. In effect,
these changes identify an evolutionary path for the divergence of enzyme function. As an
example, ACO transaminase, GABA transaminase, L-tyrosine transaminase, and
aspartate transaminase are fold-type I enzymes belonging to clusters 1, 1, 4a, and 4b,
respectively, in our CPASS-based network (Figures 1 and 2).
A direct comparison between the ACO and GABA transaminase active site structures
identified a single amino acid substitution from a threonine to an asparagine, respectively,
at the entrance to the active site (Figures 6a-b). A MSA of several ACO transaminase
enzymes further verifies that a serine/threonine is conserved at this position (Figure 7a).
The serine/threonine is most likely necessary to stabilize the larger ACO ligand through
the formation of additional hydrogen bonds. Previous work has recognized the function
of the conserved serine/threonine,59, 60 but has not identified the residue as being a
primary difference between ACO and GABA transaminases. Conversely, a MSA of
GABA transaminases confirms the presence of a conserved glycine/asparagine at the
entrance to the binding pocket (Figure 7b).
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Figure 7: MSAs of ACO, GABA, Asp, and Tyr transaminases. Segments of individual
MSAs from ACO (A), GABA (B), Asp (C), and Tyr (D) transaminases. Each segment
highlights a conserved residue corresponding to the active sites in Figure 7. PDB IDs of
the selected enzymes are on the far right of the alignment.

A small amino-acid at this location may open-up the binding pocket and/or increase
flexibility, which, in turn, may lead to substrate promiscuity.57 Thus, the
glycine/asparagine to serine/threonine substitution may simply reduce substrate
promiscuity and increase the selectivity to ACO. Inspection of the differences between
the GABA and Asp active sites reveals the addition of a Tyr side chain in the active site
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of the Asp transaminase (Figures 6b, d). The hydroxyl group on the Tyr side chain is
known to stabilize the internal aldimine between the PLP cofactor and the catalytic lysine
at physiological pH and to increase the kcat for the reaction in Asp transaminases.61
Binding pocket hydrophobicity is also increased by the presence of the Tyr side chain,
which may explain the moderate affinity of Asp transaminases for aromatic amino
acids.62 Importantly, ACO and GABA transaminases substitute a smaller glutamine
residue to hydrogen bond with the cofactor.59, 63 A MSA of several Asp transaminases
from functional clusters 4a and 4b shows that the Tyr residue is highly conserved (Figure
7c). Lastly, the progression from an Asp to Tyr transaminase follows a spatial
substitution of Asn to Tyr as opposed to a sequence substitution. The Tyr at the entrance
of the binding pocket fulfills the same role as the Asn by forming hydrogen bonds with
the PLP phosphate group. However, the effects of the spatial rearrangement are twofold.
Mutation of the Asn in Asp transaminases removes a coordinated water molecule from
the binding pocket to make room for aromatic substrates,64 and the presence of the Tyr
side chain increases the hydrophobicity of the active site.62 Therefore, a single spatial
substitution can greatly change the affinity for certain substrates in Type-I enzymes. An
MSA of five Tyr transaminases confirms the conservation of the Tyr residue in the active
site (Figure 7d)
CPASS recognized these subtle, sequential changes that occurred between these four,
nearest-neighbor active sites while also acknowledging the overall active site similarity.
This enabled the close grouping of the ACO transaminase, GABA transaminase, Ltyrosine decarboxylase, and aspartate aminotransferase within the same functional
cluster; and, importantly, the identification of a clear evolutionary path to achieve the
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observed substrate and functional divergence.

2.5 Conclusion
PLP-dependent enzymes have been a common target of molecular evolution studies, but
prior efforts have been limited to small subgroups due to the low sequence identity within
each fold-type and across all PLP-dependent enzymes.24, 31, 32 Instead, we have
demonstrated the first phylogenetic network based on functional evolution to model all
PLP-dependent fold-types together on a single network. We were able to correctly cluster
all the PLP enzymes into their previously assigned fold-type simply based on the
sequence and structure similarity of the PLP-binding site. Furthermore, the enzymes
clustered based on their EC numbers within each fold-type cluster. Our CPASS-derived
functional network allowed us to follow the step-wise evolution of substrate specificity
and catalytic activity. Effectively, nearest neighbors in the CPASS-derived functional
network were related by single-amino-acid changes for highly-conserved active site
residues. It was not possible to achieve a similar network using either global sequence or
structure similarity. Thus, the study herein successfully determined an evolutionary
relationship based on function between many diverse and highly divergent PLPdependent enzymes using the available active site structures. Also, our results clearly
verifies that CPASS is an effective approach for identifying an evolutionary relationship
based on function using similarities in active site structure and sequence.
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2.7 Supplemental Figures and Tables

Supplemental Figure 1: Sequence based network analysis of PLP-dependent
enzymes. A phylogenetic network of 204 PLP-dependent enzymes with ligand defined
active sites in the PDB. The red, yellow, green, and blue markers indicate enzymes
belonging to fold-types I, II, III, and IV, respectively. The network was built using a
MSA from Clustal Omega and the Neighbor-net algorithm.
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Supplemental Figure 2: Structure based network analysis of PLP-dependent
enzymes. A phylogenetic network of 139 PLP-dependent enzymes with ligand defined
active sites in the PDB. The network was built using pairwise TMalign scores and the
Neighbor-net algorithm. Red, yellow, green, and blue regions correspond to fold-types I,
II, III, and IV, respectively.
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Fold-type
I

Cluster
1

PDB
2JJG
1OHW
1SZS
4ATP
2PB0
2ORD
4ADB
2EH6
1VEF
4NOG
1OAT
2YKY
4AO9
4GSA
3K28
3DXV
4A6T
3I5T
3TFT
1MLY
4A0R
3DU4
3A8U
2EO5
1Z3Z

EC
2.6.1.36
2.6.1.19
2.6.1.19
2.6.1.19
2.6.1.11
2.6.1.11
2.6.1.81
2.6.1.11
2.6.1.11
2.6.1.13
2.6.1.13
2.6.1
2.6.1
5.4.3.8
5.4.3.8
5.1
2.6.1.62
2.6.1
2.6.1.62
2.6.1.62
2.6.1.62
2.6.1.62
2.6.1.18
2.6.1.19
4.1.1.64

Organism
M. tuberculosis
S. scrofa
E. coli
A. aurescens
S. typhimurium
T. maritima
E. coli
A. aeolicus
T. thermophilus
T. gondii
H. sapiens
Mesorhizobium sp.
V. paradoxus
Synechococcus sp.
B. anthracis
A. obae
C. violaceum
R. sphaeroides
M. tuberculosis
E. coli
A. thaliana
B. subtilis
P. putida
S. tokodaii
B. cepacia

Domain
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria
Archaea
Bacteria

I

2

1BJO
3E77
3QBO
2BI3
1W3U
3VOM
3IMZ
2YOB
2YRR
2DR1
3ZRP
1VJO
3ISL
1M32

2.6.1.52
2.6.1.52
2.6.1.52
2.6.1.52
2.6.1.52
2.6.1.52
2.6.1.44
2.6.1.44
2.6.1
2.6.1.51
2.6.1.51
2.6.1.44
2.6.1.44
2.6.1.37

E. coli
H. sapiens
Y. pestis
B. alcalophilus
B. alcalophilus
M. tuberculosis
H. sapiens
H. sapiens
T. thermophilus
P. horikoshii
S. solfataricus
Nostoc sp.
B. subtilis
S. typhimurium

Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota
Bacteria
Bacteria
Archaea
Bacteria
Bacteria
Bacteria

I

3

1C7G
1N8P
3COG
1IBJ

4.1.99.2
4.4.1.1
4.4.1.1
4.4.1.8

E. herbicola
S. cerevisiae
H. sapiens
A. thaliana

Bacteria
Eukaryota
Eukaryota
Eukaryota

56
1I43
1PG8
1E5F
3NMY
3NNP
4L0O
2CTZ

2.5.1.48
4.4.1.11
4.4.1.11
4.4.1.1
4.4.1.1
2.5.1.48
2.5.1

N. tabacum
P. putida
T. vaginalis
X. oryzae
X. oryzae
H. pylori
T. thermophilus

Eukaryota
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria

I

4a

2X5F
1LK9
1XI9
1V2E
1U08
1O4S
1DJU
3EI8
4FL0
3IF2
2O1B
2X5D
2ZY2
2ZY4
3DYD
1B5P
1J32
3ELE
1WST
1VP4
2ZP7
4JE5
3PPL
3IHJ
1IAX
1LKC
1GEW
1H1C
3LY1
1B8G
1D2F
3B1C
3L8A
1C7N
4DQ6
3KAX

2.6.1
4.4.1.4
2.6.1
2.6.1.15
2.6.1.88
2.6.1.1
2.6.1.57
2.6.1.83
2.6.1
2.6.1
2.6.1.1
2.6.1
2.6.1.1
2.6.1.1
2.6.1.5
2.6.1.1
2.6.1.1
2.6.1
2.6.1
2.6.1
2.6.1.39
2.6.1.39
2.6.1.1
2.6.1.2
4.4.1.14
4.1.1.81
2.6.1.9
2.6.1.10
2.6.1.9
4.4.1.14
4.4.1.8
4.4.1.8
4.4.1.8
4.4.1.8
2.6.1
4.4.1

S. aureus
A. sativum
P. furiosus
T. thermophilus
E. coli
T. maritima
P. horikoshii
A. thaliana
A. thaliana
P. arcticus
S. aureus
P. aeruginosa
Pseudomonas sp.
A. faecalis
H. sapiens
T. thermophilus
P. lapideum
E. rectale
T. profundus
T. maritima
T. thermophilus
S. cerevisiae
C. glutamicum
H. sapiens
S. lycopersicum
S. enterica
E. coli
T. maritima
P. atrosepticum
M. domestica
E. coli
S. anginosus
S. mutans
T. denticola
C. difficile
B. anthracis

Bacteria
Eukaryota
Archaea
Bacteria
Bacteria
Bacteria
Archaea
Eukaryota
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Archaea
Bacteria
Bacteria
Eukaryota
Bacteria
Eukaryota
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

I

4b

1ASF

2.6.1.1

E. coli

Bacteria

57
1AY5
3TAT
2CST
3II0
3MEB
1YAA
8AAT
4EMY

2.6.1.57
2.6.1.57
2.6.1.1
2.6.1.1
2.6.1.1
2.6.1.1
2.6.1.1
2.6.1

P. denitrificans
E. coli
G. gallus
H. sapiens
G. lamblia
S. cerevisiae
G. gallus
A. prevotii

Bacteria
Bacteria
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Bacteria

I

5

2Z67
2E7J
1WYU
3RBF
1JS3
4E1O
1C4K
2JIS
2DGK
1KMJ
4LW4
1T3I
1EG5
3LVM
3VAX
3A9X
3F9T
4EB5

2.9.1.2
2.5.1.73
1.4.4.2
4.1.1.28
4.1.1.28
4.1.1.22
4.1.1.17
4.1.1.29
4.1.1.15
4.4.1.16
4.4.1.16
2.8.1.7
2.8.1.7
2.8.1.7
2.8.1.7
4.4.1.16
4.1.1.25
2.8.1.7

M. maripauldis
A. fulgidus
T. thermophilus
H. sapiens
S. scrofa
H. sapiens
Lactobacillus sp.
H. sapiens
E. coli
E. coli
E. coli
Synechocystis sp.
T. maritima
E. coli
S. lividans
R. norvegicus
M. jannaschii
A. fulgidus

Archaea
Archaea
Bacteria
Eukaryota
Eukaryota
Eukaryota
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Archaea
Archaea

I

6

2WK8
2BWO
3TQX
1DJE
3A2B
3G8M
1BJ4
1RVU
2DKJ
4OTL

2.3
2.3.1.37
2.3.1.29
2.3.1.47
2.3.1.50
2.1.2.1
2.1.2.1
2.1.2.1
2.1.2.1
2.1.2.1

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota
Bacteria
Bacteria

2VMO
4BHE

2.1.2.1
2.1.2.1

V. cholerae El Tor
R. capsulatus
C. burnetii
E. coli
S. multivorum
E. coli
H. sapiens
O. cuniculus
T. thermophilus
B. cenocepacia
G.
stearothermophilus
M. jannaschii

3NYS
1B9H
2C7T
3BB8

2.6.1.98
2.6.1
2.6.1
2.6.1

P. aeruginosa
A. mediterranei
B. circulans
Y. pseudotuberculosis

Bacteria
Bacteria
Bacteria
Bacteria

I

7

Bacteria
Archaea

58
1MDX
2FNI
1O61
2HZP
1QZ9

2.6.1.87
2.6.1.92
unknown
3.7.1.3
3.7.1.3

S. typhimurium
H. pylori
C. jejuni
H. sapiens
P. fluorescens

Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria

II

8

1J0E
1J0A

3.5.99.7
3.5.99.7

C. saturnus
P. horikoshii

Eukaryota
Archaea

II

9

3DWI
1WKV
2JC3
3PC2
4L28
3BM5
3VBE
2ECO
1OAS
4AEC
2ISQ
3ZEI

2.5.1.65
2.5.1.47
2.5.1.47
4.2.1.22
4.2.1.22
2.5.1.47
2.5.1.47
2.5.1.47
2.5.1.47
2.5.1.47
2.5.1.47
2.5.1.47

M. tuberculosis
A. pernix
S. typhimurium
D. melanogaster
H. sapiens
E. histolytica
G. max
T. thermophilus
S. typhimurium
A. thaliana
A. thaliana
M. tuberculosis

Bacteria
Archaea
Bacteria
Eukaryota
Eukaryota
Eukaryota
Eukaryota
Bacteria
Bacteria
Eukaryota
Eukaryota
Bacteria

II

10

1KFC
1WDW
3SS9
1WTC
3HMK
2D1F
1UIM
2ZSJ
1KL7
4F4F
1VE5
1TDJ
2RKB
1P5J

4.2.1.20
4.2.1.20
4.3.1.18
4.3.1.17
4.3.1.17
4.2.3.1
4.2.3.2
4.2.3.1
4.2.3.1
4.2.3.1
4.3.1.19
4.3.1.19
4.3.1.17
4.3.1.17

S. typhimurium
P. furiosus
E. coli
S. pombe
R. norvegicus
M. tuberculosis
T. thermophilus
A. aeolicus
S. cerevisiae
B. melitensis
T. thermophilus
E. coli
H. sapiens
H. sapiens

Bacteria
Archaea
Bacteria
Eukaryota
Eukaryota
Bacteria
Bacteria
Bacteria
Eukaryota
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota

III

11

3N29
2J66
1KNW
2YXX
3N2O
3NZP
1TWI
1HKV
2NV9

4.1.1.96
4.1.1.95
4.1.1.20
4.1.1.20
4.1.1.19
4.1.1.19
4.1.1.20
4.1.1.20
4.1.1.19

C. jejuni
B. circulans
E. coli
T. maritima
V. vulnificus
C. jejuni
M. jannaschii
M. tuberculosis
P. bursaria Chlorella

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Archaea
Bacteria
Virus
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III

IV

12

13

2OO0
1F3T
2QGH

4.1.1.17
4.1.1.17
4.1.1.20

1CT5
1W8G
3R79
3CO8
4BF5
4BEQ
1RCQ
3B8W
4A3Q
3E5P

5.1.1.1
5.1.1.1
unknown
5.1.1.1
5.1.1.1
5.1.1.1
5.1.1.1
5.1.1.1
5.1.1.1
5.1.1.1

1SFT
1XFC
2DY3
1VFH
1I2K
2XPF
2Y4R
4K6N
2ZGI
3CSW
4DAA
4CMD
4CHI
2EJ3
1I1M
3UZO
3DTH
3DTG
2HGX
2COG

virus
H. sapiens
T. brucei
H. pylori

Eukaryota
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria

5.1.1.1
5.1.1.1
5.1.1.1
5.1.1.1

S. cerevisiae
E. coli
A. fabrum
O. oeni
A. hydrophilia
V. cholerae
P. aeruginosa
E. coli
S. aureus
E. faecalis
G.
stearothermophilus
M. tuberculosis
C. glutamicum
S. lavendulae

4.1.3.38
4.1.3.38
4.1.3.38
4.1.3.38
4.1.3.38
2.6.1.42
2.6.1.21
2.6.1.42
2.6.1.42
2.6.1.42
2.6.1.42
2.6.1.42
2.6.1.42
2.6.1.42
2.6.1.42
2.6.1.42

E. coli
P. aeruginosa
P. aeruginosa
S. cerevisiae
T. thermophilus
T. maritima
Bacillus sp.
N. haematococca
A. fumigatus
T. thermophilus
E. coli
D. radiodurans
M. smegmatis
M. smegmatis
H. sapiens
H. sapiens

Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota
Bacteria
Bacteria
Bacteria
Bacteria
Bacteria
Eukaryota
Eukaryota

Bacteria
Bacteria
Bacteria
Bacteria

Supplemental Table 1: PLP-dependent enzymes selected for active site evolution
analysis. A table of the 204 PLP-dependent enzymes used in this study annotated by
PDB ID. Enzymes are grouped by fold-type and then by functional cluster in the network
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analysis. The enzyme classification number, organism, and domain are also listed for
each enzyme.
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Chapter 3
Functional Evolution of Proteins
3.1 Introduction
A functional clustering of ligand-defined active sites in the RCSB Protein Data Bank
(RCSB PDB)1 was undertaken to infer an evolutionary lineage of enzymatic function.
Sequence based phylogenetic methods are typically utilized to produce evolutionary tree
structures.2 This is possible because molecular evolution occurs through random
mutations at a constant rate.3 Nevertheless, the reliability of sequence-based evolutionary
measurements becomes suspect when protein sequence homology enters the “twilightzone” and falls below 25% sequence identity.4 Simply, the accuracy of a phylogenetic
tree is directly dependent on the accuracy of the sequence alignment, which becomes
undependable at low sequence identity.5, 6 Therefore, due to the large sequential
dissimilarity for the entirety of proteins deposited in the RCSB PDB, sequence-based
evolutionary methods are not easily or reliably employed across an all-inclusive set of
protein functional classes.
Structure-based alignment is an alternative to sequence based alignments, especially
considering the tremendous reduction in structure space relative to sequence space.
Recent estimates suggest that only a few-thousand distinct protein folds exists,7, 8 which
is consistent with the 1391 protein topologies currently identified by CATH.9
Nevertheless, the alignment of protein structures is even more challenging than sequence
alignment, and fails for completely dissimilar structures.8 Like sequence, the arrangement
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of tertiary structures is extremely evolutionarily labile when considering the entirety of
known protein functions. While global protein sequence and structure may drift without
detrimental consequences, dramatic changes to an active site or functional epitope of a
protein may negatively impact the survivability of an organism. Instead, functional
evolution progresses slowly through gene duplication and functional drift to avoid
negative influence on cellular fitness.10, 11 This occurs because even minor changes in the
spatial orientation or amino acid composition within an active site may lead to dramatic
changes in substrate and reaction specificity. Consequently, protein active sites mutate at
a much slower rate relative to other structural elements and remain highly conserved over
time.12 In effect, a similarity in protein active sites may remain even though the overall
sequence or structure of a protein has completely diverged. Thus, it may be possible to
infer an evolutionary relationship based on similarities in protein active sites in situations
when global sequence or structure similarities no longer exist.
Several methods and databases have been previously published describing the clustering
of proteins from the RCSB PDB. These include sequence,13 structure,14 ligand
conformation,15 atomic properties,16 and putative cavity17 based approaches. However, a
clustering and subsequent phylogenetic analysis based on ligand-defined active sites has
not been done. The Comparison of Protein Active site Structures (CPASS) software and
database compares the geometry and amino acid similarity between pairs of
experimentally determined ligand-defined active sites. CPASS is distinctly different from
protein cavity approaches because it focuses on known binding sites rather than putative
pocket detection. Further, substrate conformation is only used in the determination of
active site residues and not in the CPASS scoring function. Consequently, the
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evolutionary analysis of proteins in the RCSB PDB based on active site similarity is a
novel approach.
We previously demonstrated the utility of CPASS to decipher the functional evolution of
proteins by comparing the active sites of 204 PLP-dependent enzymes.18 We produced
the first-ever phylogenetic tree that contained all four families or fold-types (I to IV) for
PLP-dependent enzymes. The resulting phylogenetic tree correctly distinguished between
the four individual folds and further sorted the enzymes by substrate specificity and
function. Critically, no functional information was utilized to produce the phylogenetic
tree of PLP-dependent enzymes, yet the enzymes were clustered perfectly based on EC
number (i.e., branches were comprised of enzymes with the same EC number).
Furthermore, examining individual branches of the phylogenetic tree illustrates the stepwise evolution of function through a series of single amino-acid substitutions. In effect,
nearest neighbors in the CPASS derived phylogenetic tree identified subtle differences in
active site sequences and structures that led to changes in enzymatic activity and
substrate specificity. Importantly, we were able to produce a phylogenetic tree for the
PLP-dependent enzymes despite sequence identity well-below 20% and poor structural
alignments between folds (TM-align19 score of ~ 0.3).
Based on this prior success, we expanded upon the phylogenetic tree of PLP-dependent
enzymes by using CPASS to functionally cluster all ligand-containing proteins present in
the RCSB PDB. In essence, CPASS was used to produce a phylogenetic tree containing
essentially all protein functional classes present in the RCSB PDB. CPASS was used to
make a pair-wise comparison between all of the ligand-defined binding sites within the
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RCSB PDB to produce an all-versus-all CPASS similarity score matrix. The proteins
were then clustered by the identity of the bound ligand. Principal component analysis of
the CPASS scores was employed to identify a representative structure for each functional
class (i.e., same ligand and EC number) in order to reduce the overall size of the dataset.
The representative structure for each functional class was then successfully modeled into
a single phylogenetic tree based on the CPASS similarity score matrix. The resulting
phylogenetic tree demonstrates the functional evolution across all of the protein
functional classes within the RCSB PDB. To further illustrate the effectiveness of our
approach, we also highlight two specific regions of the phylogenetic tree that demonstrate
the stepwise substrate and enzymatic evolution of fructose-6-phosphate (F6P) bound
active sites.

3.2 Methods
3.2.1 Active site Structure Comparison
Protein structures with ligand defined active sites were collected from the Protein Data
Bank20 and subjected to an all versus all comparison using CPASS.21, 22 CPASS scores
were subsequently converted to relative distances by subtracting from 100% CPASS
similarity. The distance matrix, due to size and computational constraints, was divided
into smaller matrices based on bound ligand. Principal component analysis was applied to
the smaller ligand defined matrices using MVAPACK23 where functional clusters were
generated based on Enzyme Commission (EC) number.24 For each EC number cluster, a
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95% confidence ellipse was calculated which was used to find the representative active
site with the shortest Euclidean distance to its center. A total of 3996 representative
active sites were found and utilized in the remainder of this study.

3.2.2 Phylogenetic Analysis of Representative Active sites
The CPASS distance matrix for the representative active sites was input into FastME for
tree generation using the Neighbor-join algorithm.25 Briefly, the neighbor-join algorithm
joins the two closest taxa or nodes in the distance matrix and creates a new node, which
has recalculated distances to the remaining taxa and nodes. Multiple iterations of this
process build the tree until only a pair of nodes remains. Identification and investigation
of the resulting tree structure was accomplished through visual inspection using the
Interactive Tree of Life online tool.26

3.2.3 Active site Overlays
From the CPASS representative dataset and tree, 8 enzymes were selected for additional
investigation. Structural and sequential differences between the active sites of the
enzymes (PDB IDs: 1DLJ, 1DLI, 2O2D, 1MV8, 2P3V, 1LBY, 1JP4, 1KA1) were
elucidated by visual inspection using Chimera.27 In each case, residues were considered
to be in the active site based on their relative proximity to the bound ligand in their
respective crystal structure (6Å). The orientation of the active sites relative to one another
was also determined by CPASS, as a standard 3D overlay of the tertiary structures would
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result in misalignment of the active sites.

3.3 Results
3.3.1 Functional Clustering and Principal Component Analysis of Ligand Defined Active
sites
The Comparison of Protein Active site Structures (CPASS) software and database
(http://cpass.unl.edu/) was used to compare all protein active sites from the RCSB PDB
that contained a bound ligand. CPASS performs a pairwise comparison between two
protein active sites, where active site residues were determined based on a defined
distance to the bound ligand (6Å). CPASS similarity scores are determined by similarities
in both amino acid composition and by the relative amino acid positions between the two
compared active site. An “all versus all” distance matrix derived from CPASS similarity
scores was initially calculated for all of the ligand defined active sites in the RCSB PDB.
The protein structures were then clustered based on the identity of the bound ligand in
order to create function specific protein groupings and to reduce the size of the dataset. A
total of 169 protein function groups were created based on a shared identity of the bound
ligand. Consequently, a total of 169 principal component analyses (PCA) were then
performed using our MVAPACK23 software for each of these ligand defined protein
groups. Group membership within the PCA scores plot was further defined by Enzyme
Commission (EC)24 number and demarcated by a 95% confidence ellipse. A
representative example of a PCA scores plot for the collection of fructose-6-phosphate
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(F6P) bound active sites is shown in Figure 1. There are 7 different enzymatic
functional classes (EC numbers: 2.7.1.105, 2.7.1.11, 3.1.3.11, 3.1.3.25, 3.5.1.25, 5.3.1.8,
and 5.3.1.9) and one unannotated group in the PCA scores plot.

Figure 1. The PCA scores plot of a CPASS distance matrix for fructose-6-phosphate
bound proteins. Active sites are clustered by Enzyme Commission number, which refers
to a specific function. Ellipses correspond to the 95% confidence intervals for each of the
functional clusters (colored) and the dataset (black).
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3.3.2 Structural Representatives of Functional Classes
The PCA scores plots were leveraged to find a representative protein structure for each
functional class based on EC number the type of bound ligand. For each functional class
in the PCA scores plot, the protein active site with the shortest Euclidean distance to the
center of the 95% confidence ellipse was chosen as a representative structure. Again, the
95% confidence ellipse defines the membership for a given functional class. Accordingly,
the selected protein active site should have a high CPASS similarity score or a small
variance relative to the other protein active sites in the functional class. In effect, the
selected protein active site is expected to serve as a structural “average” for the functional
class. In total, the 169 PCA score plots identified a representative structure for 3996 EC
functional classes.

3.3.3 Phylogenetic Analysis
A phylogenetic analysis was conducted using a distance matrix based on CPASS
similarity scores for the 3996 protein active sites. The phylogenetic analysis used the
neighbor-join algorithm and the resulting phylogenetic tree is shown in Figure 2. The
phylogenetic tree is shown in a circular display with leaves colored according to the
function defined by the first EC number [oxidoreductases (red), transferases (blue),
hydrolases (yellow), lyases (green), isomerases (purple), ligases (orange), not annotated
(black)]. Importantly, the functional classification was not used as part of the
phylogenetic analysis. Instead, the resulting phylogenetic tree was simply annotated with
the known functional classifications.
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Figure 2. A phylogenetic tree of 3996 representative CPASS active sites from the RCSB
PDB is presented. The phylogenetic tree highlights the functional evolutionary
relationships between protein active site structures. Leaves are colored according to the
first EC number of the annotated active site (1: oxidoreductases, red; 2: transferases,
blue; 3: hydrolases, yellow; 4: lyases, green; 5: isomerases, purple; 6: ligases, orange; not
annotated: black).
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3.4 Discussion
Herein, we report the first functional clustering and evolutionary analysis of the entirety
of proteins deposited in the RCSB PDB with a bound ligand. A functional evolution was
based on active site similarities determined by our CPASS software and database. Protein
active sites were first divided into functional classes based on the type of bound ligand.
PCA of the CPASS similarity scores was then used to visualize the relative similarities of
the functional class membership. The resulting PCA scores plot was then annotated with
EC numbers and the 95% confidence ellipses (Figure 1) were used to define the
membership of each functional class within the scores plot.
PCA has been extensively used in chemometrics and various ‘omics’ fields for
fingerprint analysis.28 In this study, PCA was used to reduce the variance within each
functional class while also reducing the size of the dataset used for the phylogenetic
analysis. The PCA scores plot for the collection of F6P bound active sites (Figure 1)
yielded several important observations. First, a number of the 95% confidence ellipses
partially overlap in the PCA scores plot. This suggests that there are structural elements
that remain consistent within the active site even though the enzymatic functions vary
considerably. Second, a complete separation of two functional classes would indicate that
the active sites have either diverged significantly over time or have converged to act upon
the same substrate. An evolutionary drift is also apparent when considering the shape and
positions of the ellipses in the scores plot. The various clusters appear to drift away from
the center of the scores plot. Assuming the center of the PCA scores plot is the structural
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average of all active sites bound to a ligand, the movement of an ellipse or active site
toward or away from the center would indicate convergent or divergent evolution,
respectively. In effect, the substrate specificity and/or enzymatic activity is diverging as
the enzyme moves away from the center of the scores plot or converging as it moves
towards its center.
The resulting scores plot also suggests that a combination of CPASS and PCA may be a
useful approach for annotating functionally unclassified or hypothetical proteins. For
example, the PCA scores plot of the active sites bound to F6P contained a functionally
unannotated class of proteins. While the 95% confidence ellipse for this unannotated
class was understandably broad (presumably because it contains different functions),
individual proteins were found to be near or within other functional classes suggesting
possible annotation(s) (Table 1). Furthermore, proteins found within the intersection of
two or more ellipses may suggest a bi-functionality or a functionally promiscuous active
site.

Table 1.
PDB ID:
Nearest EC Clustera
1UXR
3.5.1.25
2R66
3.5.1.25
3BXH
5.3.1.8
3PR3
5.3.1.9
3PT1
5.3.1.8
a
Shortest Euclidean distance to the center
of the 95% confidence ellipse
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In this study, PCA was primarily utilized to identify a representative protein structure
for each functional class. Simply, the protein structure closest to the center of each ellipse
was identified as the representative active site for the functional class. For example, a
total of eight protein structures were identified from the PCA scores plot of the F6P
bound active sites shown in Figure 1. This corresponds to one protein representative for
each of the seven EC functional classes and one protein for the single unannotated class.
In this manner, PCA allowed for a drastic reduction in the size of the dataset to about
10% of its initial size. Consequently, a distance matrix was generated from an all-vs-all
comparison of the 3996 representative protein active sites from each functional class. The
matrix of CPASS similarity scores were then subjected to the neighbor-join algorithm for
a phylogenetic analysis (Figure 2). The resulting phylogenetic tree captures the stepwise
functional evolution of essentially all of the protein functional classes present in the
RCSB PDB.
Protein active sites are paired together in the tree according to enzymatic function, which
was also seen in our previous study of PLP-dependent enzymes.18 The structure and
amino-acid composition of a protein active site is typically highly conserved in order to
maintain function and retain cellular fitness. Thus, functional evolution of a protein
progresses slowly and likely follows a step-wise process of single-amino substitutions
that also involves gene duplication. The process proceeds until a new function or
substrate specificity is achieved. Importantly, this step-wise evolution of function is
clearly evident in our phylogenetic tree of protein active sites. Nearest-neighbors, even
those from different organisms, have very subtle differences in active site structures
and/or sequence. Simply, as an active site progresses towards the next node, a change in
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substrate specificity or enzymatic activity may result from a few amino-acid
substitutions and/or minor conformational change (Figures 4, 5). Interestingly, while
nearest neighbors share similar function, an overall view of the functional distribution
throughout the entire phylogenetic tree is much more complex and diverse. This is
apparent from the relatively random distribution of color throughout the phylogenetic
tree, where leaves are colored according to the first EC number for each representative
protein. The phylogenetic tree is not uniformly divided or colored into six contiguous
functional classes. Instead, there are many small pairings and subgroupings of similar
functional classes that are evenly distributed throughout the tree. This mixing of function
is likely due to multiple ancestral active site scaffolds that have evolutionarily diverged
and then expanded their biological roles. The organization of the phylogenetic tree is also
consistent with convergent evolution where distant active site architectures have slowly
mutated toward the same enzymatic function. In essence, the dramatic dispersion of color
throughout the phylogenetic tree is further evidence of the multitude of divergent and
convergent events that have occurred in the evolution of protein functions.
Two representative regions of the phylogenetic tree have been highlighted to further
illustrate the effectiveness of an evolutionary clustering of function based on CPASS
similarity scores (Figure 3). It is important to note that two branches highlighted in
Figure 3 come from distinct regions of the phylogenetic tree. Nevertheless, both branches
contain a protein active site bound to fructose-6-phosphate (F6P), where two proteins
(1LBY29 3.1.3.25, 3M5P 5.3.1.9) were representative structures identified from the PCA
scores plot displayed in Figure 1. Using these two proteins as arbitrary evolutionary
starting points, a step-wise evolution of substrate specificity and enzymatic activity is
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easily observed. The active site of 1LBY has inositol-phosphate phosphatase activity
and was found to be most similar to 2P3V,30 which shares the same function as 1LBY
(Figure 3A). An overlay of the 1LBY and 2P3V CPASS determined active sites reveals
an almost identical match in terms of both amino acid identity and geometry (Figure 4A).
This is to be expected as nearest neighbors have the closest distance (highest CPASS
similarity). Furthermore, the primary difference between the two active sites is the
identity of the bound ligand. 2P3V is bound to S,R meso-tartaric acid instead of F6P,
which was simply a result of the crystallization conditions. This outcome also
demonstrates an important feature, the robustness of CPASS to identify highly similar
active sites independent of the identity of the bound ligand.

Figure 3. Two regions of the phylogenetic tree from Figure 2 were selected for further
detailed analysis. (A) The protein active sites in this branch of the phylogenetic tree
illustrate protein functional evolution that results in changes in substrate specificity. (B)
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The protein active sites in this branch of the phylogenetic tree illustrate protein
functional evolution that results in changes in both enzymatic activity and substrate
specificity. Proteins are listed by their PDB IDs and EC functions (3.1.3.25: inositolphosphate phosphatase; 3.1.3.7: 3'(2'), 3’ phosphoadenosine-5’-phosphate phosphatase;
5.3.1.9: glucose-6-phosphate isomerase; 1.1.1.132: GDP-mannose 6-dehydrogenase;
1.1.1.22: UDP-glucose 6-dehydrogenase).
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Figure 4. Structural overlays of the active sites for (A) 1LBY (black) and 2P3V (yellow),
and (B) 1LBY (black) and 1JP4 (green). Residues are labeled by type and sequence
position with those from 1LBY in black and those from 2P3V and 1JP4 in red. Overlays
are oriented relative to the bound F6P in 1LBY with the coordinated magnesium ions
displayed in purple. Residues were chosen for the comparative analysis if they were
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within 6Å of the bound ligand and were used in the CPASS similarity scoring.

The next nearest node to 1LBY in Figure 3A includes two protein active sites (1JP431 and
1KA132) with a similar function (identical for the first three EC numbers), but that act on
different substrates. The CPASS determined active sites for 1JP4 and 1KA1 are quite
similar (not shown), where the primary difference is the identity of the bound ligand
(adenosine monophosphate vs. adenosine-3'-5'-diphosphate). In effect, these two nearestneighbor nodes (Figure 3A) contain a pair of proteins with similar functional
classification (3.1.3.25 or 3.1.3.7), but with different bound ligands in the experimental
structures deposited in the RCSB PDB. A comparison of the 1LBY active site, an
inositol-phosphate phosphatase, with 1JP4, a 3’ phosphoadenosine-5’-phosphate
phosphatase, reveals minor structural and amino acid differences between the two active
sites (Figure 4B). Since the active sites have a similar function but different substrate
specificity, the observed changes in amino acid composition and active site geometry are
most likely related to substrate binding.
The four proteins (1LBY, 2P3V, 1JP4, 1KA1) comprising this node are magnesium
dependent phosphatases, which have an evolutionarily conserved active site and
coordinate 2 to 3 metal ions.32 The metal ions specifically enable the catalytic
dephosphorylation of bound substrates and are essential to enzyme activity. Interestingly,
the metal coordination sites are strictly conserved even though the metal ions do not
participate in substrate binding. Critical to our study, the sequence identity for members
of the Mg2+-dependent superfamily is below 25%,31 which makes sequence-based
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evolutionary analysis extremely challenging and further highlights the benefits of our
CPASS approach. In fact, the CPASS analysis further confirms the high conservation of
the metal coordination site. This is apparent in the structural overlays in Figure 4. The
active site residues identified by CPASS around the coordination sites deviate very little
in position while sequence identity is absolutely maintained. Conversely, the residues
opposite the metal coordination sites, which do change between Figures 4A to 4B, are
involved in substrate recognition.
Since the active sites for 1LBY and 2P3V have the same function and act upon the same
substrate, the tyrosine (1LBY:Tyr155, 2P3V:Tyr153) and arginine (1LBY:Arg165,
Arg167, 2P3V: Arg170, Arg172) residues on the distal side of the active site relative to
the metal ions are conserved. These residues assist in the coordination of the substrate
sugar and phosphate moieties, respectively. For 1JP4, the substrate is changed to 3’phosphoadenosine 5’-phosphate (PAP), which induces spatial changes and amino-acid
substitutions in the active site (Figure 4B). Specifically a tyrosine is replaced by a
histidine (1JP4: His198) and an arginine is replaced by a threonine (1JP4: Thr195). These
amino-acid substitutions form a new hydrogen bond network around the PAP 5’phosphate moiety.31 A reorientation of the side chain of the remaining arginine creates
space to accommodate the increase in size of the PAP ligand. Interestingly, the PAP
phosphatase maintains some of its inositol 1-phosphate/fructose-1,6-bisphosphate
phosphatase activity.31 Considering how close the active sites are to one another in the
phylogenetic tree and the similarity of the active site structures, the residual enzymatic
activity is understandable.
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A similar comparative analysis of protein evolution is illustrated by examining another
branch from the phylogenetic tree (Figure 3B). Unlike the first illustrated example that
lead to an evolution of substrate specificity (Figure 3A), this branch leads to the proteins
adopting new functions in addition to changes to substrate specificities. The evolutionary
focus of this branch is the active site of 3M5P, which is a glucose-6-phosphate (G6P)
isomerase and was identified as a representative structure from the PCA scores plot in
Figure 1.
The active site of 3M5P was found to be most similar to 2O2D,33 which has the same
function as 3M5P (EC 5.3.1.9, G6P isomerases). An overlay of the two CPASS active
site structures in Figure 5A indicates near identity in regards to both amino-acid
composition and structure. Again, the only difference in these two active site structures is
the nature of the bound ligand. 3M5P is bound to F6P; whereas, 2O2D is bound to citrate.
This difference is likely just a result of differences in the crystallization buffers. Critical
residues in the active sites of 3M5P and 2O2D that are directly responsible for enzymatic
activity are a lysine (3M5P: Lys505, 2O2D: Lys571), a glutamate (3M5P: Glu346,
2O2D: Glu411), and an arginine (3M5P: Arg261, 2O2D: Arg326). These residues are
positioned directly around the substrate sugar moiety,33 facilitate proton transfer (Lysine,
Glutamate), and stabilize the intermediate structure.
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Figure 5. Structural overlays of the active sites for (A) 3M5P (black) and 2O2D (pink),
and (B) 3M5P (black) and 1DLI (cyan). Residues are labeled by type and sequence
position with those from 3M5P in black and those from 2O2D and 1DLI in red. Overlays
are oriented relative to the bound F6P in 3M5P. Residues were chosen for the
comparative analysis if they were within 6Å of the bound ligand and were used in the
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CPASS similarity scoring.

The next nearest node to 3M5P includes three protein active sites (1MV8, 1DLJ, 1DLI)34,
35

with a similar function (Identical for the first three EC numbers), but act on different

substrates. The CPASS determined active sites for 1DLJ and 1DLI are essentially
identical (not shown), where once again the primary difference is the identity of the
bound ligand [nicotinamide-adenine-dinucleotide (NAD) vs. 1,4-dihydronicotinamide
adenine dinucleotide (NADH)]. However, the active sites are no longer conserved when
comparing 3M5P, a G6P isomerase, to 1DLI (or 1DLJ), a UDP-glucose 6-dehydrogenase
(U6DH) (Figure 5B). The lysine and glutamate residues, which are important to
enzymatic activity remain in 3M5P, but now occupy different positions within the active
site. Of particularly note, the importance of these residues to the enzymatic activity of
1DLI has been diminished. Now, the residues only assist in hydrogen bonding to the
substrate rather than serving a more integral role in the enzymatic activity of the
protein.35 Moreover, the critical arginine in the G6P isomerase active site is not in the
CPASS determined active site for U6DH. Simply, there is no longer a reaction
intermediate in U6DH that requires stabilization by an arginine. As a result, the arginine
is not conserved in U6DH and the space it occupied has been better utilized. In essence,
the overlay of active sites in Figure 5 demonstrates the stepwise evolution from a
glucose-6-phosphate isomerase to a UDP-glucose 6-dehydrogenase A similar result is
obtained when 3M5P is compared to 1MV8, in which a G6P isomerase is converted into
a GDP-mannose dehydrogenase instead of UDP-glucose 6-dehydrogenase (not shown).
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Comparing these active site structures provides a clear understanding of the slow, stepwise evolution of protein function that is essential to the survivability and adaptability of
a cell or organism.
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Chapter 4
Analysis of the Mechanism of Action of Helical Antimicrobial Peptides
4.1 Introduction
The emergence of drug resistant bacteria has made the development of novel antibacterial
agents a pressing issue.1 In fact, most experts consider bacterial infections as one of the
greatest threats to human health, and may result in upwards of 10 million deaths
worldwide by 2050.2 Bacterial resistance to common antibiotics occurs through a variety
of mechanisms.3, 4 For example, the gram-positive pathogen methicillin resistant
Staphylococcus aureus (MRSA) copes with antibiotics by increasing membrane thickness
or altering penicillin binding proteins (PBP).5 Alternatively, gram-negative bacteria such
as Enterobacter spp., K. pneumoniae, and P. aeruginosa acquire resistance by developing
efflux pumps, producing degrading enzymes, or by altering drug binding targets.6-8
An interesting alternative to combat resistant bacteria are antimicrobial peptides
(AMPs).9 AMPs are a class of molecules capable of killing a wide range of
microorganisms by membrane pore formation, membrane disruption, or through a “multihit” mechanism. AMPs can act on the cell membrane or on cytoplasmic targets such as
the inhibition of protein synthesis, enzymatic activity, or cell wall synthesis.10-12 Perhaps
the most attractive feature of AMPs as a source for new antimicrobials is the observation
that bacteria are less likely to develop resistance to AMPs as compared to non-peptide
antibiotics.13 This occurs because the fundamental structure of the membrane is not easily
altered by mutations. Thus, determining the precise mechanisms of action and the

88
structural features that give rise to AMP antimicrobial activities is key to improving
and evolving their efficacy.
Citropin 1.1 (Cit 1.1) is an AMP derived from the skin of an Australian tree frog of the
Litora genus. Cit 1.1 has shown promising activity against a large number of grampositive and gram-negative species that includes: S. aureus, S. epidermis, S. uberis, E.
fecalis, E. coli, and K. pneumonia.14 Truncation studies have shown that deletion of Gly1,
Leu2, or Phe3 completely ablated Cit 1.1 activity. Conversely, deleting Gly14, Gly15, or
Leu6 had no impact on Cit 1.1 activity.15 Tyler and co-workers suggested that the helical conformation of Cit 1.1 was critical to antimicrobial activity.16 In fact, a similar
biological activity was achieved when the secondary structure was maintained, but the Lamino acids were replaced with D-amino acids. However, reversing the peptide sequence
did yield a less potent antibacterial compound.17 In a follow up study, the same group
found that if an amide bond is formed between the amine of Leu5 and the carboxylic acid
side chain of Asp4 (an isoAsp bond, which alters the linear conformation of Cit 1.1) the
biological activity is effectively abolished while the metabolic stability of the peptide is
greatly enhanced. This conformational change does not affect the total charge of the
peptide, and only marginally changes the isoelectric point and hydrophobicity, but the
isoAsp bond significantly alters its secondary structure.18 In addition, it has recently been
proposed that two -helices are formed upon contact of Cit 1.1 with bacterial
membranes.15
Taken together, the -helical structure of Cit 1.1 appears to play an important role in the
peptide’s antimicrobial activity. Of particular note, these prior studies relied on the
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introduction of relatively large structural changes to investigate a relationship between
amino acid composition and peptide conformation on biological activity. In this report,
we expand upon these initial investigations by further characterizing the structure and
biological activity the Cit 1.1 peptide in a membrane mimetic environment. The synthesis
and antimicrobial evaluation of new Cit 1.1 AMP analogs are also reported. The
membrane-bound solution structures of the Cit 1.1 peptides were determined using
circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. The mode
of membrane disruption was visualized using microscopy techniques and validated by
NMR. The toxicity of the most potent AMP was studied in vitro, and the in vivo efficacy
was studied using a well-establish wax-moth larva assay. The resulting structural and
biological data has enabled us to define a mechanism of action for Cit 1.1, to describe the
structural arrangement of the peptide when in contact with membranes, and to understand
the impact of subtle conformational changes on peptide activity.

4.2 Materials and Methods
4.2.1 Peptide synthesis and purification
AMPs were synthesized using solid phase peptide synthesis (SPPS) on a AAPPTec Focus
XC automated peptide synthesizer (Louisville, KY) on a 0.25 mmol scale. All peptides
were synthesized using Fmoc-Rink Amide AM resin support (AAPPTec, Louisville,
KY). The resin was wetted in dichloromechane (DCM) for 30 min to maximize swelling.
The Fmoc- group was then deprotected twice using 20% 4-methyl piperidine (10 mL)
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each time. The resin was thoroughly washed twice for 10 mins each time using a 1:1
mixture of DCM and dimethylformamide (DMF). The desired amino acids were then
added to obtain a predetermined sequence in the peptide synthesizer. Molecular weight of
the AMPs was confirmed by MALDI using a SCIEX 4800 MALDI TOF/TOF analyzer
(Ontario, Canada). The AMPs were purified using a preparative reverse-phase high
performance liquid chromatography (HPLC) using a water (0.1% Trifluoroacetic acid
(TFA)) and acetonitrile (0.1% TFA) gradient on an Agilent HPLC system (Santa Clara,
CA) using a reverse phase column (Kinetex 5u XB-C18 100 A, 150 × 30.0 mm column).
Purity for each AMP was confirmed to be >95% with an Agilent analytical HPLC (Santa
Clara, CA). To determine the relative hydrophobicity, all AMPs were run through
analytical HPLC using the same column, on the same day, using the same solvent
reservoir.

4.2.2 Minimum inhibitory concentration assay (MIC)
Bacteria strains used in this experiment were Staphylococcus aureus JE2, Escherichia
coli K12, and Klebsiella pneumoniae ATCC 13883. The MICs of the amphiphilic
peptides was determined using a broth microdilution method as described in the third
edition of the ASM Clinical Microbiology Procedures Handbook.19 A stock solution of
each peptide was prepared in deionized water and then serial 2-fold dilutions were made
in Muller Hinton broth (DifcoTM, BD Diagnostics, Becton Drive, NJ), containing 5%
DMSO in Cellstar 96-well microtiter plates (Greiner Bio-One, Austria). Bacterial cultures
were prepared using the direct colony suspension method to 1.5 X 108 colony forming
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unit (CFU)/ml (0.5 McFarland) and diluted for 2 mL into 40 mL of MHB. Each well
was inoculated with 10 μl of bacterial cultures. Plates were statically incubated at 37°C
for 16-24 hr. MIC values were taken at the lowest concentration at which no growth was
observed with the unaided eye or the microplate reader. The optical density (O.D.) value
at 600 nm was recorded using a Thermo Fisher Scientific AccuSkan, MultiSkan FC
(Waltham, MA). Vancomycin (Sigma, St. Louis, MO) and Gentamicin (Alfa Aesar,
Ward Hill, MA) was used as positive control and blank media was used as negative
control. All assays were performed in triplicates.

4.2.3 Circular dichroism (CD) and secondary structure analyses
The AMPs were fully dissolved in Milli-Q water + 20% trifluoroethanol (TFE) to a final
concentration of 2 mM. CD spectroscopy was performed at 25 °C using a J-815 Jasco
Circular Dichroism Spectrometer (Easton, MD) in a 0.1 mm quartz cuvette. The solvent
system (H2O + TFE) was kept as the reference, which was then subtracted from the AMP
spectra. The wavelengths for CD analysis were ranged from 190 - 300 nm with a scan
speed of 100 nm/min. The response time was set at 2 s and the bandwidth was set to 1
nm. The spectra were analyzed for their relative proportions of secondary structure using
the Dichroweb online server for protein secondary structure analysis employing the K2D
analytical program.20 CD experiments in presence of E. Coli were done following a
previously published method.21 Briefly, E. Coli K12 was cultured in Muller Hinton Broth
and incubated at 37°C. The resultant mid-log phase cultures were diluted to a ﬁnal
concentration of 1.5x108 CFU/ml using phosphate buffer saline (0.5 McFarland). The
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spectrum of the bacterial suspension was subtracted from the spectrum collected after
addition of the AMP (2 mM) to yield the final spectrum. Helical wheel projections were
calculated using the Heliquest online interface.22

4.2.4 NMR Structure Determination
Unlabeled peptide samples were prepared similarly to previous studies.23 Briefly, 2 mM
of peptide was dissolved in 90% H2O and 10% D2O with 120 mM of SDS-d25
(Cambridge Isotope), 50 mM trimethylsilylpropanoic acid (TMSP), and phosphate
buffered saline (PBS) buffer at pH 7 (uncorrected). NMR experiments were collected at
25oC on a 700 MHz Bruker Avance III spectrometer equipped with a 5 mm QCI-P probe
with cryogenically cooled carbon and proton channels. Proton assignments and NOEs
were accomplished with TOCSY, DQF-COSY, and NOESY experiments with shifts
referenced to TMSP. NMR spectra were collected with 32 transients and 512 points in
the indirect dimension. NOESY spectra were collected with mixing times of 100 ms and
200 ms. Interstrand NOEs were identified using a 3D X-filtered experiment with a
mixing time of 120 ms and a 50/50 mixture of unlabeled peptide and a peptide uniformly
13

C, 15N labeled at Leu2.24 Initial models of the peptides were generated from Hα

chemical shifts using the CS-Rosetta webserver at the BMRB.25 Structural refinement
was carried out with XPLOR-NIH with dimer symmetry enforced.26 400 refined
structures were generated for each peptide and the lowest 20 energy structures were
subsequently subjected to water refinement in XPLOR-NIH. Validation of the peptide
ensembles was done using the Protein Structure Validation Software (PSVS) suite from
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27

the Northeast Structural Genomics Consortium.

4.2.5 One-Dimensional NMR Temperature Titration
The unlabeled NMR peptide samples used for structure determination were also
subjected to a temperature titration to monitor structure stability. 1D 1H NMR spectra
were recorded at temperatures of 25, 30, 40, 50, 60, and 70oC with 64 transients, 128K
data points, and a spectral width of 12.87ppm. Between each experiment, the samples
were allowed to rest at the target temperature for 5 min before data collection. Following
the titration, the 25oC spectrum was recollected to ensure that the sample did not undergo
irreversible degradation upon heating.

4.2.6 Paramagnetic Relaxation Enhancement Titration
The unlabeled NMR peptide samples used for structure determination were also used to
observe the effects of a diethylenetriaminepentaacetic acid gadolinium (III) dihydrogen
salt hydrate (Gd-DTPA) titration. Gd-DTPA was titrated into the samples to
concentrations of 0, 2, 4, 8, 16, and 24 mM. 1D 1H NMR spectra were recorded with 128
transients, 64K data points, and a spectral width of 12.87 ppm. Effects resulting from
sample dilution were accounted for by normalizing peak intensities to TMSP.
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4.2.7 Transmission electron microscopy
E. coli K12 and S. aureus JE2 were cultured in Muller Hinton Broth and incubated at 37
°C. The resultant mid-log phase cultures were diluted to a ﬁnal concentration of 1.5x108
CFU/ml (0.5 McFarland). The bacteria cells were treated with the AMP at 2x the MIC
value and incubated for 1 h at 37°C. A control was prepared by adding the media only.
After AMP treatment, the cells were immediately washed thrice with HyClone™
Dulbecco's Phosphate Buffered Saline solution (GE Healthcare Life Science,
Marlborough, MA) and fixed with 2.0% (v/v) glutaraldehyde28 Imaging was done on a
FEI Tecnai G2 Spirit transmission electron microscope (Japan). 10 µL of the AMPtreated or control bacterial suspension was placed on a copper grid and was allowed to
dry for 5 min. The excess suspension was blotted off of the grid and it was dried for 5
mins to remove the residual moisture.

4.2.8 Scanning electron microscopy
Bacterial suspensions for SEM were prepared identically as they were for TEM. The
suspension was then placed on 0.1% Poly-L Lysine coated glass slide and allowed to
adhere for 30 minutes. The slides were then washed thrice with PBS to remove excess
fixative. Samples were post-fixed in a 1% solution of OsO4 for 30 mins to facilitate
conductivity. They were then dehydrated in a graded ethanol series (50, 70, 90, 95, and
100%). Ethanol was removed by washing the slides thrice with hexamethyldisilazane
(HMDS). The HMDS was allowed to evaporate overnight to dry the samples. The glass
slides were attached to aluminum SEM stubs with double-sided carbon tape. Silver paste
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was applied to enhance conductivity, which was allowed to dry overnight. Samples
then were coated with ≈ 50nm gold-palladium alloy in a Hummer VI Sputter Coater
(Anatech, Battle Creek, MI) and imaged at 30kV in a FEI Quanta 200 SEM (Japan)
operating in high vacuum mode.

4.2.9 Atomic force microscopy and nano-indentation
Escherichia coli K12 and Staphylococcus aureus JE2 were cultured in Muller Hinton
Broth and incubated at 37°C. The resultant mid-log phase cultures were adjusted to a
ﬁnal concentration of 1.6x109 CFU/ml (5.0 McFarland). Cells were treated with AMP at
10 times the MIC (30µM) and incubated for 30 minutes at 37°C. An untreated control
was prepared in the same way by adding blank media. Cells were then washed thrice in
HyClone™ Dulbecco's Phosphate Buffered Saline solution, and centrifuged at 8000 rpm
for 10 mins. AFM imaging of the cells and nano-indentation measurements were
performed at ambient conditions with relative humidity of 75% using the MFP 3D system
(Oxford Instruments Asylum Research, Santa Barbara, CA). A silicon nitride cantilever
MSNL-F (MSNL, Bruker) with nominal value of spring constant in the range of 0.6 N/m
was used for both imaging and indentation. The spring constant of the cantilever was
obtained using a thermal method prior to each experiment. Indentation was performed in
the “Go There” mode after the image of the cells was obtained on various specified
points on the cell surface. Collected force-distance curves were analyzed with the Igor
Pro 6.23 software package (Wavemetrics, Portland, OR). Mechanical properties were
obtained by fitting of the force curves to a cone geometry model of the tip. Fitting was
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done with calibrated parameters of the tip geometry, which were obtained before the
experiment by indentation of the probe against the PDMS Gel reference sample (PDMSSOFT-1-12M, Bruker) with a known Young’s modulus of 2.5 MPa.

4.2.10 FITC uptake kinetics
E. coli K12 and S. aureus JE2 were cultured in Muller Hinton Broth and incubated at 37
°C. The resultant mid-log phase cultures were diluted to a ﬁnal concentration of 1.5x108
CFU/ml (0.5 McFarland). The bacteria cells were treated with the AMP at 2x the MIC
value and incubated for 1 h at 37°C. A control was prepared with solvent used to dissolve
the AMP. 100 μL of the bacterial suspension was loaded onto a 96-well plate and
fluorescein isothiocyanate (FITC) (6 μg/ml) was added and thoroughly mixed with the
bacterial cells. The initial fluorescence immediately after FITC addition was recorded and
subsequent fluorescence intensities were recorded at 30, 60, 120 and 240 min intervals.
The decrease in fluorescence intensity were expressed as % of initial fluorescence and
recorded as the means ± SD.

4.2.11 Membrane Internalization Kinetics
E. coli K12 and S. aureus JE2 were cultured in Muller Hinton Broth and incubated at 37
°C. The resultant mid-log phase cultures were diluted to a ﬁnal concentration of 1.5x108
CFU/ml (0.5 McFarland). The bacteria cells were treated with the AMP at 2x the MIC
value and the fluorescence value was immediately determined. A control was prepared by
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adding only the solvent. The initial fluorescence immediately after AMP addition was
recorded and subsequent fluorescence intensities were recorded at 30, 60, 120 and 240
min intervals. The decrease in fluorescence intensity were expressed as % of initial
fluorescence and recorded as the means ± SD.

4.2.12 In vivo assay on G. mellonella model of Staphylococcal infection
500 µL of the bacterial suspension was prepared and adjusted to 2.5×108 CFU/10 µL in
PBS buffer. 10µL of the bacterial suspension was injected to the last left pro-leg of the G.
mellonella larva. Following injection, the infected larva was incubated in top-side
perforated petri dishes for 2 hours. All larvae were found to be alive 2 hours post
infection (n=15). Following this the AMP-treated group and Vancomycin-treated groups
were treated with AMP-016 (15mg/kg) and Vancomycin (15mg/kg) respectively. The
larvae were observed every 24 hr for 5 days. A survival graph was plotted representing %
survival over time. The survival data were plotted using the Kaplan Meyer method and
comparisons were made between groups using the log rank test.

4.2.13 In vitro toxicity studies
AMPs were dissolved in Dulbecco's Modified Eagle Medium (DMEM) containing 10%
FBS and 1% penicillin streptomycin to a final concentration of 4 mM. An aliquot of this
stock solution was taken and serial dilutions were performed using DMEM buffer to
obtain the desired concentration. Cytotoxicity was performed using a celltiter blue assay
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and following the manufacturer’s protocols. Cell death was determined by observing
the change of absorbance of resazurin using a spectrophotometer. The results were
plotted as Absorbance vs AMP concentration and the IC50 (concentration that kills 50%
of the cell population) was calculated.

4.3 Results
4.3.1 Peptide Synthesis and Characterization
The crude AMPs were identified by Matrix Assisted Laser Desorption Ionization-Time of
Flight (MALDI-TOF) spectrometry (Supporting information). The purities of the AMPs
were determined to be >95% and the relative hydrophobicities of the AMPs were
determined using analytical High-Performance Liquid Chromatography (HPLC) (Table
1).

Retention
HaCat (uM)

MW
Time (mins)

AMP-001

50

17.48

1615

AMP-002

120

17.78

1629.03

AMP-003

>310

20.09

1657.04

AMP-004

>310

17.35

1658.09

AMP-005

>310

19.52

1615.99
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AMP-006

45

16.86

1586.94

AMP-007

140

16.63

1558.89

AMP-008

>310

16.44

1530.84

AMP-009

>310

18.89

1644

AMP-010

>310

21.76

1724.26

AMP-011

>310

17.88

1700.17

AMP-012

>40

17.83

1671.03

AMP-013

60

17.91

1643.01

AMP-014

>310

16.05

1673

AMP-015

>310

18.18

1629.03

AMP-016

45

18.22

1654.04

Table 1. Cytotoxicity against HaCat cell lines, relative retention times and calculated
molecular weights of the antimicrobial peptides.
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Table 2. Antimicrobial activities of Citropin and its analogues against S. aureus, E. coli,
P. aeruginosa and K. pneumoniae. Activities are listed by concentration (µM).

4.3.2 Minimum Inhibitory Concentration (MIC Assay)
Cit 1.1 showed high activity against S. aureus (10 μM), E. coli (25 μM), and K.
pneumoniae (30 μM) corroborating findings from previous studies (Table 2).16, 29-31 The
AMP-002 analog was synthesized by substituting a methyl glycine (Sar1) for Gly1.
AMP-002 retained activity against S. aureus and E. coli, but exhibited diminished
activity against K. pneumoniae (>50 μM). The N-terminus acetylation of Cit 1.1 yielded
the AMP-003 analog, which resulted in completely diminished activity against S. aureus,
E. coli and K. pneumoniae. Methylation of the N-terminus amine of Cit 1.1 yielded the
AMP-004 analog, which also resulted in full ablation of activity across all of the tested
bacterial strains. The AMP-005 analog was synthesized by substituting Gly1 with a
hydrazine group, which resulted in complete loss of antibacterial activity.
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Replacing two Lys residues (Lys7, Lys8) with ornithine (Orn, AMP-006) resulted in a
2.5-fold decrease in the MIC value against S. aureus (25 µM) and a 1.7-fold decrease
against E. coli (15 µM). The activity of AMP-006 against K. pneumoniae remained
unchanged (30 µM) relative to Cit 1.1. Replacement of the lysine residues with 2,4diaminobutyric acid (Dab) or 2,3-diaminopropionic acid (Dpr) yielded analogs AMP-007
and AMP-008, respectively. Both Dab and Dpr substitutions resulted in a complete loss
of antibacterial activity (> 50 µM). An AMP-009 analog was constructed in which Lys7
was replaced with a citrulline, which is a structural mimic of arginine and contains a urea
functional group instead of the charged guanidium group. The citrulline substitution
resulted in a complete lack of antibacterial activity for AMP-009. AMP-010 was
synthesized by methylating all of the available Cit 1.1 amine groups. AMP-011 was
generated by methylating only the Lys amine moieties to produce a peptide analog that
still contains a positive charge. Nevertheless, both AMP-010 and AMP-011 exhibited a
complete lack of antibacterial activity. AMP-012 was constructed by replacing Lys7 and
Lys8 with an arginine. Similarly, an AMP-013 analog was generated by substituting Lys7
for an arginine. The MICs for both AMP-012 and AMP-013 decreased 2-fold against S.
aureus (5 µM). However, the potency of AMP-012 and AMP-013 against gram-negative
organisms was mixed. AMP-013 exhibited a 1.7-fold higher activity against E. coli (15
µM) compared to both Cit 1.1 and AMP-012. Conversely, all three peptides exhibited the
same activity against K. pneumoniae (30 µM). A glycine residue was inserted into the Cit
1.1 sequence following Lys 8 to create the AMP-014 analog. The AMP-014 analog was
observed to be inactive against all of the bacterial strains tested. The remaining Cit 1.1
analog (AMP-015) was constructed with a modest substitution of Asp4 for a Glu. As
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expected, this substitution retained activity comparable to Cit 1.1 against S. aureus
and E. coli, but the activity against K. pneumoniae was completely lost. An AMP-016
analog was constructed where Phe3 was replaced with a Trp. The AMP-016 analog
exhibited the best antibacterial activity against both S. aureus (3 µM) and E. coli (3 µM)
relative to Cit 1.1 and the other analogs. This corresponded to 3-fold and 8-fold increase
in activity, respectively. The activity against K. pneumoniae was the same as Cit 1.1 (30
µM).

Figure 1. A) Representative CD spectra of Cit 1.1 (red), AMP-003 (green) and AMP-016
(blue) in a solution of 20% TFE+H2O at a concentration of 2 mM. B) Subtracted CD
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Spectrum of Cit 1.1 (red), AMP-003 (green) and AMP-016 (blue), incubated with live
E.coli cells. Cells (0.1 OD) were suspended in 10 mM phosphate buffer (pH 7) and AMP016 (25µM) was added to the cuvette, and the spectrum was immediately collected. The
background spectrum of the E. coli cells was subtracted from the E. coli AMP spectrum
to derive the final spectrum. (C) Plot showing the Hα deviations (ppm) from statisticalcoil chemical shifts. Amino acids are numbered according to their sequence in Cit 1.1
(red), AMP-003 (green), AMP-016 (blue). (D) TOCSY Hα region of Cit 1.1 (red), AMP003 (green), and AMP-016 (blue). Peaks are labeled according to their respective amino
acid position.

4.3.3 Circular Dichroism (CD) Spectroscopy
CD Spectroscopy is routinely employed to determine the secondary structure of proteins
and peptides.32 Accordingly, the antimicrobial activity of the Cit 1.1 analogs was
compared to α-helical content using CD spectroscopy (Figure 1A, B). The most active
peptides Cit 1.1, AMP-002, -012, -013, and -016 had the highest α-helical content
corresponding to ≥ 45% (Table 3). Conversely, the moderately active (AMP-006 and 015) or inactive peptides (AMP-003, -004, -008, -009, -010, -011, and -014) contained a
lower α-helical content of ≤ 31%. The inactive AMP-005 and -007 analogs were
exceptions and exhibited an α-helical content of approximately 40%. In general, a high αhelical content appears to be a prerequisite for Cit 1.1 activity. The secondary structures
for the Cit 1.1 analogs were also analyzed in the presence of bacteria to mimic a native
environment (Figure 1B). The Cit 1.1, AMP-003 and -016 were all observed to adopt α-
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helical structures upon incubation with E. coli despite differences in antimicrobial
activity. It has been previously demonstrated that the minima of a CD spectrum is an
indicator of the proportion of the peptides that have folded into an ordered secondary
structure.21 Accordingly, an observed difference in the minimum depth of CD spectra
may identify relative differences in the proportion of Cit 1.1 analogs that adopt α-helical
conformations. Comparing the CD spectra of Cit 1.1, AMP-003 and -016 in the presence
of E. coli cells indicates that AMP-016 has the lowest minima and, consequently, the
highest proportion of α-helical peptides. Cit 1.1 was the next lowest and AMP-003
exhibited the least α-helical content. Importantly, this trend correlates with the relative
activity of the Cit 1.1 analogs.

Table 3. Relative content of α-helix, β-sheet and random coil in the structure of Cit 1.1
and its analogs. The relative proportion of secondary structures was calculated using the
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Dichroweb online interface using K2D analytical algorithm.

20

4.3.4 NMR Spectroscopy
Negatively charged sodium dodecyl sulfate (SDS) micelles closely mimic a bacterial
membrane and were therefore chosen as a model for the structural elucidation of Cit 1.1,
AMP-003, and AMP-016 by NMR.33 Standard two-dimensional (2D) TOCSY and
NOESY datasets were collected for backbone and side-chain resonance assignments.34
NMR assignments for Cit 1.1, AMP-003, and AMP-016 were nearly complete with 94%
HN, 100% Hα, 100% Hβ, 88% Hγ, 90-100% Hδ, 60-100% Hε, 0-33% Hζ, and 100% Hη
of the assignments made. Figure 1C shows the Hα chemical shift deviations from
statistical-coil values for the three peptides bound to SDS micelles.35, 36 The three
peptides show negative chemical shift differences across the entirety of the sequence,
which is strongly suggestive of an α-helical conformation along the SDS micelle.
Chemical shift differences between the Cit 1.1, AMP-003, and AMP-016 peptides are
more apparent when the HN chemical shifts are included. This is illustrated by an overlay
of the Hα region of the 2D TOCSY spectra for the three peptides as shown in Figure 1D.
Major chemical shifts changes are observed for residues 3 to 7, which are consistent with
the Hα chemical shift changes plotted in Figure 1C.
The NMR structures for the Cit 1.1, AMP-003, and AMP-0016 peptides in SDS micelles
were determined to further elucidate the role that structure plays in antimicrobial activity.
An initial dimer model was generated for each peptide using CS-ROSETTA.37 The three
peptide dimer structures were then refined with XPLOR-NIH38 based on 536 to 622
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intramolecular NOE restraints, and 16 intermolecular (peptide-peptide) NOE
restraints. A total of 400 models were calculated per peptide of which the 20 lowest
energy structures were further water refined. The structural statistics for the three
peptides (Table 4) indicates that the experimental data agrees well with the calculated
structures. Backbone RMSDs for each of the peptides was 0.3Å, 0.7Å, and 0.4Å for Cit
1.1, AMP-003, and AMP-016, respectively. The structures did not contain any NOE
violations >0.5Å or dihedral angle violations >5°. The high quality of the NMR structures
is also evident by the PROCHECK z-scores of -0.3, -0.95, and -0.47 for Cit 1.1, AMP003, and AMP-016, respectively.39 Further, 92-94% of all residues are located in the most
favored region of the Ramachandran plot. An overlay of the water refined 20 lowest
energy NMR structures for the Cit 1.1, AMP-003, and AMP-016 peptides are shown in
Figure 2A-C.

Structure statistics for:

Cit 1.1

AMP-003

AMP-016

NOE Restraints

622

552

536

Short Range (|i-j|<=1)

414

390

362

Medium Range (1<|i-j|<5)

208

162

174

Long Range (peptide-peptide)

16

16

16

ϕ/ψ in most favored region

91.70%

94.20%

92.9

ϕ/ψ in additionally allowed
region

8.30%

5.80%

7.1

ϕ/ψ in generously allowed

0%

0%

0

ϕ/ψ in disallowed region

0%

0%

0
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Backbone atoms rmsd (Å)

0.3

0.7

0.4

Heavy atoms rmsd (Å)

0.5

0.7

0.6

NOE violations (>0.5Å)

0

0

0

PROCHECK (all) Z-score

-0.3

-0.95

-0.47

Table 4. Structure statistics for Cit 1.1, AMP-003, and AMP-016.

Figure 2. The ensemble of the lowest energy, water refined structures of (A) Cit 1.1, (B)
AMP-003, and (C) AMP-016. Peptide ribbon structures for (D) Cit 1.1, (E) AMP-003,
and (F) AMP-016 with binned amide proton temperature titration data according to
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the ΔH ranges 0 to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red). NOE connectivity
plots for (G) Cit 1.1, (H) AMP-003, and (I) AMP-016. Weights of the connectivities are
normalized to the NOE intensities.

The resulting NMR structures indicate that the Cit 1.1, AMP-003, and AMP-016 peptides
adopt a head to tail helical dimer (Figure 2D-F). The head-to-tail orientation of the
peptides was confirmed by the presence of NOEs from Leu2 of strand A to Ile13/Leu16
of strand B. These long-range structural restraints are only possible for a head to tail
dimer. Of particular note, a significant number of NOEs exist at the N-terminus (Figure
2G, I), which is consistent with the presence of both an α- and 310-helix for the
biologically active peptides (Cit 1.1 and AMP-016). It is possible that the peptides adopt
both conformations (or are in equilibrium) when bound to a SDS micelle. In this case, the
NMR structure would simply represent an overall average of the conformational
exchange. Importantly, the inactive AMP-003 lacks a similar NOE pattern (and number
of NOEs) at the N-terminus and, thus, it exclusively adopts an α-helical structure (Figure
2H). Since the only difference between Cit 1.1 and AMP-003 is the N-terminal
acetylation, this clear difference in helix composition between the peptides is due to the
acetylation.
Amide proton temperature titrations up to 70oC were performed on the three peptides to
characterize helical stability (Figures S1-3). The titration data was binned according to
the relative magnitude of the HN chemical shift changes (ΔHN): minor (0 to -0.05,
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yellow), intermediate (-0.05 to -0.25, orange), and major (-0.25 to -0.45, red). The
peptide ribbon diagrams in Figure 2D-F are colored based on these HN chemical shift
changes in order to qualitatively assess the thermal stability of the helices. Amino acid
residues exhibiting major chemical shift changes upon heating are transitioning from a
stable and structurally-ordered state to a disordered and unstructured state. Conversely,
residues with relatively unchanged chemical shifts are likely already in a transiently
disordered state at room temperature.
The peptides were titrated with gadolinium-diethylenetriamine pentaacetic acid (GdDTPA) and monitored by NMR to identify the solvent exposed residues while the peptide
was bound to SDS micelles (Figure S4-6). The addition of a paramagnetic species will
reduce the NMR signal intensity for residues in contact with the solvent proportionally to
the amount of the added paramagnetic species. Upon the addition of Gd-DTPA, the
majority of the amino acids exhibited an approximate linear decrease in peak intensity
regardless of location in the dimer structure. This is most likely due to multiple binding
sites for Gd-DTPA on each peptide, an aggregation of the peptides along the surfaces of
the micelles, and a dynamic association/dissociation of the dimer.40 Leu2 in Cit 1.1 and
AMP-016 was an exception to this general observation. The NMR peak intensity for
Leu2 increased, at first, with the addition of Gd-DTPA. Of note, the peak intensity for
Leu2 was relatively weak compared to the other residues (Figure 1D), which is
suggestive of a high exchange rate and/or a transiently disordered structure.
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4.3.5 Transmission Electron Microscopy (TEM), Scanning Electron Microscopy
(SEM) and Atomic Force Microscope (AFM) imaging
Treatment of S. aureus and E. coli with AMP-016 lead to membrane disruption
accompanied by the formation of distinct vesicle-like structures budding as seen by SEM,
TEM, and AFM (Figures 3, 4A-D).

Figure 3. SEM Micrograph of (A) E. coli (control) (B) E. coli (treated) (C) S. aureus
(control) (D) S. aureus (treated). TEM Micrograph of (E) E. coli (control) (F) E. coli
(treated) (G) S. aureus (control) (H) S. aureus (treated). For both TEM and SEM, bacteria
(106 CFU) were treated with AMP-016 (6uM) for 30 mins.
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Figure 4. AFM Micrograph of (A) E. coli (control) (B) E. coli (treated) (C) S. aureus
(control) (D) S. aureus (treated). Young’s Modulus of (E) E. coli (F) S. aureus. Adhesion
forces of (G) E. coli (H) S. aureus. Young’s modulus and adhesion forces are presented
as mean±SD and were collected over 50 randomly selected points. Statistical significance
was determined by Student’s t-test. P < 0.05 was considered to be statistically significant.
The bacterial cells were first imaged and the mechanical properties were subsequently
determined from the same samples. Bacteria at 106 CFU were treated with AMP-016
(6uM) for 30 mins.

4.3.6 Stiffness of Bacterial Membrane by AFM Nano-Indentation
Untreated E. coli membrane was found to have a Young’s modulus of about 17.6 GPa,
which reduced to only 4.7 GPa upon AMP-016 treatment, a 3.7-fold reduction in stiffness
(Figure 4E, G). Young’s modulus of S. aureus reduced from 700 MPa to 160 MPa, a 4.4fold reduction in membrane stiffness (Figure 4F, H). Previous AFM nano-indentation
studies on E. coli have yielded stiffness values ranging between 200 MPa and 3.700
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41, 42

GPa.

Although our reported values are higher, these variations might result from

differences in bacterial strains, sample processing, or the state of the cells at the time of
the study (vegetative vs spore).43, 44

4.3.7 Fluorescein Isothiocyanate (FITC) Uptake Kinetics
Membrane disruption causes cellular internalization of FITC and an associated decrease
of fluorescence intensity outside the bacterial cells.45 Thus, a correlation between an
increase in antimicrobial activity and the rate and extent of FITC uptake is expected for
active Cit 1.1 analogs. AMP-012, -013, and -016 peptides exhibited a greater rate and
extent of FITC uptake when compared to Cit 1.1 (Figure 5A).

Figure 5. A) FITC uptake kinetics of AMPs. E. coli (106 CFU) was treated with AMPs
(2X MIC) for 240 mins and the percent decrease in fluorescence was determined. The
data are presented as mean percent of the initial fluorescence. B) Membrane
internalization kinetics of AMPs. E. coli (106 CFU) was treated with the AMPs and
incubated for 240 mins. Data are presented as mean percent of initial fluorescence.
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Untreated control (black), Cit 1.1 (red), AMP-003 (green) AMP-012 (turquoise),
AMP-013 (purple), AMP-016 (blue).

4.3.8 AMP Internalization Kinetics
Treatment of E. coli with AMP-012, -013, or -016 resulted in a significant decrease in
fluorescence when compared to Cit 1.1 (Figure 5B). This is consistent with the
observation that AMP-012, -013, and -016 displayed a similar or higher antimicrobial
activity relative to Cit 1.1 (Table 2). Minimal internalization was observed with AMP003, which corresponds with its lower antibacterial activity. Introduction of tryptophan or
arginine residues into Cit 1.1 appears to increase the rate of membrane binding or the
affinity of the peptide dimer to the membrane.

4.3.9 In-vivo Efficacy Study
In vivo efficacy of the most active compound, AMP-016, was determined in a wax moth
model for staphylococcal infection due to its maximum activity. The AMP-016 treated
group displayed a comparable survivability to the vancomycin treated group at a dose of
15 mg/kg (Figure 6).
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Figure 6: In-vivo survival analyses of G. mellonella larva following S. aureus infection
and drug treatment. Larvae were infected with a S. aureus suspension (1.5×107 CFU).
The larvae were then treated with AMP-016 (15 mg/kg) and vancomycin (15 mg/kg), 2
hr post-infection. A log rank test for trend was performed to determine the statistical
difference of the curve (p = 0.017).

4.4 Discussion
4.4.1 Antimicrobial Activity
Helical AMPs have been extensively studied as potential antimicrobial candidates for
topical and systemic uses; and utilized as the antimicrobial component of anti-biofouling
surfaces. However, little attention has been given towards the structural determinants of
AMP activity beyond properties such as charge, helicity and hydrophobicity. To this end,
we have rationally designed analogs of the Cit 1.1 AMP to look beyond conventional
factors thought to be major determinants of antibacterial activity. The N-terminus of
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AMPs tend to be polar or ironic, which is likely to play a key role in membrane
interactions.13 For example, a number of helical AMPs contain either a glycine, a
positively charged residue (Arg, Lys) or a polar residue (Ser, Asp, Gln) at the N-terminus
(e.g., magainin-2, pexiganan, thanatin, esculetin). In effect, all of these helical peptides
have an exposed N-terminal amine which are capable of forming hydrogen bonds and are
known to participate in electrostatic interactions with negatively charged bacterial
membranes. However, the actual role of the N-terminus in AMP activity or the nature of
its potential interaction with the membrane remains unclear. To understand the potential
importance of electrostatic interactions with the N-terminus of AMPs, several Cit 1.1
analogs were synthesized with various modifications at the N-terminus. The AMP-002
analog, in which Gly1 was replaced with a methyl glycine, exhibited comparable activity
to Cit 1.1 against S. aureus and E. coli. However, the activity of AMP-002 against K.
pneumoniae was completely abolished. The methylation of a primary amine changes the
lipophilicity at the N-terminus. Thus, the reduction of activity due to the Sar substitution
also suggests multiple H-bond donors may be needed at the N-terminus of AMPs for full
activity. This is also consistent with the observation that the AMP-003 analog, which is
acetylated at the N-terminus, was completely inactive. Acetylation of amines alters the
pKa and the isoelectric point of a peptide while also reducing the net charge of the
peptide.46 In effect, the acetylation eliminated the ability of the N-terminus of the AMP003 to hydrogen bond with the membrane.
To further investigate the importance of the primary amine on Cit 1.1 activity, the Nterminus was converted into a quaternary amine (AMP-004). This modification was
expected to have two distinct and positive impacts on Cit 1.1 activity. First, a permanent
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positive charge was incorporated into the Cit 1.1 structure that cannot form a
hydrogen bond. The role of a resident positive charge in the activity of many
antibacterials is well established.47-49 Second, the quaternary amine makes AMP more
resistant to proteolysis.50 Improved antimicrobial activity would be expected if the
peptide is stabilized and has a longer bioavailability. Thus, based on previous
observations, AMP-004 was expected to exhibit a better activity than Cit 1.1.
Unexpectedly, AMP-004 was observed to be inactive against all tested bacterial strains.
This indicates that a positive charge on the N-terminal amine is not sufficient to interact
with the negatively charged bacterial membrane. Similarly, replacing Gly1 with a
hydrazine group resulted in the complete loss of antibacterial activity for the AMP-005
analog. Hydrazines have a lower pKa (~8.3) than amines (~9.6), which is further lowered
when near an electron-withdrawing group.51, 52 As a result, the alkylated hydrazine
nitrogen is likely not protonated (note that the alkylated nitrogen is the most likely site of
protonation53) under the conditions of the MIC assay. Furthermore, an internal hydrogen
bond may form between the hydrogen on the hydrazine and the amide carbonyl. In
addition to preventing a hydrogen bond with the bacterial membrane, this internal
hydrogen bond may also affect the overall peptide structure and alter its biological
activity. The inactive AMP-003, AMP-004 and AMP-005 analogs clearly emphasize the
importance of the N-terminus in AMP activity and the potential critical role that
hydrogen bonds play in the interaction with the bacterial membrane.
In addition to the N-terminal amine, most AMPs contain two or more ionizable amino
acids such as Lys and Arg. It is widely recognized that Lys and Arg side-chains are
positively charged at biological pH (6.9 to 7.4), which allows for a potential electrostatic
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interact with the bacterial membrane. This important structural feature has also led to
the alternative common name for AMPs of cationic antibacterial peptides, which
emphasizes the peptides charge over other properties essential to activity. Accordingly,
several modifications to Cit 1.1 were made to evaluate the role of these charged residues
to antibacterial activity. Lys7 and Lys8 were replaced with progressively shorter amine
bearing sidechains: ornithine (Orn), 2,4-diaminobutyric acid (Dab), and 2,3diaminopropionic acid (Dpr). Orn, Dab, and Dpr are successively one methylene shorter.
Replacing the two Lys with Orn (AMP-006) resulted in a peptide with a 2.5-fold decrease
in the MIC value against S. aureus (25 µM), and a 1.7-fold decrease against E. coli (15
µM). The activity against K. pneumoniae remained unchanged (30 µM) relative to Cit
1.1. The Dab (AMP-007) and Dpr (AMP-008) substitutions resulted in complete loss of
antibacterial activity (>50 µM). These findings suggest the –NH3+ moiety or the longer
side-chain of Lys is necessary for membrane interaction and the antibacterial activity of
Cit 1.1. Another possibility is that the decrease in –CH2 units results in a lower
hydrophobicity. This is supported by the shorter HPLC retention times for Orn, Dap and
Dpr (16.44 to 16.86 mins.) compared to Cit 1.1 (17.48 min). This finding suggests that
the incorporation of lysine analogs with longer side-chains may enhance the antibacterial
activity of AMPs.
To further explore the relative contribution of the electrostatic interaction and hydrogenbond formation by the Lys side chain to Cit 1.1 activity, the Lys residues were
methylated (AMP-010 and AMP-011) to produce analogs that still contain a positive
charge. Unexpectedly, and despite having a permanent +3 charge, both AMP-010 and
AMP-011 were found to be inactive. Increasing the methyl substitution of the lysine side
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chain amine has been found to produce a less favorable cation-π stacking interactions
in terms of energy and geometry.54 This observation raises the possibility that a crucial
cation-π stacking interaction exists between a lysine side chain and the phenylalanine at
position 3. Additionally, it is possible that the inability of the lysine -NH2 to form a
hydrogen bond with the bacterial membrane might be the cause of the peptide’s
inactivity.
Arginine-rich peptides have been previously shown to exhibit potent antibacterial
activity.55-57 In fact, a number of studies have indicated that an increase in arginine versus
lysine content has resulted in enhanced antimicrobial activity.58-64 Nevertheless, others
have observed a deviation from this arginine-to-lysine enrichment rule.65-68 It appears that
a “sweet spot” exists in the choice of arginine or lysine based on hydrophobicity,
hydrophobic ratio, secondary structure, and isoelectric point. To investigate this issue, a
Cit 1.1 analog (AMP-012) was constructed where Lys7 and Lys8 were replaced with an
arginine. An AMP-013 analog was also constructed that only replaced Lys7 with an
arginine. The MICs for both AMP-012 and AMP-013 decreased 2-fold against S. aureus
(5 µM). The increase in antimicrobial activity may be explained by an enhanced
translocation of peptides within the microbial cells.58, 60, 69-71 However, the potency of
AMP-012 and AMP-013 against gram-negative organisms was mixed. AMP-013
exhibited a 1.7-fold higher activity against E. coli (15 µM) compared to both Cit 1.1 and
AMP-012. Conversely, all three peptides exhibited the same activity against K.
pneumoniae (30 µM). To further explore the importance of Lys or Arg to Cit 1.1 activity,
an AMP-009 analog was constructed in which Lys7 was replaced with a citrulline, which
is a structural mimic of arginine, but contains a urea functional group instead of the
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charged guanidium group. The citrulline substitution resulted in a complete lack of
antibacterial activity for AMP-009, further establishing the importance of a Lys at
position 7 in the activity of Cit 1.1. Although the citrulline urea group is capable of
hydrogen bond formation, its side chain is uncharged. Accordingly, the citrulline
substitution reduces the net charge of AMP-009 to only +1. This suggests that the overall
net charge of the peptide may also contribute to the antimicrobial activity of AMPs.
Previous studies have shown that Cit 1.1 adopts an α-helical conformation, but there has
also been some debate about the exact details of the Cit 1.1 structure. Instead of a single
-helical chain, two helices separated by a β-turn has been suggested for the Cit 1.1
structure.15 To address this possibility, a glycine residue was inserted into the Cit 1.1
sequence following Lys8 to create the AMP-014 analog. The insertion of Gly9 was
expected to provide added flexibility to the peptide72 and potentially enhance its activity
if the two helix model was correct. AMP-014 was observed to be inactive against all of
the bacterial strains tested and suggests the two helix model for Cit 1.1 may be incorrect.
Nevertheless, it is important to note that the Gly insertion does lengthen the peptide and
shifts the sequence beyond Lys8. The sequence shift does affect the amino acids found on
each Cit 1.1 surface (Figure 7). Thus, the loss in activity may also be explained by an
interruption in the hydrophilic α-helix surface, which leads to a disruption in membrane
binding. Of course, if the Cit 1.1 structure is comprised of two -helices separated by a
flexible link, then the added flexibility of the inserted Gly would allow enough mobility
for the correct surface of the -helices to interact with the membrane.
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AMP-001

AMP-012

AMP-013

AMP-014

AMP-015

AMP-016

Figure 7. Alpha helical properties and position of the amino acid residues were predicted
using the Heliquest online analysis tool.22

Tryptophan-rich peptides have also been shown to enhance the activity of AMPs.55, 56, 73
Thus, the potential impact of incorporating a tryptophan into the Cit 1.1 peptide was also
investigated. The AMP-016 analog was constructed where Phe3 was replaced with a Trp.
The AMP-016 analog exhibited the best antibacterial activity against both S. aureus (3
µM) and E. coli (3 µM) relative to Cit 1.1 and the other analogs. This corresponded to 3fold and 8-fold increase in activity, respectively. The activity against K. pneumoniae was
the same as Cit 1.1 (30 µM). The indole ring in tryptophan is likely acting as a better
anchor to the bacterial membranes than the smaller phenyl ring.73 Biologically active
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tryptophan-rich peptides typically have multiple tryptophan residues. Therefore, the
dramatic increase in antimicrobial activity following such a modest change was
remarkable and unexpected.
The remaining Cit 1.1 analog AMP-015 was constructed with a modest substitution of a
Glu for Asp4. As expected, this substitution retained an activity comparable to Cit 1.1
against S. aureus and E. coli, but the activity against K. pneumoniae was completely lost.
Given the similarities between the peptides, an explanation for this observation is not
apparent at this time.

4.4.2 NMR Spectroscopy
Cit 1.1, AMP-003, and -016 were analyzed by NMR to elucidate the relationship between
structure and antimicrobial activity. Interestingly, Figure 1C indicates that the largest Hα
chemical shift difference between the three peptides occurs at the N-terminus between
residues Asp3 and Lys7. Although the dissimilarity between AMP-016 and Cit 1.1/AMP003 can be attributed to the tryptophan substitution at position 3, the minor deviation of
Asp4 is likely a result of the acetylation of the N-terminus. In the case of AMP-016, the
steric and electronic effects from the indole side chain are likely to increase the local
flexibility at position 3 and potentially lead to a significant decrease in helicity. Nterminal acetylation does not induce any significant effect on the overall helicity of
AMP-003 except for a slight decrease at Asp4. The removal of the charged N-terminus
may slightly change the polarity or the hydrogen-bond network around Asp4 that may
contribute to a decrease in helicity. Figure 1D shows the overlay of the Hα region of the
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2D TOCSY for the three peptides. The significant chemical shift differences of the Nterminal residues highlight a changing local environment for residues 3 to 7 that is likely
a result of minor alterations in the structure of the three peptides. Accordingly, these
subtle changes in the peptide’s structure may be directly related to differences in
antimicrobial activity.
Our NMR derived structures for Cit 1.1, AMP-003, and -016 differ significantly from the
previous results of Sikorska et al. that describe the presence of two helices separated by a
β-turn.23 Experimentally determined NOEs were found along the full length of each of
the peptides and (Figure 2G-I) and between the helices in a dimer orientation. Although
the Cit 1.1, AMP-003, and AMP-016 dimers are not completely superimposable, there
are no major structural differences between the three peptide structures that appear to
explain the difference in activity. In all cases, the dimers pack together along a
hydrophobic face, which then exposes charged residues to the solvent. Consequently, the
peptides’ NMR structures are consistent with the prior observation that the number and
distribution of hydrophobic residues is crucial for antimicrobial activity.74 Increasing
peptide hydrophobicity increases antimicrobial activity, but only if the overall
hydrophobicity remains below an optimal upper threshold. If too many hydrophobic
residues are inserted into the peptide sequence then unintended peptide aggregation
occurs, which leads to a loss in activity. Therefore, the Cit 1.1 peptide must maintain a
hydrophobic surface to allow for a stable dimer in order to carpet a bacterial cell
membrane, but to also avoid the formation of inactive aggregates. This, however, does
not explain the differences in activity between the active (Cit 1.1/AMP-016) and inactive
(AMP-003) peptides since all the peptides form a similar head-to-tail dimer. Instead, the
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primary difference between the active and inactive peptide dimers is the N-terminal
acetylation.
Acetylation of the N-terminus in Cit 1.1 most likely changes the polarity and hydrogen
bond network near the modification site, which appears to have a profound effect on
antimicrobial activity. It has been previously observed that N-terminal acetylation
increases the propensity of α-helix formation in peptides regardless of the amino acid
sequence.75 N-terminal acetylation also increases the overall stability of an α-helix. In the
case of Cit 1.1, the apparent increase in helical stability due to acetylation resulted in a
loss of activity. Consequently, antimicrobial activity may be correlated with a certain
amount of structural disorder or mobility within the peptide. This is consistent with a
mechanism previously observed for α-synuclein. N-terminal acetylation increased the
helical propensity of α-synuclein and substantially decreased protein aggregation.76, 77
Thus, the antimicrobial activity of Cit 1.1 may likely depend on an equilibrium between a
disordered monomer in solution and helical dimers coating the membrane surface. In the
presence of bacteria, the equilibrium shifts from disordered monomer to the helical
dimer. The dimer is then able to associate with other dimers on the membrane surface and
promote antimicrobial activity through a proposed carpet mechanism. However, if the
peptide is stabilized in solution than the equilibrium is shifted away from interacting with
the bacterial membrane and the antimicrobial activity is abolished. We hypothesize that
Cit 1.1 exists as a disordered monomer in solution and dimerizes and aggregates along
the anionic surface of the bacterial membrane. In the inactive form, the N-terminal
acetylation stabilizes the transiently formed monomer α-helix in solution and the
aggregation on the membrane surface, which promotes antimicrobial activity, is greatly
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diminished. Again, the observation that the inactive AMP-003 dimer is exclusively αhelical and the Cit 1.1/AMP-016 dimers are a mixture of α- and 310-helix is supportive of
the proposal that helix stability affects antimicrobial activity. To further investigate the
role of α-helical stability in regards to antimicrobial activity, NMR was used to measure
the thermal stability and solvent accessibility of the Cit 1.1, AMP-003, and AMP-016
peptides.
The temperature-dependent chemical shift changes clearly define the dimer interface as
the residues with the largest ΔHN values (Figures 2D-F, S1-3). The residues in the dimer
interface correspond to: Ile6, Val9, Ala10, Ile13, and Gly14. Importantly, the inactive
AMP-003 peptide exhibited the smallest HN chemical shift changes for these residues.
This suggests the inactive AMP-003 is relatively less stable as a dimer in the SDS micelle
compared to the active peptides. Interestingly, there are additional AMP-003 residues
outside of the dimer interface that also exhibit a temperature-dependent chemical shift
change. This was not observed for the Cit 1.1 or AMP-016 peptides. One possible
explanation for this difference is that the AMP-003 peptide still maintains an α-helical
structure as a monomer, which undergoes further temperature-dependent denaturation.
This does not appear to occur for Cit 1.1 or AMP-016. In fact, more residues in the Cit
1.1 peptide compared to AMP-003 are disordered based on the lack of a temperaturedependent chemical shift change. This further suggests that a certain amount of structural
disorder or dynamics is necessary for antimicrobial activity.
The presence of a helical dimer is also suggested by the Gd-DTPA titration experiments.
At low concentrations of Gd-DTPA, the amide peak intensity for Leu2 was found to
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increase, which indicates a reduction in the chemical exchange with the solvent. It is
plausible that the coordination of Gd-DTPA by the active peptides stabilizes the dimer
structure and reduces the amide chemical exchange of Leu2 causing an initial sharpening
of the peak. Only at higher Gd-DTPA concentrations does the Leu2 NMR resonance
broaden like the other amino acid residues. This effect is not seen in the inactive peptide
(AMP-003), suggestive of a more stable α-helix along the entirety of the peptide
monomer.

4.4.3 Transmission Electron Microscopy (TEM), Scanning Electron Microscopy (SEM)
and Atomic Force Microscope (AFM)
Bacterial membrane disruption can be described either by the worm-hole, the barrelstave, or the carpet model.78, 79 Previously reported data on the Cit 1.1 interaction with
negatively charged lipid vesicles hinted towards involvement of the carpet mechanism.14
In the carpet-model of membrane disruption, the AMPs bind parallel to the membrane
and cover the entire surface. This causes cell membrane permeation and eventually
release of small vesicles from the membrane.78, 79 A separate study involving giant
unilamellar vesicles (GUVs) corroborated the carpet mechanism shown in the previous
studies.72 However, these prior studies relied on negatively charged phospholipid model
membranes, which are structurally simple compared to bacterial membranes. These
model membranes do not accurately represent the complexity of single or doublemembraned gram-negative organisms. Furthermore, these studies relied on indirect
fluorometric observations instead of direct microscopic imaging.14, 78 Treatment of S.

126
aureus and E. coli with AMP-016 lead to membrane disruption accompanied by the
formation of protruding blebs as visualized by SEM, TEM, and AFM (Figures 3, 4A-D).
Previous electron micrographs of S. aureus showed discontinuous membrane surfaces
that did not conform to any of the prevailing modes of membrane disruption,31, 78 The
absence of blebs in the prior studies is most likely due to damaged membrane architecture
caused during cell-sectioning.
The carpet mechanism of membrane disruption is commonly associated with detergentlike antibacterials displaying indiscriminant cell lytic properties. It has been also
suggested that peptides acting by this mechanism do not require a specific peptide
structure.11 Contrary to these beliefs, we have shown that even those AMPs that disrupt
membranes in a detergent like fashion are highly sensitive to subtle structural
modifications. A human host defense peptide, LL-37, has also been shown to disrupt
membranes following the “carpet model”.80 However, their innocuous presence within
human bodies illustrates a high selectivity between prokaryotic and eukaryotic cells.

4.4.4 Stiffness of Bacterial Membrane by AFM Nano-Indentation
Although AMPs are widely thought to disrupt bacterial membranes, few studies exist that
have investigated their influence on bacterial membrane stiffness. Consequently, little is
known about the mechanical properties of the disrupted membrane. AMP-006 treatment
lowered the membrane stiffness by four-fold in both gram-positive and gram-negative
bacteria. Based on the electron micrographs from this study and those from others,
membrane disruption appears to be a strictly localized phenomenon occurring at specific
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points of the membrane. However, the highly narrow standard deviation of the
Young’s modulus indicates the uniformity with which membranes were disrupted over
the entire cell. Thus, we conclude cell membrane softening occurred globally in the
bacterial membrane. As previously stated, Cit 1.1 appears to disrupt membranes by the
carpet model, requiring peptide molecules to bind parallel to the bacterial membrane and
then inserting a hydrophobic face into the membrane to cause a disruption.31 This would
require the AMPs to cover the entire bacterial surface, which most likely explains the
global reduction in membrane stiffness on AMP treatment even though we observe only
localized features of disruption in the form of blebs and leakage.
AMP mediated membrane softening however, has greater implications in augmenting
bacterial chemotherapy and overcoming drug resistance. It has been recently shown that
disruption of the outer membrane of E. coli by pentamidine facilitates overcoming drug
resistance in gram-negative bacteria.81 Pentamidine, however, requires a much higher
concentration (25 μM) of drug to disrupt the outer membrane. AMP-016 on the other
hand, not only disrupts both the outer and inner membrane at a concentration 5 times
lower than pentamidine, it also lowers the membrane stiffness about four-fold on average
in both gram-positive and gram-negative bacteria (Figure 4E-H). Depletion of factors
which are responsible for maintaining membrane fluidity have been shown to reduce
membrane stiffness.82 Others have shown that altered membrane stiffness has a profound
influence on cell channel functions.83 Reduced membrane fluidity has been a prime
mechanism for acquiring drug resistance.84, 85 Therefore, AMP mediated lowering of
membrane rigidity may be an attractive means of facilitating drug penetration and
overcoming resistance.
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4.4.5 AMP Internalization Kinetics
The rate of membrane internalization was used to measure the relative interaction of Cit
1.1 analogs with bacterial membranes by monitoring changes in peptide fluorescence.
Aromatic groups like phenylalanine and tryptophan may anchor a peptide into the
bacterial membrane,73 where the insertion of the side chain is expected to lead to
fluorescence quenching. Treatment of E. coli with AMP-012, -013, or -016 resulted in a
significant decrease in fluorescence when compared to Cit 1.1 (Figure 5B). This is
consistent with the observation that AMP-012, -013, and -016 displayed a similar or
higher antimicrobial activity relative to Cit 1.1 (Table 2). Introduction of tryptophan or
arginine residues into Cit 1.1 appears to increase the rate of membrane binding or the
affinity of the peptide dimer to the membrane. These findings may be explained by the
ability of arginine and tryptophan to allow the Cit 1.1 analogs to penetrate deeper into the
bacterial membrane.86

4.4.6 FITC Uptake kinetics
Membrane disruption caused cellular internalization of FITC and an associated decrease
of fluorescence intensity outside the bacterial cells.45 Thus, a correlation between an
increase in antimicrobial activity and the rate and extent of FITC uptake is expected for
active Cit 1.1 analogs. AMP-012, -013, and -016 peptides exhibited a greater rate and
extent of FITC uptake when compared to Cit 1.1 (Figure 5A). Again, this is consistent
with the increased rate of membrane internalization (Figure 5B) and the relative increase
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in antimicrobial activity (Table 2) of these peptides. Thus, the arginine and
tryptophan modifications to Cit 1.1 appear to induce greater membrane damage compared
to the wild-type peptide. These results are consistent with prior observations that arginine
and tryptophan-rich peptides enhance antibacterial activity by imparting greater amount
of damage to the cell membrane.55-57

4.4.7 In-vivo efficacy study
In vivo efficacy of the most active compound, AMP-016, was determined in a wax moth
model for staphylococcal infection. Cit 1.1 has been shown to have a protective effect
against both gram-negative and gram-positive bacteria in in-vivo models of sepsis.87, 88
The AMP-016 treated group displayed comparable survivability to the vancomycin
treated group at a dose of 15 mg/kg. AMP activity is often diminished in the presence of
salts and serum, which are major obstacles to successful translation to a clinical trial.89, 90
Our results (Figure 6) indicate that AMP-016 activity is not sensitive to physiological salt
or serum proteins and holds significant potential as a new antimicrobial treatment.

4.5 Conclusion
Using finely tuned Cit 1.1 analogs, we have probed the various interactions essential for
membrane disruption and antibacterial activity of helical AMPs. Cationic N-terminal
residues form crucial hydrogen bonds that were found to be indispensable for
antibacterial action. Ablation of either the hydrogen bond donors or the positive charge
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resulted in inactivity, which suggests hydrogen bonding and electrostatic interactions
synergistically cooperate in membrane disruption. We further discovered that the
projection of lysine side chains were essential to antibacterial activity. A shortening of
the side chain and corresponding reduction of the amine projection led to decreased
activity against all tested bacterial strains. Increased bulk of the hydrophobic anchor was
found to have the most pronounced influence on the AMPs. Mutation of Phe3 to a Trp
produced a peptide with significantly increase antimicrobial activity. NMR studies
revealed the propensity of AMPs to form head to tail dimers on the surface of anionic
membranes and bacterial surfaces. Both NMR and CD spectroscopy show a positive
correlation between a-helicity of the AMPs and their antibacterial activity. Further,
equilibrium between a disordered monomer and the helical dimer structures was
proposed that supports the carpet model of membrane disruption. This was subsequently
confirmed by electron microscopy in both gram-positive and gram-negative bacteria.
Fluorometric studies revealed increased internalization of the AMPs and FITC, which
further supports membrane disruption. AFM nano-indentation showed a four-fold global
reduction membrane rigidity upon AMP treatment. Reduction in membrane rigidity has
far-reaching implications for augmenting antibacterial therapeutics and in overcoming
drug resistance by using AMPs as part of multidrug therapy.
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4.7 Supplemental Figures

Figure S1. Temperature titration data for Cit 1.1. The change in the amide proton
chemical shift (ΔH) was monitored as a function of temperature. Labels are found right of
the graph and follow the peptide sequence in order. The largest changes in chemical
shifts correspond to stable amino acids becoming disordered at elevated temperature.
Coloring corresponds to binned amide proton temperature titration data according to
the ΔH ranges 0 to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red).
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Figure S2. Temperature titration data for AMP-003. The change in the amide proton
chemical shift (ΔH) was monitored as a function of temperature. Labels are found right of
the graph and follow the peptide sequence in order. The largest changes in chemical
shifts correspond to stable amino acids becoming disordered at elevated temperature.
Coloring corresponds to binned amide proton temperature titration data according to
the ΔH ranges 0 to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red).
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Figure S3: Temperature titration data for AMP-016. The change in the amide proton
chemical shift (ΔH) was monitored as a function of temperature. Labels are found right of
the graph and follow the peptide sequence in order. The largest changes in chemical
shifts correspond to stable amino acids becoming disordered at elevated temperature.
Coloring corresponds to binned amide proton temperature titration data according to
the ΔH ranges 0 to -0.05 (minor chemical shift, yellow), -0.05 to -0.25 (intermediate
chemical shift, orange), and -0.25 to -0.45 (major chemical shift, red).
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Figure S4: Gd-DTPA titration of Cit 1.1. The intensities of the amide proton peaks for
each amino acid were monitored upon titration with Gd-DTPA at the listed
concentrations. Intensities for each peak (I(x)) are normalized to the corresponding peak in
the initial spectrum (I(0)).
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Figure S5: Gd-DTPA titration of AMP-003. The intensities of the amide proton peaks
for each amino acid were monitored upon titration with Gd-DTPA at the listed
concentrations. Intensities for each peak (I(x)) are normalized to the corresponding peak in
the initial spectrum (I(0)).
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Figure S6: Gd-DTPA titration of AMP-016. The intensities of the amide proton peaks
for each amino acid were monitored upon titration with Gd-DTPA at the listed
concentrations. Intensities for each peak (I(x)) are normalized to the corresponding peak in
the initial spectrum (I(0)).
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Chapter 5
The NMR Solution Structure and Function of RPA3313: A Putative
Ribosomal Transport Protein from Rhodopseudomonas palustris
5.1 Introduction
Rhodopseudomonas palustris is a unique organism known for its metabolic diversity and
extensive distribution throughout the environment.1 It has the ability to grow under four
distinct modes of metabolism (photoautotrophic, photoheterotrophic, chemoautotrophic,
and chemoheterotrophic) on a wide assortment of carbon sources. R. palustris is typically
found in soil and freshwater sources, but has also been discovered in swine waste and
coastal sediments.2 As a purple non-sulfur photosynthetic bacterium, it belongs to the
alphaproteobacterium order.3 Within this order exists many species which are similarly
metabolically versatile, yet there are clear phylogenetic differences. In fact, based on 16S
rRNA sequencing the inherent divergence in the order is not based on phototrophic
ability but rather demonstrates a mixing of phototrophs and non-phototrophs.3 R.
palustris is of particular biotechnological interest because it utilizes aromatic
hydrocarbons as a carbon source under both aerobic and anaerobic growth conditions.
Also, R. palustris fixes more nitrogen when grown on aromatic hydrocarbons relative to
aliphatic substrates.4 Furthermore, growth of the organism can occur on aromatic
substrates containing a range of functional moieties. The combination of all of these
factors makes R. palustris a model organism for bioremediation, energy production, and
other biotechnological applications.5-9
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In 2004, the genome of R. palustris was sequenced and published along with a
prediction of general gene functional classes.2 Approximately 15% of the genome is
believed to be devoted solely to transport, which is surprising since prokaryotes usually
commit only a third of this amount (5-10%) to transport.10 Nevertheless, this greater
commitment of R. palustris to transport is consistent with its observed metabolic
diversity. A larger assortment of transport proteins would be necessary for R. palustris to
readily adapt to various carbon and energy sources; or to proliferate under changing
respiration or environmental states. Conversely, 29% of the genome has been tentatively
labeled as hypothetical or of unknown function. An additional 8% of the genome is only
annotated with a general function. A follow-up LC-ES-MS/MS proteomics analysis of R.
palustris included a more detailed functional annotation based on protein sequence
analysis.11 But, the percentage of functionally uncharacterized or partially annotated
proteins remained unchanged. Of particular note, the proteome of R. palustris was
analyzed for each metabolic mode of growth. Thus, the relative expression rates of R.
palustris proteins under each metabolic mode of growth are known.11 The large fraction
of unannotated or partially annotated R. palustris genes presents a significant obstacle for
the further development of biotechnological applications and hinders additional
biochemical studies.
The R. palustris protein RPA3313 (7.45 kDa, 70 amino acids) is a hypothetical protein
targeted for structural elucidation by the Structural Genomics Consortium at the
University of Toronto (http://www.thesgc.org/). RPA3313 is currently classified by
UniProtKB12 (Q6N4M4) as an uncharacterized protein. A BLAST search of the
RPA3313 sequence reveals a group of 93 hypothetical yet conserved proteins (> 32%
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identity) from only the alphaproteobacterium order (Figure 1). Unfortunately,
minimal structural or functional information was obtained from the sequence analysis
since no structures of homologous proteins are present in the Protein Data Bank
(http://www.rcsb.org/).14

Figure 1. (A) A neighbor-join tree of the protein BLAST results of RPA3313 against
non-redundant protein sequences. All of the sequence hits belong the
alphaproteobacteria order and have identities >32%. The three colored groups are
dominated by species belonging to the genera listed next to them. The tree highlights the
fact that this protein is a member of an unannotated and a structurally uncharacterized
class of proteins. (B) The BLAST sequence alignment of RPA3313 with the nine other
Rhodopseudomonas proteins. The secondary structure is indicated above the sequence
alignment and was generated with Polyview-2D.13 RPA3313 is indicated in the
phylogenetic tree and sequence alignment with a dot.

RPA3313 was identified in the previously reported R. palustris proteomics study11 and
was only observed to be expressed during photoautotrophic growth. Photoautotrophic
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organisms, such as R. palustris, sequester atmospheric CO2 and convert it to energy
rich carbon sources. Ribulose 1,5-bisphosphate carboxylase/oxygenase (RubisCO) are
found in photoautotrophic organisms and are responsible for most of the organic carbon
in the environment. As the most abundant protein in nature, RubisCO is found in plants,
bacteria, and archaea in at least four molecular forms.15 The genome of R. palustris
contains multiple forms of RubisCO, which further contributes to its adaptability to
diverse environmental conditions.16 The combined adaptability and RubisCO activity of
R. palustris may be beneficial to biotechnological applications involving bulk removal of
CO2 from the atmosphere. However, the photoautotrophic mode of metabolism in R.
palustris and other alphaproteobacteria remains relatively unknown.17
Although the hypothetical protein RPA3313 has been experimentally verified as an
expressed protein during photoautotrophic growth; the function and structure of
RPA3313 still remains elusive. Structural approaches are a valuable alternative to
obtaining a functional annotation when sequence similarity techniques fail and leaves a
large class of functionally uncharacterized proteins.18,19 Thus, obtaining an NMR solution
structure for R. palustris protein RPA3313 is expected to provide a better understanding
of its general biological role and also provide a putative structure and function for the 93
homologous proteins (Figure 1). RPA3313 forms a novel split ββαβ fold with a
conserved ligand binding pocket. The NMR structure combined with a bioinformatics
analysis and mass spectrometry proteomics suggest RPA3313 may assist in the
transportation of substrates to or from the ribosome for further processing.
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5.2 Methods
5.2.1 Protein expression and purification
Uniformly 15N and 13C labeled RPA3313 samples were prepared for NMR structural
studies as follows. The target sequence for RPA3313 (70 amino acids with a 21 amino
acid histidine tag for purification, MGSSHHHHHHSSGRENLYFQG) was expressed
from a pRI952 with glyT construct transformed into BL21(DE3) cells.20 Cells were
grown in Luria-Bertani (LB) media at 37°C until an approximate optical density (OD600)
of 0.6 and then spun down and transferred to M9 minimal media at 37°C containing 4%
U-13C glucose and 1% U-15N NH4Cl. Expression of RPA3313 was induced after one hour
of equilibration in the M9 media with isopropyl β-D-1-thiogalactopyranoside (IPTG).
Cell lysates were collected 4 hours after induction with IPTG and purified with a Co2+
affinity column (HisPur Cobalt Resin, Thermo Scientific). Sample homogeneity was
assessed by SDS-PAGE. ESI-MS and size exclusion chromatography was used to
confirm the monomeric solution state and exact mass of RPA3313 (Supplemental Figure
S1). The protein sample was stored in an NMR sample tube in 18 mM 2-(4morpholino)ethanesulfonic acid (MES) buffer with 0.01% sodium azide, 80 mM sodium
chloride and 10% D2O at a pH of 5.6 (uncorrected).

5.2.2 NMR structure determination
All NMR experiments were collected with non-uniform sampling at 20% sparsity using a
Poisson-gap schedule21 at 298K on a 700 MHz Bruker Avance III spectrometer equipped
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with a 5 mm QCI-P probe with cryogenically cooled carbon and proton channels.
Backbone and side-chain assignments were completed using the standard triple resonance
approach consisting of the following experiments: 1H-15N HSQC, 1H-13C HSQC, HNCO,
HN(CA)CO, HNCA, HN(CO)CA, CCANH, CBCA(CO)NH, HNHA, HBHA(CO)NH,
CC(CO)NH, HCC(CO)NH, HCCH-COSY, and HCCH-TOCSY.22,23 Identification of
nuclear Overhauser effects (NOEs) was accomplished with 15N-edited NOESY-HSQC
and 13C-edited NOESY-HSQC experiments using a mixing time of 150 ms. The resulting
data was reconstructed using multidimensional decomposition (MDD) and processed in
TopSpin 3.2 followed by evaluation in CCPNMR Analysis.24 Initial model generation
according to backbone chemical shifts was undertaken using CS-ROSETTA25-27 on the
open webserver at the BMRB (https://csrosetta.bmrb.wisc.edu/). The CS-ROSETTA
software was only used for the creation of an initial model for RPA3313. CS-ROSETTA
was not used to further refine the RPA3313 ensemble.
XPLOR-NIH version 2.37 was used to refine the initial model of target RPA3313.28,29
Briefly, the refinement involved 912 manually assigned NOE distance restraints, 66
hydrogen bond distance restraints, 30 3JNHα coupling constants, 128 13Cα/13Cβ chemical
shifts, and 102 predicted dihedral angle restraints from TALOS+.30 1000 total structures
were generated during the XPLOR-NIH structure refinement and the 20 lowest energy
structures were subsequently subjected to water refinement according to the RECOORD
conventions. The coordinate average structure for the water-refined models was further
subjected to the same explicit water refinement method for energy minimization. The
water-refined ensemble and average structure for target RPA3313 was analyzed with the
PSVS software suite, which is comprised of commonly used structural validation
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packages.

31-35

UCSF Chimera was used for the structural visualization and surface

representation of RPA3313.36

5.2.3 Chemical crosslinking and in-gel digestion
Approximately 3 hours following the induction of RPA3313 in Lysogeny broth (LB)
media, the E. coli culture was pelleted and resuspended in crosslinking buffer (1%
paraformaldehyde, 1X PBS, pH 8, 37°C). Crosslinking was allowed to proceed for 15
minutes before quenching with 1.25 M glycine. The E. coli cells were lysed by sonication
and RPA3313 with crosslinked binding partners was purified using the RPA3313
histidine tag and a Co2+ affinity column as described above in the protein purification
section. The sample preparation procedure also efficiently removes the formaldehyde
crosslinking. The purified proteins were then visualized by SDS-PAGE. Protein bands
were excised before submission to the Nebraska Center for Mass Spectrometry for
MS/MS analysis.
Rhodopseudomonas palustris (ATCC) was propagated in a filled flask of 500 mL of 112
medium at 30°C for several days until reaching stationary growth. Bacterial growth was
red in color indicating that photoautotrophic had occurred. The culture was pelleted by
centrifugation and resuspended in water prior to lysis by sonication. Extracted proteins
were frozen and lyophilized overnight. Approximately 2 mg of pure RPA3313 was added
to the R. palustris protein extract before the addition of crosslinking buffer. The
crosslinking was performed similar to the E. coli crosslinking above. RPA3313 with
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crosslinked binding partners was purified using the RPA3313 histidine tag and a Co

2+

affinity column as described above in the protein purification section.

5.2.4 MS proteomics
Protein bands separated with SDS–PAGE were digested in situ using a slightly modified
version of a published method.37 Briefly, the samples were washed with
100 mM ammonium bicarbonate, reduced with 10 mM DTT, alkylated with
55 mM iodoacetamide, washed twice with 100 mM ammonium bicarbonate, and digested
in situ with 10 ng/µL trypsin (Promega, Madison, WI, USA). Peptides were extracted
with two 60 µL aliquots of 1:1 acetonitrile:water containing 1% formic acid. The extracts
were dried down using a SpeedVac and then reconstituted into 15 uL of water + 0.1%
formic acid. Four microliters of the extract solution was injected onto a trapping column
(300 µm × 1 mm) in line with a 75 µm × 15 cm C18 reversed phase LC column (Waters,
Milford, MA, USA). Peptides were eluted from the column using a water + 0.1% formic
acid (A)/ acetonitrile + 0.1% formic acid (B) gradient with a flow rate of 500 nL/min.
The gradient was developed with the following time profile: 0 min, 5% B; 5 min, 5% B;
35 min, 35% B; 40 min, 45% B; 42 min, 60% B; 45 min, 90% B; 48 min, 90% B; and
50 min, 5% B.
The eluting peptides were analyzed using a Synapt G2S Q-TOF tandem mass
spectrometer (Waters, Milford, MA, USA) with electrospray ionization. Analyses were
performed using data-dependent acquisition (DDA) with the following parameters: 0.7
sec. survey scan (380–200 Da) followed by up to four MS/MS acquisitions (50-2000 Da).
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The instrument was operated at a mass resolution of 18000. The instrument was
calibrated using a solution of NaI in 1:1 water:acetonitrile. The MS/MS data were
processed using Masslynx software (Micromass, Milford, MA, USA) to produce peak
lists for database searching. Mascot (Matrix Science Ltd, London, UK) was used as the
search engine. Data were searched against the National Centre for Biotechnology
Information (NCBI) non-redundant database. The following search parameters were
used: mass accuracy 20 ppm, enzyme specificity trypsin, fixed modification
carboxyamidomethylcysteine (CAM), variable modification oxidized methionine. Protein
identifications were based on random probability scores with a minimum value of 25.

5.2.5 Bioinformatics Analyses
The RPA3313 sequence (excluding the 21 residue histidine tag) and the NMR structure
were submitted to the ConSurf webserver to identify evolutionary conserved residues.38-41
Structural comparison was done with PDBeFold42 and protein-protein interaction
residues were predicted with cons-PPISP.43,44 Results from the ConSurf and cons-PPISP
analyses were mapped onto the surface of the protein with UCSF Chimera.45 Surface
hydrophobicity was also calculated within Chimera. The BLAST hits were visualized
with the neighbor-join algorithm using Dendroscope.46
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5.3 Results and Discussion
5.3.1 Solution Structure of R. palustris protein RPA3313
Backbone and side-chain resonance assignments for RPA3313 were made for the 68
assignable residues excluding the N-terminus histidine tag (Figure 2). The NMR
assignments are nearly complete with 68 of 68 N, 68 of 68 HN, 68 of 68 Cα, 76 of 76 Hα,
60 of 60 Cβ, 93 of 97 Hβ, 33 of 55 Cγ, 57 of 60 Hγ, 13 of 28 Cδ, 32 of 39 Hδ, 3 of 12 Cε,
16 of 21 Hε, 0 of 9 Cζ, and 4 of 7 Hζ. The monomeric solution structure of RPA3313 was
calculated using 912 distance restraints, 102 angle restraints, 30 3JNHα coupling constants,
128 13Cα/13Cβ chemical shifts, and an initial model generated using CS-ROSETTA.25-27
During structure generation, 1000 structures were initially created and the 20 lowest
energy models were selected for further water refinement. A coordinate average of the 20
water-refined structures was subjected to water refinement for additional minimization.
The water refined ensemble structures did not contain any distance violations >0.5 Å or
dihedral angle violations >5°. Also, the NMR data agrees well with the calculated
structures since the RMSD of the backbone secondary structure residues is 0.70±0.07 Å
and the RMSD for heavy atoms is 1.2±0.12 Å. Complete structural statistics for the
RPA3313 NMR structures are listed in Table 1. Chemical shift assignments have been
submitted to the BMRB as entry 30070 and coordinate files have been uploaded to the
PDB as entry 5JN6.
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Figure 2. A 2D 1H-15N HSQC NMR spectrum of RPA3313 with peaks labeled according
to their respective residue numbers or side-chain identification. Unlabeled peaks
correspond to the 6x His tag, which was not included in the structure generation or
analysis.

The overall quality of the RPA3313 NMR structure was assessed with the PSVS software
suite (Table 2). All but one residue was located in the most favored region (98.3%) of the
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Ramachandran plot with the remaining residue in the allowed region (1.7%).
PROCHECK further supported the dihedral angle quality of the RPA3313 NMR structure
with Z-scores of 0.12 and -0.71 for ϕ, ψ angles and all angles, respectively. Overall
model quality was further assessed with ProsaII that produced a good Z-score of -0.58.
An excellent quality score of -0.45 was also obtained from a MolProbity analysis, which
evaluates atom clashes in the 3D structure. The ProsaII, PROCHECK and MolProbity
scores are consistent with other high-quality NMR structures deposited in the PDB.
Conversely, the Verify3D structure assessment yielded only a modest score of -1.93, but
the analysis is still within an acceptable range compared to other NMR structures.
Verify3D measures agreement between the 3D structure and the primary sequence. The
novel fold for the RPA3313 structure may be a factor in the relatively low Verify3D
score.

Table 1. Structure Calculation Statisticsα
rmsd for distance restraints (experimental) (Å)

<SA>

( SA )r

all (912)

0.048±0.004

0.039

inter-residue sequential (|i-j| = 1) (269)

0.019±0.009

0.002

inter-residue short-range (1 < |i-j| < 5)
(238)
inter-residue long-range (|i-j| ≥ 5) (83)

0.075±0.006

0.067

0.070±0.019

0.054

intraresidue (256)

0.007±0.003

0.005

H-bonds (66)

0.022±0.007

0.024

0.654±0.032

0.626

rmsd for dihedral angle restraints (deg) (102)
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3

rmsd for JHNα restraints (Hz) (30)

0.515±0.050

0.569

bonds (Å)

0.007±0.000

0.008

angles (deg)

0.716±0.027

0.461

impropers (deg)

1.075±0.090

0.977

-2161.44

bond

1900.73±89.02
29.05±3.24

angle

87.92±8.88

96.49

dihedral

3.58±1.76

2.43

impropers

49.58±8.67

39.10

van der Waals

-184.53±10.91

-191.49

NOE

63.30±10.65

41.50

3

8.03±1.51

9.73

77.89±10.00

65.75

rmsd (covalent geometry)

energy (kcal/mol)
total

JHNα

Cα and Cβ shifts

30.99

RMSD from mean (residues 2-21, 27-55) (Å)

α

Backbone

0.70±0.07

Heavy Atoms

1.20±0.12

<SA> represents the ensemble of the 20 water-refined simulated annealing

structures. ( SA )r represents the water refined average of the ensemble.

Table 2. Structure Evaluation

PSVS Z-score (residues 6-54)
Verify3D

-1.93
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ProsaII (-ve)

-0.58

Procheck (ϕ and ψ)

0.12

Procheck (all)

-0.71

MolProbity

-0.45

Ramachandran Space (all residues)
most favored regions

98.30%

allowed regions

1.70%

disallowed regions

0.00%

The structure of RPA3313 adopts a split ββαβ motif formed by 3 β-strands (β1-3) packed
against an α-helix (Figure 3). There are no known structures of homologs to RPA3313
and a search against the PDB using PDBeFold did not yield any significant results.
Although the ββαβ motif is ubiquitous, when the RPA3313 structure is compared to
proteins with similar motifs there is either a different handedness, or the orientation of the
sheet along the α-helix is askew. This is not uncommon for this type of fold, as the
sheet typically curls or flexes to cover the hydrophobic core of the protein.47
Starting at the N-terminus, the first 2 β-strands are formed antiparallel to one another and
are connected by a β-hairpin turn. The initial residues at this terminus do not contribute to
β1 and are disordered. At the beginning of β2, Trp15 creates significant bulk in the core
of the protein near the β-hairpin. The indole side chain reaches from β2 toward the
surface of the protein, which forces Gly10 to accommodate this structural perturbation.
Both β1 and β2 have branched side chains forming the center of the protein. Connecting
β2 to the α-helix is an extended loop region comprised mostly of negatively charged,
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polar residues. This loop outlines the top of a cavity formed with β1 and the Nterminus of the α-helix. An additional Tyr residue in the loop has its side chain in close
proximity to Lys30, which marks the beginning of the α-helix. The length of the α-helix
is approximately 17 residues and is terminated by Gly48. Alanine residues line the inside
of the helix and polar residues, including one cysteine, create the solvent exposed surface.
A γ-turn links the α-helix to β3, which runs parallel to β2. The side chain of Arg52 on β3
is angled toward the center of the β-sheet and creates a stacking interaction with Arg14
on β2 (Figure 4). This interaction is stabilized by Glu50, which may explain why the αhelix to β3 turn contains only 2 residues. The bottom of β3 is hydrophobic and consists of
branched chain amino acids.

Figure 3. (A) An ensemble of the 20 best water-refined structures of RPA3313 for
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residues 6-54 and (B) the coordinate average structure of the ensemble after water
refinement. The structures are colored according to secondary structure: red for α-helix,
blue for β-strand, and white for loops and disordered regions. The structural elements and
the N- and C-terminus are labeled. The disordered C-terminus has been excluded for
clarity.

Following the last β-strand is the disordered C-terminus. At approximately 15 residues in
length, this tail is mostly unstructured except for a small α-helical propensity centered on
Val67. Seemingly uninteresting at first, the disordered C-terminus probably has a
significant physiological function. Disordered termini are known to serve in a broad
range of roles such as protein-protein interaction sites, chaperones, and signal
processing.48 The proximity of the terminus to the large cavity on the surface of
RPA3313 also suggests that it may potentially serve a role in activity (Figure 3b). Singlestranded DNA (ssDNA) binding proteins in prokaryotes maintain evolutionary conserved
disordered C-termini that compete with the DNA binding site in order to exclude
unwanted binders.49 Although it is not known if RPA3313 binds ssDNA, the mechanism
of the competition between the disordered tail and ligand remains a possibility. Also,
many photosynthetic organisms possess globular proteins that have extended termini and
are involved in a wide array of functions.50 These extensions are highly variable and
show little conservation between homologous species. However, they are necessary for
host protein regulation and function. Since RPA3313 is expressed during
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photoautotrophic growth, it is possible that the disordered tail is involved in a light
dependent mechanism.

Figure 4. Arginine stacking interaction on the surface of RPA3313. Arginines 14 and 52
interact across the top of the β-sheet and are stabilized by glutamate 50. Each of the
residues is evolutionarily stable indicating the occurrence of a conserved interaction.
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5.3.2 Conserved Residue Analysis
The structure of RPA3313 was submitted to the ConSurf server for conserved residue
analysis. ConSurf identifies and scores residue conservation based on a BLAST search
and a subsequent multiple sequence alignment. Plotted on a surface representation of the
RPA3313 NMR structure are the ConSurf scores, which range from 0 (blue) to 1 (red)
with 1 signifying high conservation (Figure 5). Clearly visible is a conserved pocket
between the extended loop and the top of β1. The deepest region of the cavity is defined
by the peptide backbone of the α-helix and Tyr6. Conserved residues with side chains
pointing into the pocket are Asp20, Tyr27, Lys30, and Phe34 (Figure 6). The Asp, Tyr,
and Lys residues have the ability to form hydrogen bonds with a ligand. Additionally,
Lys and Asp are possible metal coordinators and Tyr and Phe may be involved in π-π
interactions with a ligand. Also conserved are small flexible residues Gly2, Ala4, and
Gly25. Each residue is either at the top or the bottom of the pocket and likely contributes
to important structure flexibility. These small residues would enable the protein to bend
in order to accommodate a larger ligand, or to change the size of the entrance to the
pocket based on other structural perturbations or modifications. Gly2 is doubly important
as it follows the N-terminal start methionine. Small flexible residues trailing methionine
enable truncation by an aminopeptidase and it is anticipated that the physiological form
of RPA3313 lacks this initial methionine residue.51 Distal to the pocket, the γ-turn
between α-helix and β3 is also highly conserved. It is possible that this turn also acts like
a hinge between the β-sheet and α-helix to allow the protein to adjust to a possible change
in the hydrophobic core resulting from binding a ligand or a protein-protein interaction.
The aforementioned stacked arginine residues (14, 52) are also moderately conserved.
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The ConSurf score of approximately 0.5 indicate that this could be an evolutionary
newer interaction or function. The stabilizing Glu50 residue has a higher conservation
score (~0.7) than the arginines, but lower than the other residues in the γ-turn. This
suggests that Glu50 may have a dual role in providing flexibility at the hinge in addition
to stabilizing the arginine stacking interaction. Lastly, a highly conserved proline residue
(56) exists at the end of β3. Proline is known to disrupt secondary structure formation and
is most often found in disordered regions or turns. In this case, proline is acting as a
terminator of a β-strand, which may assist in keeping the C-terminus residues in a
disordered state. Furthermore, proline residues are associated with protein-protein
interactions involving disordered protein regions.52 In these situations the disordered tail
or region adopts an induced fit upon interaction or binding.

Figure 5. ConSurf Analysis. (A) ConSurf per residue scores for the structure RPA3313.
Conserved residues are red and non-conserved residues are blue. (B) ConSurf scores
mapped onto the molecular surface representation of RPA3313. A conserved pocket is
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formed between the N-terminus of the α-helix and the first β-strand. Residues found
to be less conserved are mostly found in the loop regions and the disordered tail (Cterminus, not shown).

Figure 6. Surface pocket and possible ligand binding site on RPA3313. Shown are the
residues with side chains that point into the pocket of the protein. The evolutionarily
conserved residues are labeled. The remaining residues may also participate in the
function of the pocket even though they are not highly conserved.
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5.3.3 Protein-Protein Interaction Site Prediction
A further bioinformatics analysis of the structure of RPA3313 was carried out with consPPISP. The cons-PPISP server utilizes a neural network to predict position specific
interaction sites on protein surfaces. Based on the output of cons-PPISP, it is possible to
reliably identify clusters of residues that suggest a potential protein binding site. Two
large sites were successfully identified that, when visualized on the surface of the
RPA3313 NMR structure, lie opposite of one another (Figure 7). One potential protein
binding site is between the β-sheet and α-helix on the bottom of RPA3313, while the
other crosses the width of the β-sheet on the top of the protein. The bottom protein biding
site consists of side chains from residues Tyr6, Trp15, Phe34, Cys38, Ser42, Ile45,
Lys46, Glu50, Val51, Arg52, Ile53, and Thr54 (Figure 7a). Although mostly hydrophobic
in composition (Figure 7c), these residues form a likely interaction hotspot due to their
high abundance in other known protein-protein interactions.53 Furthermore, the surfaces
of β-sheets are known to commonly participate in protein binding. A protein binding
event at this bottom location on the RPA3313 surface could induce a significant
reshuffling of the hydrophobic core as discussed earlier. The second predicted protein
binding site runs perpendicular to the β-sheet and lies directly opposite the first predicted
binding site (Figure 7b). Solvent exposed side chains from residues Val9, Tyr27, Ala32,
Ala36, Ala39, and Asn43 populate the surface of the top protein binding site. This
putative protein interaction site has both hydrophobic and hydrophilic regions (Figure 7d)
indicating that multiple binding partners are possible.
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.

Figure 7. cons-PPISP predictions and surface hydrophobicity. (A) Front and (B) back
orientations of RPA3313 with predicted protein interaction sites colored red. (C) Front
and (D) back surface hydrophobicity colored from blue (hydrophilic) to orange
(hydrophobic).
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5.3.4 Protein-Protein Crosslinking
A simple crosslinking experiment was carried out in order to determine possible protein
binders to RPA3313. The crosslinking experiment was performed both in vivo in E. coli
and in vitro with a proteome extract from R. palustris. The replicate crosslinking
experiments were performed to reliably identify physiologically-relevant interaction
partners to RPA3313. RPA3313 was overexpressed in E. coli and prior to the two distinct
crosslinking experiments the cell culture was split into two separate samples. A small
aliquot of the total cell culture was removed for the in vivo crosslinking experiment, and
the remaining cell culture was then used to extract and purify the overexpressed
RPA3313 protein.
Purified RPA3313 was spiked into a total protein extract from an R. palustris cell culture
and the formaldehyde crosslinking was then performed in vitro. In contrast, the E. coli
cell culture overexpressing RPA3313 was simply treated with formaldehyde for an in
vivo crosslinking experiment. Formaldehyde was used to covalently link lysine side
chains through amide bond formation and subsequently removed by heating the sample
after purification. Following purification, the crosslinked proteins were resolved by SDSPAGE and identified by MS/MS analysis. Proteins found to be crosslinked to RPA3313
belonged to ribosomal subunits in both E. coli and R. palustris (Table 3). Moreover, most
of the protein component of the ribosome from both organisms was identified to bind
RPA3313. Thus, RPA3313 appears likely to bind to the ribosome at one or multiple
points. Since it is also possible that the ribosome remained intact during the crosslinking
and purification process, the number of binding sites for RPA3313 on the ribosome
remains undetermined. It is important to note that RPA3313 was only overexpressed in E.
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coli and not in R. palustris. This insures that the results are physiologically relevant
and not a simple artifact of an overexpressed protein being crosslinked to equally
abundant ribosomal proteins. In fact, an additional in vivo crosslinking experiment with a
second overexpressed protein (human DJ-1) served as a negative control and verified that
the RPA3313 results were not an artifact of a protein overexpression system. Despite
identical experimental conditions and unlike RPA3313, human protein DJ-1 did not
crosslink with any (as expected) E. coli proteins in vivo.
A previous study successfully sequenced and identified the ribosomal subunits from R.
palustris.54 During the study, other uncharacterized proteins were purified with the
ribosome, but none of them were identified as RPA3313. Like many ribosomal subunits
from other organisms, some of the subunits from R. palustris contained disordered Ctermini. The disordered C-terminus acts as an anchor and buries itself into the RNA core
and also promotes proper assembly of the ribosome.55,56 Globular portions of the proteins
are then exposed to the solvent to interact with other proteins. While RPA3313 is not part
of the ribosome, its tertiary structure mimics a ribosomal subunit with the multiple
protein-protein binding sites and a disordered C-terminus. RPA3313 may instead act as a
chaperone or transporter for substrates traveling to or from the ribosome.
Table 3. In vivo and in vitro Crosslinking Results
Organism
E. coli
R. palustris
E. coli
(DJ-1 control)

Identified Ribosomal Proteins
S2-11, S13, S15, S16, S18, S19, S21, L2-6, L9-11, L13-22, L24, L27,
L28, L32
S6-13, S15-17, S19-21, L1-3, L6, L7/12, L9, L10, L15, L17-19, L21,
L23, L24, L30, L32, L33
NA
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5.4 Conclusion
RPA3313 is a conserved protein from R. palustris and a member of functionally
unannotated class of proteins in alphaproteobacteria. The purpose of this study was to
structurally characterize this class of proteins and provide an initial functional
characterization. An NMR solution structure reveals that RPA3313 adopts a novel
globular split ββαβ motif followed by a disordered C-terminus tail. PSVS evaluation of
the ensemble of the 20 lowest energy structures of RPA3313 produced generally good
quality scores consistent with other high-quality NMR structures deposited in the PDB.
Bioinformatics analyses led to the identification of several possible protein-protein
interaction sites on the surface of RPA3313 and a large conserved pocket sandwiched
between the β-sheet and α-helix. Crosslinking analysis revealed that RPA3313 interacts
with the ribosome both in vivo and in vitro. Multiple ribosomal subunits were pulled
down with RPA3313 in E. coli and in R. palustris, so the exact nature of the interaction
between the two is unknown. In silico dockings, 15N NMR titrations, and ligand
screenings were done in an attempt to determine the physiological role of RPA3313 (data
not shown). However, a binder with a sub-millimolar binding constant was not found. It
is possible that the tertiary structure of RPA3313 changes the shape of its binding pocket
when in contact with another protein or in a much larger complex. Also, the C-terminus
tail could be blocking or competing for the binding site and the lack of an N-terminus
methionine truncation could also impede the binding site. The expression conditions of
RPA3313 also remain unknown. It is possible that the protein is only expressed during
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certain metabolic modes of growth, as this protein is not found in evolutionary distant
bacterial species with more limited metabolism. The combined structural and proteomic
analyses in this study strongly suggests that RPA3313 by itself or in a larger complex
may serve as a ribosomal transport protein.
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5.6 Supplemental Figures

Supplemental Figure S1. Intact mass analysis using ESI-MS of RPA3313 from Figure
1. ESI-MS confirms the major state of RPA3313 is a monomer.
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Chapter 6
Identification of a Ligand-Binding site on the Staphylococcus aureus
DnaG Primase C-Terminal Domain
6.1 Introduction
The initiation of DNA synthesis in living organisms and many large viruses results from
the coordinated interaction of two enzymes - primase and helicase.1, 2 In bacteria, DnaG
primase is the specialized DNA-dependent RNA polymerase that synthesizes short
oligoribonucleotide polymers called primers. DNA polymerase, an enzyme that lacks the
ability to initiate chain synthesis, elongates the primers. DnaG primase is stimulated by
the homohexameric DnaB helicase. (Note: The name DnaB helicase is used here for the
protein that is actually named DnaC helicase in Staphylococcus aureus and Bacillus
subtilis because, in all other bacteria, DnaB is the name of the replicative helicase and
DnaC is the name of the helicase-loading enzyme). DnaB helicase dissociates the two
strands of duplex DNA during DNA replication while hydrolyzing ATP, and travels
processively in the 5’-3’ direction along the single-stranded lagging template toward the
replication fork, communicating allosterically with the multi-subunit replicative DNA
polymerase. This action keeps it in proximity of the replication fork and ensures the
primers are synthesized on the exposed single-stranded DNA nearest to the replication
fork. Since primase activity is weak, the stimulation by DnaB causes primase to
synthesize primers only at the replication fork when and where they are needed.3, 4
Finally, the DnaG-DnaB interaction is an attractive antibiotic target because it is
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conserved in bacteria, essential for DNA replication, and is distinctly different from
that of viruses, archaea, and eukaryotes.5-7
DnaG primase is composed of three functional domains: the N-terminal zinc-binding
domain (ZBD, Pfam: PF08275) responsible for DNA binding specificity; the RNA
polymerase domain (RPD, Pfam: PF01751) responsible for enzymatic activity; and the Cterminal domain (CTD, Pfam: PF10410) responsible for the interaction with the DnaB
helicase.8-10 The 110-residue ZBD contains the highest percentage of conserved residues
and structural conservation, whereas the 140-residue CTD has the least sequence
conservation and the most structural diversity (Table S1). Of these domains, the ZBD is
unique to bacterial primases, the magnesium-binding residues of the RPD shares some
similarity to the magnesium-binding residues of topoisomerases and some DNAhydrolyzing enzymes, while the CTD is similar only to the N-terminal domain of DnaB
helicases, the domain to which it binds.11-14 Currently, no high-resolution structure has
been solved for a full, intact bacterial primase, but structures are available for all three
individual domains. The primase CTD is the domain with the most experimental
structures.6, 15-18 There are X-ray crystal structures and NMR solution structures (Table 1)
from S. aureus (2LZN, current paper), E. coli (2HAJ, 1T3W), G. stearothermophilus
(1Z8S, 2R6A), and H. pylori (4EHS). In addition, the ZBD-RPD domain pair from
Aquifex aeolicus has been experimentally determined.11 It has been proposed that the
conformations of the two E. coli structures in 1T3W may not be biologically relevant due
to crystallization conditions and packing effects.17
To develop the DnaG-DnaB interface as an antibiotic target, we determined the solution
structure of the DnaG CTD from S. aureus. This organism was chosen because there is an
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urgent need for new antibiotic targets due to the rapid rise in antibiotic resistance. A
comparison to known structures from other bacteria indicated that the S. aureus CTD was
composed of two subdomains. The CTD from Firmicutes and Proteobacteria may adopt
similar conformations when bound to helicase, but may adopt different free
conformations. A study of the structural dynamics of the free S. aureus CTD confirmed
that the junction between the two subdomains is the focal point for the greatest
movement. Also, one of the subdomains is significantly more ordered than the other. The
structure was used to identify three small compounds that bound to the close
conformation, which is likely to reduce the primase-helicase interaction.

Table 1: Primase CTD structures used for analysis
Species

PDB ID – chain

Reference

S. aureus

2LZN – 14

Current paper

G. stearothermophilus

1Z8S – 5

6

E. coli

2HAJ – 19

17

G. stearothermophilus

2R6A – C

16

H. pylori

4EHS – A and 4EHS – B

20

E.coli

1T3W – A and 1T3W – B

18
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6.2 Experimental Procedures
6.2.1 Chemicals
The dimethyl sulfoxide-d6 (99.9% D) and deuterium oxide (99.9% D) were obtained from
Aldrich (Milwaukee, WI). The 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt
(98% D) was purchased from Cambridge Isotopes (Andover, MA). The potassium
phosphate dibasic salt (anhydrous, 99.1% pure) and monobasic salt (crystal, 99.8% pure)
were purchased from Mallinckrodt (Phillipsburg, NJ). All compounds used for screening
were obtained as described earlier.21 Briefly, the compound library is composed of 437
known biologically active compounds distributed across 113 mixtures with 3-4
compounds in each mixture.

6.2.2 Proteins
Uniformly 13C,15N-labeled S. aureus DnaG primase CTD and uniformly 15N-labeled S.
aureus DnaG primase CTD were designed and purified by Nature Technologies (Lincoln,
NE). The details of protein expression and purification were previously described.22 The
vector added 20 N-terminal residues: an HN metal affinity tag
(MGHNHNHNHNHNHNGG) followed by a protease-sensitive DDDD sequence.22

6.2.3 NMR data analysis, structure calculations and refinement
The NMR spectra for obtaining the protein backbone assignments were collected at 298
K on a five-channel 600-MHz Bruker Avance spectrometer equipped with a 5-mm TXI
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probe. The NMR spectra for the protein side chain assignments were collected at the
Rocky Mountain Regional 900-MHz NMR Facility on a four-channel 900-MHz Varian
INOVA spectrometer equipped with a 5-mm HCN probe. The nearly complete S. aureus
DnaG primase CTD NMR resonance assignments have been previously reported.22
Distance constraints were obtained from 3D 15N-edited NOESY and 3D 13C-edited
NOESY that were collected at 900 MHz.23 Hydrogen bond constraints were determined
using the (CLEANEX-PM)-FHSQC experiment.24 All torsion angle constraints were
obtained by chemical shift analysis using the TALOS25 software program, and measured
coupling constants from an HNHA experiment.26
For the backbone NMR assignment experiments, 13C,15N-labeled protein was
concentrated to 1.2 mM in a 95% H2O/5% D2O buffered solution of 100 mM NaCl, 25
mM potassium phosphate at pH 6.64 (uncorrected) using an Amicon ultra centricon (MW
cutoff 10,000 Da). Long-term protein stability was enhanced by adding 50 mM arginine
and 50 mM glutamine. For the side chain experiments, 13C,15N-labeled protein was
concentrated to 1.4 mM in the same buffer. All multidimensional experiments were
processed using NMRPipe27 and analyzed using PIPP28 and CCPNMR.29
Nuclear Overhauser Effect (NOE) assignments were obtained by using 3D 15N-edited
NOESY and 3D 13C-edited NOESY. NOE intensities were sorted visually into four
classes: strong (1.8–2.5 Å), medium (1.8–3.0 Å), weak (1.8–4.0 Å), and very weak (3.0–
5.0 Å). Upper limits for distances involving methyl protons and non-stereospecifically
assigned methylene protons were corrected appropriately for center averaging. Initial
NOE assignments were completed by the program Autostructure.30 Despite the high
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magnetic field of 900 MHz, the extent of cross-peak overlap was great enough to
warrant manual refinement of the NOE assignments.
Hydrogen bond constraints were determined using the (CLEANEX-PM)-FHSQC
experiment, which identifies amide residues with fast water exchange rates.24 Hydrogen
bond constraints were assigned to amides in secondary structure regions for any 2D 1H15

N HSQC peaks lacking a corresponding peak in the (CLEANEX-PM)-FHSQC

spectrum. The carboxyl oxygen to amide nitrogen hydrogen bond distances were set at
2.8 Å while the carbonyl oxygen to amide proton distances were set at 1.8 Å. All
carboxyl groups within 2.5 Å of slowly exchanging amide groups were constrained to be
involved in a hydrogen bond.
The structures were refined using the hybrid distance geometry dynamic-simulated
annealing method31 using the XPLOR-NIH program32, 33 adapted to incorporate
pseudopotentials for 3J(HN-Hα) coupling constants, secondary 13Cα/13Cβ chemical shift
constraints, and a conformational database potential.34-38 The force constant for the
conformational database was kept relatively low (0.5–1.0 kcal/mol) throughout the
simulation to allow the experimental distance and torsion angle constraints to
predominately influence the resulting structures. The force constant for the NOE and
dihedral constraints were 30 times and 10 times stronger than the force constants used for
the conformational database.39 All peptide bonds were constrained to be planar and trans.
There were no hydrogen-bonding or electrostatic empirical potential energy terms in the
target function. A total of 1000 structures were calculated and the 20 lowest energy
structures were selected to become the ensemble of S. aureus DnaG primase CTD
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structures. Each of these twenty structures were subjected to further energy
minimization using explicit water with Crystallography and NMR system (CNS) version
1.2.40 Explicit water solvation was accounted for with Lennard-Jones and electrostatic
potentials using a modification of the procedure and force field of Nilges.41, 42

6.2.4 Protein backbone dynamics
The NMR experiments for protein dynamics analysis were collected on a Bruker 500
MHz Avance spectrometer (Billerica, MA) equipped with a triple resonance, Z-axis
gradient cryoprobe. The sample was uniformly 15N-labeled S. aureus DnaG primase CTD
concentrated to 1.2 mM in a 95% H2O/5% D2O buffered solution of 100 mM NaCl, 50
mM arginine, 50 mM glutamine, 25 mM potassium phosphate, pH 6.64 (uncorrected)
using an Amicon ultra centricon (MW cutoff 10 000 Da).
The previously described43-45 experiments included a 2D 15N-1H HSQC experiment
(hsqct1etf3gpsi) designed to measure T1 relaxation rates with delay times of 0.0 ms, 5.39
ms, 53.92 ms, 134.80 ms, 269.60 ms, 404.40 ms, 539.20 ms, 674.00 ms and 1078.40 ms,
a 2D 15N-1H HSQC experiment (hsqct2etf3gpsi) designed to measure T2 relaxation rates
with delay times of 0.0 ms, 17.6 ms, 35.2 ms, 52.8 ms, 70.4 8 ms, 105.6 ms, 123.2 ms,
140.8 ms, 158.4 ms, 176.0 ms, and a 2D 15N-1H HSQC experiment (hsqcnoef3gpsi)
designed to measure NOE changes.
The relaxation rates (T1, T2) for each amino acid within the structure were calculated by
fitting the intensity of each peak to the intensity decay curve (eq 1) where It is the
intensity of each peak at the delay time t, I0 is the initial steady state intensity.

𝑡

𝐼𝑡 = 𝐼0 exp(− 𝑇 )
1,2
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eq 1

The NOE values were determined by the ratio of peak intensity between the saturated
(Isat) and unsaturated (Iunsat) spectra.
𝑁𝑂𝐸 = 𝐼𝑠𝑎𝑡 /𝐼𝑢𝑛𝑠𝑎𝑡

eq 2

The T1 rates, T2 rates, and NOE ratios were determined from their fits to their respective
equations using Kaleidagraph (Synergy Software, Reading, PA) and exported to the
FAST-MODEL FREE program46 to calculate an overall correlation time (τm); and per
residue order parameters (S2), internal motion (τe), and chemical exchange (Rex) using the
Lipari-Szabo model-free method.47 Some of the NOE ratios were above the theoretical
maximum of 1.0 and were set to 1.0 to run the FAST-MODEL FREE program.

6.2.5 Primase CTD and C1 subdomain similarity phylograms
An all-versus-all root-mean-square deviation (RMSD) matrix table (Table S2) was
generated using the MatchMaker tool in UCSF Chimera.48 All chains from X-ray
structures were included in the structural comparison. Only the best representative
structure from the NMR ensemble, identified by XPLOR as having the lowest RMSD
relative to the mean, was included in the comparison (See Table S3).
The computed RMSD matrices were then inserted into the Splitstree449 program to
generate the unrooted phylogenic trees depicted in Figure 3. The trees were generated
using the Neighbor-join algorithm. The pairwise RMSDs were calculated between the
complete C-terminal domains (Figure 3A) as well as between the aligned C1 subdomains
(Figure 3C).
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6.2.6 Primase CTD sequence similarity
The sequences for the E. coli, G. stearothermophilus, H. pylori, and S. aureus primase Cterminal domains were acquired from the Protein Data Bank.50 Three different sequence
alignment programs, Muscle, T-Coffee, and Clustal Omega,51-53 were used to determine a
sequence similarity between the four primase CTD proteins. The results obtained from
the three sequence alignment programs were identical and were converted into the Phylip
format for analysis using Splitstree4.49 The unrooted phylogenic tree (Figure 3B) was
created using the Neighbor-join algorithm and equal angle method.

6.2.7 NMR ligand affinity assays
Sample preparation and experimental parameters for the NMR ligand affinity screen were
performed as described previously.54 Briefly, each ligand mixture (113 total) was
screened using a 1D 1H NMR spectrum with excitation sculpting.55 Each NMR sample
2O

buffered solution of 20

mM d19-bis-Tris at pH 7.0 (uncorrected) with 2% DMSO-d6 to maintain ligand solubility
and 11.1 µM 3-(trimethylsilyl)propionic-2,2,3,3-d4 acid sodium salt as a chemical shift
reference. All 1D 1H NMR spectra were processed with the ACD/1D NMR manager v.
12.0 (Advanced Chemistry Development, Inc., Toronto, Ontario). Each 1D 1H NMR
spectrum was compared to the corresponding free ligand mixture reference spectrum and
visually analyzed to identify binding ligands based on a decrease in the intensity of ligand
NMR resonances. A 2D 1H-15N HSQC spectrum was collected for each ligand with a
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positive response from the 1D H NMR line1

H NMR

screen except for 95% H2O/5% D2O. A single ligand-free 2D 1H-15N HSQC spectrum
was collected as a reference, where a binding event was confirmed based on a clustering
of surface residues that incurred a chemical shift change one standard deviation above the
average.

6.2.8 Protein-ligand titration and docking
DnaG primase CTD HSQC was collected at a protein concentration of 1 mM and was
titrated with adenosine (0.9, 1.8, 2.6, 3.3, and 4.0 mM), acycloguanosine (0.7, 1.9, 3.5,
and 5.2 mM), and myricetin (0.9, 1.8, 2.6, 3.3, and 4.0 mM). All NMR data was collected
at 25 ˚C on a 700 MHz Bruker Avance III spectrometer equipped with a 5 mm QCI-P
probe with cryogenically cooled carbon and proton channels. The 2D 1H-15N HSQC
protein titration data was processed and analyzed in NMRPipe.27 Briefly, the spectral
titration data for each ligand was automatically peak picked and adjusted manually within
NMRDraw. The 1H-15N and 15N chemical shifts from the selected peaks were then fit to a
Ka (1/Kd) according to a previously published method.56 Subsequently, the peaks that
showed significant binding were manually assigned to residues. AutoDock was then used
to individually dock the three ligands into a primase CTD binding site defined by the
observed chemical shift perturbations. Chimera was used to visualize the lowest energy
docked complexes.48
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6.3 Results
To fight antibiotic-resistant infections, there is a need to identify new antibiotic targets.
The bacterial primase C-terminal domain is an especially promising target because
eukaryotic primases do not have a cognate sequence or structure and because its critical
function is to interact with DnaB helicase to limit DNA replication to the replication fork.
Among a number of factors, evaluating the “drugability” of a protein target requires a
fundamental understanding of its structure-function relationship.57 As a first step towards
this goal, we determined the three-dimensional structure of the primase CTD from the
pathogen S. aureus.

6.3.1 S. aureus primase CTD structure determination
Backbone and side chain resonance assignments were completed using standard triple
resonance NMR experiments.22 In summary, the backbone resonance assignment was
93% complete with 133 amino acids out of the 143 primase residues assigned
unambiguously in the 2D 1H-15N HSQC spectrum. Nearly all the peaks were uniformlyshaped and separated from the others, which indicates that each residue is in a unique
environment and that S. aureus primase CTD exists in a single conformation. Unassigned
residues include M1-H13, D19, E470, H479, L480, M481, T500, R536, E537, E543,
P551, and Y552. Primase CTD residues are numbered relative to the complete DnaG
primase sequence, while the N-terminal purification tag is simply numbered from residue
1 to 20. Most of the unassigned residues were located in the purification tag or within
highly solvent exposed regions. The structure consists of eight α-helices. Residues H479,
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L480, and M481 were in a turn region between helix 1 and 2. Residue T500 was in an
unstructured loop region between helix 2 and helix 3, whereas residues P551 and Y552
were in an unstructured loop region between helix 5 and helix 6. The only unassigned
residues that appear to be localized within a secondary structure were E470, R536, E537,
and E543. E470 is the second residue of helix 1, while R536 and E537 are in the middle
of helix 5, and E543 is near the end of helix 5. An exhaustive analysis of the NMR data
set was unable to yield assignments for these residues, suggesting the end of helices 1 and
5 may undergo partial unfolding leading to chemical shift exchange broadening for these
residues.
The solution structure of the S. aureus primase CTD was calculated using 1823 distance
constraints, 280 dihedral constraints, 256 13Cα and 13Cβ carbon chemical shift
constraints, and 82 3JNHα coupling constant constraints, among others (Table 2). In the
initial phase, 1000 structures were calculated from 10 individual sets of 100 structures
each using XPLOR-NIH32, 33 as described previously.58 Each set of structures was started
from a randomly generated seed. The lowest energy structures were consolidated to
generate a set of 20 low energy structures that were further refined within a virtual water
environment using the RECOORD recalculated coordinates42 as implemented in CNS.40
The resulting S. aureus primase CTD structures (Figure 1) form a self-consistent set as
determined by a range of statistical analyses (Table 2). The root mean square deviation
(RMSD) for all 1823 experimental distance constraints is 0.040 (± 0.023) Å, which
implies a good agreement between the structural ensemble and the constraints. None of
the distance constraints have a violation that exceeds 0.247 Å. There are also low
deviations from the constraints for the 13Cα chemical shifts, 13Cβ chemical shifts, and the
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J(HN-Hα) coupling constants, indicating consistent conformations for both the

backbone and side chains. Similarly, the deviations from idealized covalent geometries
are consistent with good quality structures.

Table 2: Structure Statisticsa
<SA>

σ

(SA)r

All (1823)

0.040

0.023

0.022

Inter-residue sequential (|i-j| = 1) (460)

0.056

0.021

0.030

Inter-residue short range (1 < |i-j| ≤ 5) (444)

0.062

0.018

0.041

Inter-residue long-range (|i-j| > 5) (140)

0.247

0.093

0.374

Intra-residue (663)

0.001

0.001

0.003

Backbone hydrogen bonds (116)

0.014

0.005

0.008

1.21

0.23

1.12

1.05

0.05

1.08

1.06

0.04

1.09

0.011

0.0005

0.011

Root mean square parameter
Distance restraints (Å)

Dihedral restraints (deg) (280)

3

J

coupling restraints (Hz) (82)

FNOE (kcal mol-1)

87

36

46

Ftorsion (kcal mol-1)

28

20

21

FVDW (kcal mol-1)

-509

31

-510

Idealized covalent geometry
Bond length (Å) (2400)

0.0114

0.0005

0.0108

All angles (deg) (4302)

1.44

0.06

1.43

Improper torsion angles (deg) (1287)

1.95

0.23

1.84
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a

<SA> is the average value from an all-versus-all comparison of the set of 20 annealed structures;  is
the standard deviation for the all-versus-all comparison; and (SA)r is the value for the restrained
minimized mean structure. The number of restraints for each parameter is given in parentheses. For
backbone NH-CO hydrogen bonds, the two restraints are r(NH-O) = 1.5 - 2.3 Å and r(N-O) = 2.5 - 3.3 Å.
The values of the square-well NOE (FNOE) and torsion angle (Ftorsional) potentials59 are calculated with force
constants of 50 kcal mol-1Å-2 and 200 kcal mol-1rad-2, respectively. The value of the Lennard-Jones van
der Waals term (FVDW)60 is calculated with a force constant of 4 kcal mol-1Å-4 with the CHARMM61
empirical energy function. The improper torsion angle restraints serve to maintain planarity and chirality.

Figure 1: Primase CTD ensemble overlay. (A) A ribbon diagram of the average water
refined structure. The C1 subdomain is composed of helices 1-6 and the C2 subdomain is
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composed of helices 7-8. All structures were generated with Visual Molecular
Dynamics (VMD-XPLOR) and are colored according to the secondary structure: red, αhelix; green, loop. (B) An overlay of the backbone trace of the 20 lowest-energy, waterrefined structures aligned with residues 468-566 from the C1 subdomain. (C) An overlay
of the backbone trace of the 20 lowest-energy structures aligned with residues 570-603
from the C-terminal C2 subdomain.

The quality of the S. aureus primase CTD NMR structure was assessed using two suites
of programs (Table 3). PROCHECK62 indicates the average minimized structure has an
overall G-Factor of -0.12 ± 0.04 with no bad contacts, consistent with a good quality
structure. The Protein Structure Validation Software suite of programs (PSVS)63 gave a
Verify3D score of -4.58 ± 0.71, which is within the typical range. The Molprobity
module indicates that the S. aureus primase CTD structure has a very good Z-score (2.50) compared to the average Z-score (-10.74) for all NMR structures in the Protein
Data Bank. Finally, a Ramachandran plot of backbone dihedral angles for all non-glycine
residues indicates that 83.4 ± 3.2% lie within the “most favored” region and only 0.7 ±
0.6% lie within “disallowed” regions. That is, one residue in 14 of the 20 structures is
found in the disallowed region but never in a consistent location within the structure
(Table S4). These residues tend to have a lower number of constraints, which results in a
low penalty for unusual conformations during energy minimization.
The final step in the analysis was to compare the 20 energy-minimized structures with the
mean structure (Table 4). Within the C1 subdomain comprising the first two-thirds of the
residues, the average root-mean square deviation (RMSD) of the 20 lowest energy
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structures about the mean coordinate position is 1.54 ± 0.19 Å for backbone atoms
and 2.37 ± 0.17 Å for all heavy atoms. When only secondary structure elements are used
for alignment, the mean coordinate position deviation is 1.18 ± 0.14 Å for backbone
atoms and 1.93 ± 0.16 Å for all heavy atoms. These deviations indicate the backbone
structure is well defined. The side chain residues have fewer constraints and
correspondingly higher structural disorder.

Table 3: Ensemble self-consistencya
<SA>

σ

(SA)r

-0.12

0.04

-0.09

H-bond energy

0.82

0.06

0.8

Number bad contacts/100 residues

0.0

Parameter
PROCHECKb
Overall G-Factor

0.0

PSVS Z-scoresc
Verify3D

-4.58

0.71

-4.82

ProsaII (-ve)

-1.14

0.34

-1.20

Procheck (phi-psi)

-0.56

0.42

-0.28

Procheck (all)

-1.92

0.32

-2.07

MolProbity clash score

-2.50

0.97

-2.46

Most favored regions

83.4%

3.2

85.5%

Additional allowed regions

14.5%

3.0

13.0%

1.2

0.7%

Ramachandran spaced

Generously allowed regions

1.43%
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Disallowed regions
a

0.56

0.7%

<SA> is the average value from an all-versusstandard deviation for the all-versus-all comparison; and (SA)r is the value for the restrained minimized
mean structure.

b

c

0.7%

PROCHECK values are in comparison to the likelihood of finding each residue within the derived
structure as compared to a database of residues found in similar environments within structures with
resolution below 1.8 Å.

PSVS (Protein Structure Validation Suite) provides an analysis of five separate structural analysis
programs, each of which measures a different parameter. The PSVS reports Z-scores for each analysis,
where a Z-score is the number of standard deviations from the mean. The authors of PSVS suggest that
Z-scores lower than -5 should be reevaluated.

d

Ramachandran space analysis from the PDB sum website uses a database of structures with resolution
below 1.8 Å to decide whether a region is considered to be “most favored”, etc.

Table 4: Ensemble self-consistency of the C1 subdomaina
Comparison

Backbone atoms

All heavy atoms

<SA> vs. SAmean

1.54 ± 0.19 Å

2.37 ± 0.17 Å

<SA> vs. (SA)r

1.98 ± 0.28

3.05 ± 0.32

(SA)r vs. SAmean

1.26

1.94

<SA> vs. SAmean

1.18 ± 0.14

1.93 ± 0.16

<SA> vs. (SA)r

1.56 ± 0.22

2.55 ± 0.26

(SA)r vs. SAmean

1.03

1.66

All residues

Secondary structures

a

<SA> is the average value from an all-versus-all comparison of the set of 20 annealed structures; (SA) r is
the value for the restrained minimized mean structure; and SA mean is the Cartesian mean structure
created from the geometric mean for each atom of all 20 structures. The SA mean structure does not
adhere to any of the restraints for bond lengths, angles, etc. The secondary structure residues are: 469-52
secondary structure rmsd values were measured by aligning all secondary structure elements and
calculating an average and standard deviation.
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6.3.2 S. aureus primase CTD structure
The 20 energy-minimized S. aureus primase CTD structures (Figure 1) are deposited in
the Protein Data Bank (PDB) with the identification code 2LZN. The structure is
composed of 8 helices arranged into two subdomains as is the primase CTD NMR
structure from G. stearothermophilus.6 In our S. aureus primase CTD structure, the first
six helices create the C1 subdomain and encompass residues 467 to 565 (Figure 1A). The
last two helices, 7 and 8, create the C2 subdomain encompassing residues 572 to 603.
When the 20 structures are overlaid using the alignment of the C1 subdomain backbone
residues as a guide (Figure 1B), the C2 subdomain structures do not superimpose well.
The converse overlay based on the alignment of the C2 subdomain shows the same effect
(Figure 1C). The poor superimposition arises because of the very low number of
structural restraints between the subdomains. However, the linker between the
subdomains is constrained by 11 NOEs from the C1 subdomain, 77 NOEs within the
linker, and 17 NOEs from the C2 subdomain. On the other hand, the loop region between
the subdomains lacks sequential NH-NH NOEs in the 1H-15N HSQC-edited NOESY and
the loop residues G567, Q568 and E569 exhibit exchange peaks in the CLEANEX
experiment.24 These residues are likely undergoing rapid exchange with the solvent, a
feature indicative of exposed residues that lack protection from hydrogen bonds found in
secondary structures. As we shall see below, the dynamics analysis indicates that the
subdomains behave as two independent domains.
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The surface charge distribution shows the exposed surface is uniformly but weakly
electrically positive (Figure 2). The buried interface between the subdomains is
electrically negative, as reflected in the moderately large Verify 3D Z-score. This
repulsion may destabilize the interaction between the C1 and C2 subdomains, causing
them to prefer a more extended conformation. In addition, there are some partially buried
electrically negative residues in the C1 subdomain. The overall charge distribution is
unlike the uniformly negative CTD from G. stearothermophilus,6 suggesting that it is not
a universal feature of primase CTDs.

Figure 2: Electrostatic surface potential. Surface charge distribution of the C-terminal
domain showing (A) the face toward the RNA polymerase domain (F463 is the N-
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terminal residue of this domain) with space-filled C2 subdomain on the left and the
ribbon diagrammed C1 subdomain on the right. (B) The solvent-exposed face (180°
rotation around the x-axis relative to the structures in panel A) with space-filled C1
subdomain and ribbon diagrammed C2 subdomain.

6.3.3 Primase CTD conformations
Every enzyme family has a distinct sequence/structure relationship linked to the
evolutionary pressures on the sequence and structure within each organism.64 To
determine how the S. aureus primase CTD structure relates to other known primase CTD
structures (Table 1), the MatchMaker tool in UCSF Chimera48 was used to calculate
pairwise RMSDs for the eight known primase CTD structures (Table S2). The resulting
unrooted phylogram (Figure 3A) shows three main branches that correlate with distinct
conformations (Figure 4). The first branch (conformation A) includes our NMR structure
from S. aureus (2LZN-14) and the G. stearothermophilus NMR structure (1Z8S-5). The
second branch (conformation B) includes the E. coli NMR structure (2HAJ-19), the G.
stearothermophilus crystal structure (2R6A-C), and both H. pylori crystal structures
(4EHS-A and B). The third branch (conformation C) includes both E. coli crystal
structures (1T3W-A and B). Conformations A and B are more similar to each other than
they are to conformation C. Furthermore, it has been proposed17 that conformation C may
not be biologically relevant because the crystals were formed at low pH (4.6), which
resulted in a packing effect of swapped dimer conformation.
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Since the unrooted phylogram for the full length structure did not split according to
sequence phylogeny, we created unrooted phylograms based on CTD sequence similarity
(Figure 3B) and the primase CTD C1 subdomain structure (Figure 3C). From the
sequence similarity phylogram, we observed two distinct branches corresponding to the
expected phylogenetic split between the Firmicutes (G. stearothermophilus, S. aureus)
and the Proteobacteria (E. coli, H. pylori). The same phylogenetic split was observed for
the C1 subdomain structures, showing that there is a structure-sequence phylogenetic
split for this protein.
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Figure 3: Unrooted phylograms. Representation of the primase CTD structure (A),
sequence similarity (B) and primase CTD C1 subdomain structure (C). All trees were
generated with SplitsTree4 Each tree contains the following species: S. aureus primase
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CTD (this study), G. stearothermophilus primase CTD, H. pylori primase CTD, and
E. coli primase CTD.

Figure 4: Primase CTD conformation classes. The species structures were categorized
in three conformations from Figure 3A based on compactness: A compact, B
intermediate, C extended. Conformation C may be biologically irrelevant.17

6.3.4 Primase CTD flexibility
An NMR dynamics analysis of the S. aureus primase CTD structure was conducted to
complement the structural analysis. The NMR relaxation parameters T1 and T2, and the
relative ratio of NOE enhancement were measured on a per residue basis and analyzed
using the Fast-Model free program46 to calculate order parameters (S2) and chemical
exchange (Rex) values (Figure 5). In general, the T1 values for the C1 subdomain residues
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were higher than the T1 values for the C2 subdomain residues, indicating that the two
subdomains exhibit different dynamics. A similar observation was made for the T2
values, except that the T2 values for the C1 subdomain were lower than the T2 values for
C2.
It is important to note that Fast-Model free did not converge on a result when using the
entire primase CTD structure. This is consistent with the observation that the C1 and C2
subdomains behave as two separate domains and are dynamically independent. A
convergent result was only obtained when the NMR dynamics data of the C1 and C2
subdomains were modeled separately. The C1 subdomain included residues 463-572 and
the C2 subdomain included residues 565-605. The linker region, corresponding to
residues 565-572, was included in the dynamics analysis for both subdomains.
The order parameters (S2) for the C1 subdomain residues covered a large range (0.2401.000) whereas the C2 subdomain residues were close to 1 (Figure 5D). The average S2
values were 0.79 ± 0.02 and 0.97 ± 0.03 for the C1 and C2 domains, respectively. In
general, an S2 value approaching 1.0 indicates a highly ordered residue with limited
flexibility, while a lower S2 value indicates greater flexibility. This implies that the C1
subdomain has a greater overall flexibility relative to C2.
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Figure 5: Dynamics of S. aureus primase CTD. The NMR relaxation parameters T1 (A)
and T2 (B), NOE enhancements (C), S2 order parameter (D), and Rex chemical exchange
rate are plotted per residue. The C1 subdomain included residues 463-572 and the C2
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subdomain included residues 565-605. The linker region corresponding to residues
565-572 was included in the dynamics analysis for both subdomains.

Within the primase CTD structure there are two stretches of three or more residues with
S2 values less than 0.75: residues 488 to 498; residues 555 to 557 and residues 561 to
563. Residues 488 to 498 lie in helix 2 and the linker between helix 2 and 3. Residues
555 to 557 and 561 to 563 lie in helix 6 (Table S5). The flexibility of the linker between
helix 2 and 3 is consistent with the variable lengths for helix 3 observed in the structures
from other organisms. It is possible that the reduction in the flexibility of helix 3 is part of
an allosteric system that provides an entropic energy change when helix 6 and 8 bind to
the helicase NTD.65 The flexibility of the second half of helix 6 shows how the
unstructured linker between helix 6 and 7 may act as a nucleus for unraveling helix 6.
Surprisingly, the linker region corresponding to residues 565-572 was observed to be
dynamic, indicating that the point of flexibility between the two domains is located at the
end of helix 6. This finding further suggests that the dynamic, second half of helix 6
(residues 561-564) compensates by either unraveling or bending for the increased motion
between the two subdomains at the linker region.
To identify the hinge between the two subdomains, we searched for a residue with a low
order parameter and fast chemical exchange. N564 had one of the lowest order
parameters (0.658) and the fastest chemical exchange (17.7 Hz), indicating a high degree
of motion on both the ps-ns and ms timescales. It is the final residue of helix 6 and is
located between a very rigid C2 subdomain and a flexible C1 domain, potentially
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implicating N564 as a key residue for a conformational change.
In addition to per-residue order parameters and chemical exchange rates, an overall
correlation time (τm) was calculated for each subdomain. The correlation times for the C1
and C2 subdomains were 7.2 ns and 6.4 ns, respectively. The predicted value for a
hydrated protein with a molecular weight of 17.2 kDa, corresponding to the intact
primase CTD structure,

m

≈ MW/2400.66 The predicted tumbling times

were 5.45 ns and 2.1 ns for C1 (13.1 kDa) and C2 (5.0 kDa). The observed τm values for
both subdomains are substantially higher than predicted and share a greater degree of
similarity than the predicted values. This indicates the C1 and C2 subdomains are both
tumbling at approximately the same rate as the intact protein. The model that emerges is
one in which the two subdomains can adopt a wide range of relative orientations, with
N564 as a pivot point, but share an overall tumbling rate.

6.3.5 Identification of ligands that bind to S. aureus primase CTD
A high-throughput NMR ligand affinity screen of the S. aureus primase CTD was
undertaken to identify potential binding compounds. Out of the 423 compounds tested, a
total of 12 compounds were shown to bind S. aureus primase CTD using a 1D 1H NMR
line-broadening screen: acycloguanosine, 3-aminopropionitrile fumarate, chelerythrine
chloride, didecyldimethylammonium bromide, 5,5-diphenylhydantoin, L-histidine, (±)-αlipoamide, 1-methylimidazole, mitoxantrone dihydrochloride, myricetin, (±)-propranolol
hydrochloride, sodium creatine phosphate, and sodium DL-lactate. Of these compounds,
acycloguanosine and myricetin were further analyzed for binding with primase CTD
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from S. aureus. Furthermore, adenosine was selected for binding studies due to its
structural similarity to acycloguanosine. Quercetin, luteolin and kaempferol were also
selected for their structural similarity to myricetin, but their low solubility prevented
further study.
A 2D 15N-1H HSQC spectrum was collected for free primase and for the primase-ligand
complex using acycloguanosine, adenosine, or myricetin. All three compounds were
shown to bind primase CTD based on protein chemical shift perturbations (CSPs) of
Y552, N564, T570, L574, E580, I584, G585, L589, and Q590 (Figure 6A). Although
initially unassigned, Y552 was discovered during the titration experiment and assigned
based on spatial proximity to other perturbed residues. None of the three compounds
reached CSP saturation at the highest concentration tested (≥ 4.0 mM), indicating that
their KD’s were greater than 4 mM. Acycloguanosine, adenosine and myricetin exhibited
CSPs above one standard deviation from the average of all non-binding site residues.
Specifically, acycloguanosine, adenosine and myricetin caused CSPs of 0.35 ± 0.09 ppm,
0.16 ± 0.29 ppm and 0.07 ± 0.02 ppm, respectively, for the binding site residues.
When the nine residues incurring CSPs were mapped onto the structure of primase CTD,
eight of the residues were located adjacent to one another on helix 6 or 7 (Figure 6B).
The residue furthest from the other binding site residues was N564, which was previously
identified as a key residue for a C1-C2 conformation change (Figure 5). When adenosine
was docked into the groove between helices 6 and 7 (Figure 6B), the adenine moiety
filled a hydrophobic pocket while its ribose was exposed to solvent and made specific
interactions with three residues: Y552, I584, and G585 (Figure 6C). All three compounds
docked into the same primase CTD pocket and adopted a uniform binding conformation.
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The hydrophobic fused rings were buried deep into the pocket and the hydrophilic
moieties interacted with the same three residues at the opening of the pocket (Figure 6D).
Since these compounds bind to the closed conformation of primase CTD, they are likely
to act as an inhibitor and reduce the helicase-primase interaction.

Figure 6: Adenosine binding site identification. When S. aureus primase CTD (1 mM)
was titrated with up to 4.0 mM adenosine, nine residues exhibited chemical shift
perturbations in the 2D 1H-13C HSQC spectrum of primase CTD. A detail from the
overlay of the 2D 1H-13C HSQC spectra is colored according to the addition of 0 mM
(blue), 2.6 mM (purple) and 4.0 mM (red) of adenosine (A). Expanded view of a surface
rendition of the primase CTD NMR structure is superimposed onto a ribbon structure to
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highlight secondary structure elements. Adenosine (blue tessellated structure) was
docked into the primase CTD region defined by the nine residues with significant
chemical shift perturbations (colored purple), which are located between helices 6 and 7.
The side chains for all the residues that interact with adenosine are drawn with licorice
-helices 6
and 7 are labeled (B). An expanded view of the ligand-binding pocket (flipped 180
degree from panel B) represented as a ribbon structure with side chains interacting with
adenosine shown as licorice bonds. The residues interacting with adenosine are labeled.
The labels for residues with significant CSPs are colored purple (C). Superposition of the
docked conformations of myricetin (green), adenosine (black), and acycloguanosine
(orange) into the same expanded view of the primase CTD binding site from panel C (D).

6.4 Discussion
We report the first primase CTD structure from a medically relevant, mesophilic
Firmicutes bacterium. Its structure shares many features with the known thermophilic
Firmicutes and mesophilic proteobacterial primase CTD. It has an N-terminal 6-helix
bundle called the C1 subdomain connected by linker residues to a C-terminal helix-turnhelix called the C2 subdomain. The C1 subdomains from different species share the same
overall fold, although there are differences in the lengths of several helices such that S.
aureus and G. stearothermophilus are more similar to each other than to E. coli or H.
pylori. The overall resolution of the S. aureus structure was low due to significant peak
-helical
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content of the CTD, coupled with a high degree of dynamic motion, led to peak
broadening such that only 56% of side chain Hγ and 76% Hδ could be unambiguously
assigned. The number of long range (>5 Å) NOEs was also lower than anticipated (140)
for a protein of 19.6 kDa. Nevertheless, the overall rmsd of the 20 lowest energy
structures was reasonable at 1.54 (± 0.19) Å and the ensemble of structures lies in
acceptable ranges of common structure validation programs (all Z-scores above -5.0).
When a representative structure for S. aureus primase CTD was compared to the x-ray
and NMR CTD structures from other organisms, three conformational classes were
observed (Figure 3A, 4). Two of the conformations are likely related to the function of
primase. The conformation of the E. coli 1T3W structure is probably not biologically
relevant given the low pH of its crystallization and some strong interface packing
effects.17 Of all the structures, the G. stearothermophilus crystal structure 2R6A is the
only one bound to helicase.16 This suggests that the structures of H. pylori (4EHS) and E.
coli (2HAJ) are also helicase-bound forms. Since conformation B contains members from
both Firmicutes and Proteobacteria, it indicates that the helicase-bound form of primase
CTD is not phylum-dependent. Since the solution structures of G. stearothermophilus
and S. aureus primase CTD are in conformation A, it appears to be the conformation
adopted when primase dissociates from helicase. In the case of S. aureus, it has also been
possible to use NMR dynamics to identify N564 as the key hinge residue that allows
helix 6 to bend into helices 6 and 7.
Three small molecules, acycloguanosine, adenosine, and myricetin, were discovered to
bind a common site on the closed conformation of primase CTD. The ligand-binding
pocket is only created when helices 6 and 7 are adjacent to one another. Among the nine
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residues with CSPs that define this ligand-binding site, N564 exhibited the largest
CSP and was also identified as a key residue in a conformational change between the
open and closed form of primase CTD. As a result, this ligand-binding site is a potential
target for the further development of small molecule inhibitors that may “lock” primase
CTD in its closed form and prevent its interaction with the NTD of the helicase. In fact,
two of the compounds shown to bind primase CTD have known inhibitory effects on
DNA replication proteins, although their known mode of actions are different from the
one identified here. Acycloguanosine is a known inhibitor of the primase-helicase
interaction in herpes simplex virus and acts as a chain terminator.67, 68 Additionally,
myricetin inhibits bacterial helicases with an IC50

69

by competing with the

ATPase active sites.
Since the S. aureus CTD structure shares many features with the G. stearothermophilus
solution structure, we used the G. stearothermophilus DnaB/primase CTD co-crystal
structure16 to identify potential interface residues. The co-crystal structure of the G.
stearothermophilus primase CTD C2 subdomain (Figure 7A,C) contains five nonpolar
residues (F577, L578, A581, A584, and I588) in the final helix that could make contact
with DnaB NTD1 (L67, A72, A75, L80 and V86) (Table S6). Following this idea, we
created a homology model of the S. aureus primase CTD and DnaB NTD (Figure 7B, D)
and found there were conserved but not identical residues in the equivalent positions. The
S. aureus CTD C2 subdomain residues were V598, L594, K591, E588 and V587, and the
S. aureus DnaB NTD1 residues were V67, D72, S75, L80, and P86. It has been
previously shown that a C-terminal fragment containing the last three helices of the G.
stearothermophilus C2 subdomain6 exhibited sub-nanomolar binding affinity to DnaB,
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but was not capable of stimulating the ATPase activity of DnaB. It could be that
DnaG and DnaB from these two organisms interact using spatially similar, hydrophobic,
but differently sized residues. The DnaG and DnaB structures may have coevolved to
preserve the primase CTD interaction in a manner that led to species-specificity.
The observation that the primase CTD-helicase structural interface is species-specific is
consistent with previous studies showing that S. aureus helicase will only stimulate
primer synthesis when incubated with the cognate primase.6 Stimulation of DnaB ATPase
activity by primase binding has been shown to involve the C1 subdomain Y548 in G.
stearothermophilus70 and F534 in the H. pylori20 C1 subdomain. Mutation of these
residues to an alanine reduced binding affinity and ATPase stimulation. An examination
of the G. stearothermophilus primase CTD structure shows that Y548 and the adjacent
residue D547 in helix 6 of the C1 subdomain make contact with P97, T98, and N101 in
the DnaB NTD2 (Figure 7C, Table S5). The structural equivalent residues in S. aureus
C1 subdomain are D558 and Y559 and within the S. aureus DnaB NTD2 are also P97,
T98, and N101 (Figure 7D). Since the residues are identical between G.
stearothermophilus and S. aureus, it indicates the mechanism of ATPase stimulation is
highly conserved.
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Figure 7: Critical interface residues between primase and helicase. The co-crystal
structure of the complex from G. stearothermophilus involves two DnaB NTDs, one of
which interacts with the C1 subdomain of the primase and the other with the C2
subdomain (A). The specific interface residues are shown in an expanded view (C). This
was the template for the homology model of S. aureus primase CTD and DnaB NTDs
(B), which is also shown in an expanded view (D).
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6.6 Supplemental Figures and Tables
Table S1: Bacterial primase sequence alignment
According to the Clustal Omega FAQ page
(http://www.ebi.ac.uk/Tools/msa/clustalo/help/faq.html#23)
* indicates positions which have a single, fully conserved residues.
: indicates conservation between groups of strongly similar properties – scoring > 0.5 in
the Gonnet PAM 250 matrix.
. indicates conservation between groups of weakly similar properties – scoring =< 0.5 in
the Gonnet PAM 250 matrix
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Blue – indicates S. aureus zinc binding domain
Green – indicates S. aureus RNA polymerase domain
Red – indicates S. aureus C-terminal domain

CLUSTAL multiple sequence alignment by MUSCLE (3.8)

Staphylococcus
-MRIDQSIINEIKDKTDILDLVSEYVKLEKRGRNYIGLCPFHDEKTPSFTVSEDKQICH
Bacillus
MGNRIPEEVVEQIRTSSDIVEVIGEYVQLRKQGRNYFGLCPFHGENSPSFSVSSDKQIFH
Geobacillus
MGHRIPEETIEAIRRGVDIVDVIGEYVQLKRQGRNYFGLCPFHGEKTPSFSVSPEKQIFH
Francisella
MAKKVSNSFIKELVATADIVDVVSRYVNLKKTGKNYKGCCPFHNEKTPSFFVNPEKNFYH
Aquifex
----MSSDIDELRREIDIVDVISEYLNLEKVGSNYRTNCPFHPDDTPSFYVSPSKQIFK
Pseudomonas
MAGLIPQSFIDDLLNRTDIVEVVSSRIQLKKTGKNYSACCPFHKEKTPSFTVSPDKQFYY
E.coli
MAGRIPRVFINDLLARTDIVDLIDARVKLKKQGKNFHACCPFHNEKTPSFTVNGEKQFYH
Yersinia
MAGRIPRVFINDLLARTDIIDLIDARVKLKKQGKNYHACCPFHHEKTPSFTVNGEKQFYH
:. :
**::::. ::* . * *:
**** :.:*** *. .*::
Staphylococcus
CFGCKKGGNVFQFTQEIKDISFVEAVKELGDRVNVAVDIEATQSNSNVQIASDDLQMIE
Bacillus
CFGCGEGGNVFSFLMKMEGLAFTEAVQKLGERNGIAVAEYTSGQGQQEDISDDTVIMQQ
Geobacillus
CFGCGAGGNAFTFLMDIEGIPFVEAAKRLAAKAGVDLSVYELDVRGRDDGQTDEAKAMTE
Francisella
CFGCQASGDALTFVKNINKLEFIDAVKNLAEIVGKPVEYENYS-QEDIQKEQLYNKCIS
Aquifex
CFGCGVGGDAIKFVSLYEDISYFEAALELAKRYGKKL---------DLEKISKDEKVYV
Pseudomonas
CFGCGAGGNALGFVMDHDQLEFPQAVEELAKRAGMDVPREERGGRGHTPRQPTDSPLYP
E.coli
CFGCGAHGNAIDFLMNYDKLEFVETVEELAAMHNLEVPFEAGSGPSQIERHQRQT-LYQ
Yersinia
CFGCGAHGNAVDFLMNYDRLEFVESIEELATMHGLEVPYEAGSGTTQIERHQRQS-LYQ
****
*:.. *
. : : ::
*.
. :
Staphylococcus
MHELIQEFYYYALTKTVEGEQALTYLQERGFTDALIKERGIGFAPDSSHFCHDFLQKKGY
Bacillus
AHELLKKYYHHLLVNTEEGNEALSYLLKRGITKEMIEKFEIGYASPAWDAATKILQKRGL
Geobacillus
AHALLKRFYHHLLVHTKEGQAALDYLQARGWTKETIDRFEIGYAPDAPDAAAKLLESHSF
Francisella
FLAAAQKYYRWNLGNSVTKDKAINYLKKRGIDSSLAKFFGIGYSSEGWNNITELAKSINI
Aquifex
ALDRVCDFYRESLL---KNREASEYVKSRGIDPKVARKFDLGYAPSSEALVKVLKENDL
Pseudomonas
LLSAAAEFYKQALKSHPARKAAVNYLKGRGLTGEIARDFGLGFAPPGWDNLLKHLGGDNL

233
E.coli
LMDGLNTFYQQSLQQPVATSARQYLEKRGLSHEVIARFAIGFAPPGWDNVLKRFGGNPE
Yersinia
LMESLSAFYQQSLKGQNAKQAREYLKHRGLSEEIIQHFAIGFAPPGWDNALKRFGRDGE
:*
*
* *:
Staphylococcus
QEPKYLNSP
Bacillus
DTPKYLNSP
Geobacillus
GHPKYVNSP
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RVTEDSDGVKYINSP
Aquifex
KSPKYINSP
Pseudomonas
DKPKYLNSP
E.coli
DTPKYLNSP
Yersinia
GVPKYLNSP
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:*::. .

.

DIELAYEAGLLSRNEENFSYYDRFRNRIMFPLKNAQGRIVGYSG-RTYTGSLSSMEQAGLLIRSEKDGSHYDRFRGRVMFPIYTLQGKVIAFSG-RALGDSLPVMEKAGLLTKK-EDGRYVGRFRNRIMFPIHDHRGETVGFSG-RLLGEPEEILVDTGLAIKN-DKGNLYDRFRGRVMFPIRNIQGNVIAYGGLEAYLETKNLLSPT--KGVYRDLFLRRVVIPIKDPRGRVIGFGGRRIVEDQLKAMLDAGLLVENSDTGKRYDRFRDRVMFPIRDSRGRIIAFGG-RVLGDNRQSLIDAGMLVTN-DQGRSYDRFRERVMFPIRDKRGRVIGFGG-RVLGNSRTALNDAGMLVTN-DTGRTYDRFRERVMFPIRDKRGRVIAFGG-RILGD.:
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. *

*:::*:
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:.:.* *

**:***
Staphylococcus
ETPIFQKRKLLYNLDKARKSIRK----LDEIVLLEGFMDVIKSDTAGLKNVVATMGTQL
Bacillus
ETPIFHKSKLLYNFHQARPFIRK----RGQVVLFEGYADVLAAVKSGVEEAVATMGTAL
Geobacillus
ETPVFRKGAILYHFHAARVPIRK----RQEALLVEGFADVISAAQAGIDYAIATMGTSL
Francisella
ETLVFQKNNILYGLYEYRERKKQYPDLINQSLVVVEGYMDVVGLAQHGFYAAVATLGTAF
Aquifex
DSRVFKKGENLFGLYEAKEYIKE----EGFAILVEGYFDLLRLFSEGIRNVVAPLGTAL
Pseudomonas
ETPVFHKGQELYGLYEARQKNRD----LDEIMVVEGYMDVIALAQQGIRNAVATLGTAT
E.coli
ETDIFHKGRQLYGLYEAQQDNAE----PNRLLVVEGYMDVVALAQYGINYAVASLGTST
Yersinia
ETEIFHKGRQLYGLYEAQVNHPN----PTRLLVVEGYMDVVALAQFGIDYAVASLGTAT
:: :*.*
*: :
.
.
::.**: *::
Staphylococcus
SDEHITFIRKLTSNITLMFDGDFAGSEATLKTGQH---LLQQGLNVFVIQLPSGMDPDE
Bacillus
TEEQAKLLRRNVETVVLCYDGDKAGREATMKAGQL---LLQVGCQVKVTSLPDKLDPDE
Geobacillus
TEEQARIL-RPCDTITICYDGDRAGIEAAWAAAEQ---LSALGCRVKVASLPNGLDPDE
Francisella
SPNHAKILFRETSSVILCFDGDEAGQKAALRTIKILLPMLDGNKKLKILTLPDKDDPDD
Aquifex
TQNQANLLSKFTKKVYILYDGDDAGR---KAMKSAIPLLLSAGVEVYPVYLPEGYDPDE
Pseudomonas
SEEHIKRLFRLVPSILFCFDGDQAGRKAAWRALESVLPNLQDGKRVRFLFLPEGEDPDS
E.coli
TADHIQLLFRATNNVICCYDGDRAGRDAAWRALETALPYMTDGRQLRFMFLPDGEDPDT
Yersinia
TAEHIQLLFRATDNVICCYDGDRAGRDAAWRALETALPYLNDGRQLRFMFLPDGEDPDT
: ::
: .
.:
:*** **
: :

*.

.

:

.:*.:**
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***
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Staphylococcus
YIGKYGNDAFTTFVKNDKKSFAHYKVSILKDEIAHNDLSYERYLKELSHDISLMKSSIL
Bacillus
YVQQYGTTAFENLVKSSISFVGFKINYLRLGKNLQDESGKEEYVKSVLKELSLLQDAMQ
Geobacillus
YIRVYGGERFAGEAGCRRPLVAFKMAYLRRGKNLQHEGERLRYIDEALREIGKLSSPVE
Francisella
YIKKYGLERFLTALDNSLAVADFVIDNLIQGKDLRKAEAKAEVLENLKNFLADVEDNIY
Aquifex
FIKEFGKEELRRLINS-----SGELFETLIK---TARENLEEKTREFRYYLGFISDGVR
Pseudomonas
LVRAEGEDAFRARITQQAQPLAEYFFQQLMLEADPATLEGKAHLATLAAPLLEKIPGNNL
E.coli
LVRKEGKEAFEARMEQAMPLSAFLFNSLMPQVDLSTPDGRARLSTLALPLISQVPGETL
Yersinia
LVRKEGKDAFEQRMEAAQPLSTFLFETLMPQVDLSSPDGRAKLSTLALPLISQVPGEAL
:
*
:
. *

:

: .

Staphylococcus
QQKAINDVAPFFNVSPEQLAN-------------------------------------Bacillus
AESYLKSLSQEFSYSMETLLN-------------------------------------Geobacillus
QDYYLRQLAEEFSLSLSALHEQLSRSQRE-----------------------------Francisella
SESITATIADKIGIKVEQFKN-------------------------------------Aquifex
RFALASEFHTKYKVPMEILLM-------------------------------------Pseudomonas
RLLMRQRLSEITGLSGENIGQLAHHSPPPSSMDHGASGVLDGDDYFAASAYYENEPSHAP
E.coli
RIYLRQELGNKLGILDDSQLE-------------------------------------Yersinia
RLYLRQQLGNKLGLLDDSQLD-------------------------------------.
.
Staphylococcus
--------EIQFNQAPANYYPEDEYGGYDEYGGYIEPEPIGMAQFDNLSRREKAERAFL
Bacillus
--------QLHQYRKEQKVQQKQVK--------QVSKPSQIVQTKPKLTGFERAEREII
Geobacillus
--------RTKPREAPDGETARPMLA------------------KKLLPAFQNAERLLL
Francisella
--------LLKIRKQTTLNVNR----------------------QQNIQQKKLAKNLLL
Aquifex
--------KIEKNSQEKEIK------------------------------LSFKEKIFL
Pseudomonas
FDAAPGYVEAQPRKSWNKDKKPWDGKKWDGKKKWDKGGRGDFKAPQRTPVSVESTTLNAL
E.coli
--------RLMPKAAESGVS------------------------RPVPQLKRTTMRILI
Yersinia
--------KLMPKQIDNANT------------------------YQPPQLKRTTMRILI
:
Staphylococcus
KHLMRDKDTFLNYYESVDKDNFTNQHFKYVFEVLHDFYAENDQYNISDAVQYVNSNELRE
Bacillus
YHMLQSPEVAVRMESHI-EDFHTEEHKGILYELYAYYEKGNEPSVGTFLSWLSDEKLKN
Geobacillus
AHMMRSRDVALVVQERIGGRFNIEEHRALAAYIYAFYEEGHEADPGALISRIPGELQPL
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Francisella
EEFVLA-ELFVNIADFRILQHTND--------FEIFATSKNLDILAKSLKILKEDSSNQ
Aquifex
KGLI---ELKPKID-------------------LEVLNLSPELKELA-----------Pseudomonas
RTLLHHPQLALKVDDAGTLAREQDTYAQLLVSLLEALQKNPRQSSMQLIARWHGTPQGRL
E.coli
GLLVQNPELATLVPPLENLDENKLPGLGLFRELVNTCLSQPGLTTGQLLEHYRGTNNAAT
Yersinia
GLLVQNPQLATLIPSLQGLEQAKLAGLPLFIELVETCLAQPGLTTGQLLELYRDNKFSQQ
::
:
.
.
Staphylococcus
-TLISLEQYNLNG---------EPYENEIDDYVNVINEKGQETIESLNHKLREATRIGD
Bacillus
IITDISTDEFINP--------EYTEEVLQSHLETLRRHQEKLEKMEIIFKIKQMEKTDP
Geobacillus
ASDVSL--LLIAD---------DVSEQELEDYIRHVLNR-------PKWLMLKVKEQEK
Francisella
IEAVILIQLLAEDYPDYREYFFELLSYGIRNTQKKYAED---KYQEQMFVMLKRVENSS
Aquifex
VNALNGEEHLLPK---------EVLEYQV-DNLEKLFNN-----------ILRDLQKSG
Pseudomonas
LQALGEKEWLIVQ---------ENLEKQFFDTITKLSES-------QRFGEREERLRSV
E.coli
LEKLSMWDDIADK---------NIAEQTFTDSLNHMFDS-----------LLELRQEEL
Yersinia
LETLATWNHMIVE---------DMVEPTFVDTLASLYDS-----------ILEQRQETL
: . . .
Staphylococcus
Bacillus
Geobacillus
Francisella
Aquifex
Pseudomonas
E.coli
Yersinia

VELQKYYLQQIVAKNKERM---------------VEAAKYY-----VAYLQNQKARK-----------TEAERRK----DFLTAAR-IAKEMIEMKKMLSSSVKKRLKYLGSLPFRSDVQEMERKYLVAKLGNSNII
KKRKKRG-----LKNVNT----------------MQKSYSE-----LTDEEKALLREHYSVAASSPSQS
IARERTH----GLSNEER---LELWTLNQELAKKIARDRTH----GLNAEER---KELWSLNLALARKK

Table S2: Pairwise structure comparison matrices for all eight primase C-terminal
domain structures: (A) root mean square deviation (RMSD) and (B) number of aligned
residues

A. RMSD
E.coli
1T3W_A

E.coli
1T3W_B

E.coli
2HAJ-19

S.aureus
2LZN-14

G.stearo
1Z8S-5

G.stearo
2R6A_C

H.pylori
4EHS_A

H.pylori
4EHS_B

E.coli
1T3W_A

0

4.369

14.444

22.447

12.324

13.578

18.049

17.751

E.coli
1T3W_B

4.369

0

15.897

14.734

12.675

14.268

19.743

19.735

E.coli
2HAJ-19

14.444

15.897

0

12.162

11.226

5.870

13.047

12.891
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S.aureus
2LZN-14
G.stearo
1Z8S-5
G.stearo
2R6A_C
H.pylori
4EHS_A
H.pylori
4EHS_B

22.447

14.734

12.162

0

6.511

13.097

12.254

15.522

12.324

12.675

11.226

6.511

0

10.937

11.578

12.535

13.578

14.268

5.870

13.097

10.937

0

8.780

9.014

18.049

19.743

13.047

12.254

11.578

8.780

0

0.444

17.751

19.735

12.891

15.522

12.535

9.014

0.444

0

B. Number of aligned residues

E.coli
1T3W_A
E.coli
1T3W_B
E.coli
2HAJ-19
S.aureus
2LZN-14
G.stearo
1Z8S-5
G.stearo
2R6A_C
H.pylori
4EHS_A
H.pylori
4EHS_B

E.coli
1T3W_A
134

E.coli
1T3W_B
134

E.coli
2HAJ-19
134

S.aureus
2LZN-14
98

G.stearo
1Z8S-5
125

G.stearo
2R6A_C
126

H.pylori
4EHS_A
110

H.pylori
4EHS_B
109

134

135

135

126

134

126

95

94

134

135

135

125

132

126

95

94

98

126

125

143

139

140

114

85

125

134

132

139

146

141

108

110

126

126

126

140

141

141

111

110

110

95

95

114

108

111

124

122

109

94

94

85

110

110

122

122

Table S3: Residues of the twenty 2LZN ensemble structures that are in the
Ramachandran plot disallowed regions

Model 1: Asn 91
Model 2: none
Model 3: His 37, Glu 127
Model 4: Glu 127, Thr 128
Model 5: His 37
Model 6: none
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Model 7: Asp 53, Asn 91
Model 8: Thr 128
Model 9: none
Model 10: His 37
Model 11: Asn 91
Model 12: none
Model 13: none
Model 14: Thr 128
Model 15: Gln 126, Glu 127
Model 16: Thr 128
Model 17: His 37, Asn 91
Model 18: Gln 126
Model 19: Asn 91, Pro 109
Model 20: none

Table S4: Equivalent interface residues in the DnaC helicase N-terminal domain of G.
stearothermophilus and S. aureus, where yellow highlights show interaction with primase
C1 subdomain, and green highlight show interaction with primase C2 subdomain

Clustal run
G.stear
60

MSELFSERIPPQSIEAEQAVLGAVFLDPAALVPASEILIPEDFYRAAHQKIFHAMLRVAD-

S.aureus

MDRMYEQNQMPHNNEAEQSVLGSIIIDPELINTTQEVLLPESFYRGAHQHIFRAMMHLNE
*..::.:.

*:. ****:***::::**

:

:.*:*:**.***.***:**:**::: :
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G.stear
120

RGEPVDLVTVTAELAASEQLEEIGGVSYLSELADAVPTAANVEYYARIVEEKSVLRRLIR-

S.aureus

DNKEIDVVTLMDQLSTEGTLNEAGGPQYLAELSTNVPTTRNVQYYTDIVSKHALKRRLIQ
: :*:**:

:*::.

*:* ** .**:**:

G.stear

TATSIAQDGYTREDEIDVLL

S.aureus

TADSIANDGYNDELELDAIL
** ***:***. * *:*.:*

***: **:**: **.:::: ****:
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Chapter 7
Enhanced Conformational Dynamics in a Parkinsonian Mutant of DJ-1
Causes Pathogenic Instability at Physiological Temperature
7.1 Introduction
Parkinson’s disease results from the progressive death of dopaminergic neurons in the
midbrain. While the cause of most cases of Parkinson’s disease is unknown, the study of
heritable forms of parkinsonism has helped elucidate the biochemical basis of
dopaminergic neurodegeneration. Recessively inherited mutations in three proteins can
cause parkinsonism: parkin (PARK2), PINK1 (PARK6) and DJ-1 (PARK7).1 These three
proteins are natively neuroprotective, particularly against mitochondrial dysfunction.
Human DJ-1 is a conserved, ubiquitously expressed homodimeric protein that
participates in multiple pathways2-8 to protect cells against oxidative stress9-12 and to
maintain proper mitochondrial function.13 In addition to parkinsonism, loss of DJ-1
mediated cytoprotection is also implicated in ischemia-reperfusion injury, as occurs in
stroke and myocardial infarction.14, 15 Despite abundant evidence that DJ-1 participates in
multiple cytoprotective pathways, the details of its molecular activity remain
incompletely understood.
Several pathogenic missense mutations in DJ-1 decrease protein stability, thereby causing
disease.3, 16 For example, the L166P, L10P, and P158Δ parkinsonian mutations disrupt
the DJ-1 dimer, causing poor folding and proteolytic degradation of the protein.1, 17
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However, several other disease-associated mutants in DJ-1 are more structurally
benign16, 18, 19 and thus the molecular basis of their pathogenicity is not understood.
M26I DJ-1 is an example of a mutant whose underlying molecular defect is obscure.
Steady state levels of M26I DJ-1 are lower than wild-type protein in cell culture3, 20 and
in vivo,21 indicating reduced protein stability in the cellular environment.3, 20, 21 However,
X-ray crystallography, NMR, and biophysical studies indicate that M26I DJ-1 is highly
structurally similar to the wild-type protein and both proteins have comparable stability to
thermal and chemical denaturation.16, 17 Therefore, it is not clear from prior work why
M26I DJ-1 is less stable in cells than the wild-type protein.
The absence of a structural explanation for the established pathogenicity of M26I DJ-1
suggests that the conformational dynamics of the protein might be changed by the
mutation, potentially decreasing DJ-1 stability. The dynamical hypothesis for M26I DJ-1
pathogenesis is untested, as no comprehensive study of the dynamics of DJ-1 or any of its
pathogenic mutants has been reported to date. However, recombinant M26I DJ-1 is prone
to spontaneous aggregation in vitro that is not observed for the wild-type protein.19, 22
This enhanced in vitro aggregation indicates that M26I DJ-1 has intrinsically reduced
stability that would likely result in greater turnover and reduced steady-state levels of the
protein in vivo. Such an effect in M26I DJ-1 would provide a rare example of a direct
connection between aberrant protein dynamics and disease.
Here we show that the M26I mutation does not alter the picosecond-nanosecond
timescale dynamics of DJ-1 but does increase protein flexibility on longer timescales.
The enhanced conformational dynamics of M26I DJ-1 causes transient exposure of the
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hydrophobic core to solvent and results in pronounced aggregation near physiological
temperatures (35-37°C) but not below. The dynamically driven instability of M26I DJ-1
at physiological temperature provides an explanation for why the M26I mutation
destabilizes the protein in cells and causes loss of DJ-1 protection. These results also
illustrate a common and underappreciated limitation of in vitro experiments performed at
room temperature, where the functional consequences of protein dynamics may not be
evident.

7.2 Materials and Methods
7.2.1 Protein Expression and Purification
Human wild-type and mutant (M26I, M26V, M26L, L101W, Y141W, M26I Y141W)
DJ-1 proteins were expressed from pET15b (Novagen) constructs23 and purified using
Ni2+ affinity chromatography as previously described23 except that all buffers contained
freshly added 2.5 mM dithiothreitol (DTT). Uniformly 15N-labeled proteins (wild-type,
M26I, M26L DJ-1) were expressed as previously described.24
Purified proteins were dialyzed against storage buffer (25 mM HEPES pH 7.5, 100 mM
KCl, 2.5mM DTT) overnight at 4C and concentrated to 1 mM using an ultrafiltration
concentrator with a 10 kDa MWCO regenerated cellulose membrane (Millipore), snapfrozen in small aliquots on liquid nitrogen, and stored at -80°C until needed. All proteins
ran as a single band in overloaded Coomassie Blue stained SDS-PAGE gel and had
correct intact masses determined using electrospray mass spectroscopy (Redox Biology
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Center, UNL). Only DJ-1 that was >95% reduced at Cys106 was used for the
experiments in this study.

7.2.2 NMR Sample Preparation
For NMR experiments, purified 15N-labeled DJ-1 samples were dialyzed against 25 mM
MES pH 6.5, 25 mM NaCl, 2.5 mM DTT and concentrated to 0.9 mM. The 15N labeling
efficiency as well as intact protein mass was determined using reverse phase liquid
chromatography-mass spectrometry (LC-MS) as detailed previously.16, 24 Proteins were
diluted in water and analyzed using an Agilent 1200 LC system (Agilent Technologies)
and a Q-Trap-4000 MS (AB Sciex) at the Metabolomics and Proteomics Core Facility in
the Redox Biology Center (RBC) and the University of Nebraska-Lincoln (UNL).
Samples for T1, T2, and NOE measurements were prepared by adding D2O to a final
concentration of 10% by addition of 99.9% D2O (Sigma-Aldrich) and the sample was
transferred to a 5 mm, high-throughput 7” standard series NMR tube (Norell).
Samples for NMR-detected H/D Exchange (HDX) experiments were dialyzed against 10
mM ammonium acetate pH 6.7 and 5 mM DTT at ~21C. Samples were flash frozen with
liquid nitrogen, lyophilized, and stored at -80C until needed. To ensure that
lyophilization did not cause irreversible changes in DJ-1, we compared the 2D 1H-15N
HSQC spectra obtained from protein before and after lyophilization. No differences were
observed. HDX was performed by resuspending the lyophilized protein in 25 mM MES
pH 6.1, 25 mM NaCl, 2.5 mM DTT in 100% D2O. The solution pH was adjusted to 6.1
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with a 40% solution of NaOD (Sigma-Aldrich) and the pD calculated according to:
pDcorrected = pH + 0.4 (therefore the final pD of this buffer was 6.5).25

7.2.3 T1, T2 Relaxation and NOESY Experiments
All 2D 1H-15N heteronuclear single quantum coherence (HSQC) spectra were collected
using a Bruker AVANCE DRX 500 MHz spectrometer equipped with a 5 mm triple
resonance, Z-axis gradient cryoprobe with a cold proton channel at the University of
Nebraska-Lincoln’s Research Instrumentation Facility. 2D 1H-15N HSQC spectra
acquired for T1 (Bruker pulse sequence hsqct1etf3gpsi), T2 (hsqct2etf3gpsi), and NOE
(hsqcnoeetf3gpsi) measurements were collected at 35C. The delays for T1 (0.2696,
0.05392, 0.5392, 0.005392, 0.4044, 1.0784, 0.1348, 0.6740, 0.2696 sec) and T2 (0.0176,
0.0352, 0.0528, 0.0704, 0.0880, 0.1056, 0.1231, 0.1408, 0.1584, 0.1760, 0.1936, 0.2112
sec) relaxation experiments were randomized to minimize systematic error. All spectra
were collected using a total of 2048 and 256 data points and spectral sweep widths of
7309.942 and 2027.164 Hz along the proton and nitrogen dimensions, respectively. Free
induction decays (FIDs) were Fourier transformed, zero-filled, phased, and baseline
corrected using NMRPipe26 and analyzed using NMRViewJ.27 Chemical shift
assignments for wild-type DJ-1 were retrieved from the Biological Magnetic Resonance
Data Bank with accession number BMRB 17507.17 Our 35C spectra are shifted ~0.16
ppm in the hydrogen dimension compared to the previously collected 27°C spectra,17 as
expected with an increase in temperature.
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The relaxation times (T1, T2) for each amide resonance were calculated by fitting a
decay curve (see Eq. 1) to the intensity of each peak plotted against the associated delay
(in msec), where It is the intensity of each peak at the specified delay time t, and I0 is the
initial steady state intensity. The inverse of the relaxation times produced relaxation rates
(R1, R2) (converted to sec-1).

It = I0exp(-t/T1,2)

[EQ. 1]

R1,2 = 1/T1,2

Interleaved 2D 1H-15N NOESY spectra were collected using 2048 and 128 data points
along the direct and indirect axis, respectively, with 30 msec of proton saturation applied
(or not) during a 5 sec relaxation interval. The NOE values were calculated by dividing
the peak intensity for the saturated (Isat) spectrum by the unsaturated (Iunsat) spectrum (see
Eq. 2)

NOE = Isat / Iunsat

[EQ. 2]

The R1, R2 relaxation rates and NOE data were used to calculate the generalized order
parameter (S2), internal motion (e), chemical exchange (Rex), and the overall correlation
time (c) using Lipari-Szabo model free parameters in the FAST-Modelfree program
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(Facile Analysis and Statistical Testing for Modelfree), interfaced with ModelFree
4.20.28-30 The PDB coordinate files for the WT and mutant proteins were first input into
PDBInertia to translate their centers of mass to the origin. For each R2/R1 list and
respective PDB file output from PDBInertia, the R2R1-Diffusion program was used to
predict the axially symmetric diffusion tensor based on the approach of Tjandra, et al.31
The NMR spin-relaxation data (R1, R2, NOE) and the PDB obtained from R2R1-Diffusion
was then input into the FAST-ModelFree software package.30 To ensure that the
dynamics analysis was not converging on a local minimum, the random seed value was
changed for each run and the same seed value was never used more than once. Further,
each FAST-ModelFree run was done in triplicate to verify that the output values were
reproducible.
Temperatures for all NMR experiments were calibrated using 100% ethylene glycol as a
temperature standard. Briefly, the separation between the OH resonances and the CH2
resonances in ethylene glycol were measured (, ppm) and the sample temperature
calculated, according to the following equation: T = (4.637 - ) / 0.009967, where T is
the calculated temperature (Kelvin), and  is the shift difference (in ppm) between OH
and CH2 peaks (Bruker Instruments, Inc. VT-calibration manual).

7.2.4 H/D Exchange (HDX) NMR Spectroscopy
For HDX measurements, protonated 15N-labelled proteins were lyophilized and
resuspended in 500µL of 25 mM MES pH 6.5, 25 mM NaCl, 2.5 mM DTT in 100% D2O.
2D 1H-15N HSQC spectra (sfhmqcf3gpph) were collected every 10 min for 60 hrs at 35˚C.
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Spectra were collected using a total of 2048 and 256 data points with spectral sweep
widths of 7309.942 and 3041.362 Hz along the proton and nitrogen dimensions,
respectively. The pulse program was edited to use a reburp shape pulse32 and to include a
delay equal to 300 sec. This delay occurs before data collection to allow the cryoprobe
coil temperature to equilibrate after each acquisition. The 300 sec delay was only applied
for subsequent acquisitions in the first 60 hrs of data acquired. Each spectrum had a
reburp pulse duration of 1 msec, receiver gain set to 3k, SP23 set to 24.05 dB, SP24 set to
13.11 dB, PC9 set to 3 msec, thereby making each SoFAST-HSQC’s total acquisition
time 5 min 8 sec.
HDX rates (kex) were calculated similarly to T1 and T2 relaxation rates (see above). A
protection factor (PF) was calculated by dividing an estimated intrinsic rate (kint) for each
residue by the measured rate (kex) for that residue,33-36 i.e. PF = kint/kex. The PFs presented
within the manuscript are the log10(kint/kex) referred to as log10PF.37, 38 Due to rapid
exchange, we had to estimate kex values for several residues for wild-type DJ-1 (47 for
the monomer) and M26I DJ-1 (85 for the monomer) as described below. For residues that
could be observed in a T1 HSQC but were not present in the first HDX HSQC, the rate
constant for exchange was estimated to be ten times greater than the collection time for
the HDX HSQC (e.g. kex=1/1.4 min-1 for an HSQC spectrum obtained after 14 minutes of
H/D exchange); this affected 85 residues for M26I and 44 residues for wild-type DJ-1.
For all residues present in the first HDX spectrum, but then exchanged before a second
spectrum could be collected, the kex was estimated to be ten times faster than the second
HDX HSQC collection time, in min-1; this affected three residues for wild-type DJ-1
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only. There were also a total of six residues for M26I and 12 residues for wild-type
DJ-1 that did not exchange with D2O over the 60 hr experiment.

7.2.5 DJ-1 aggregation as a function of temperature
Because Ni2+-NTA purified DJ-1 (referred to as ‘As Purified’ in Fig. 5a) has been
reported to be more susceptible to aggregation than a sample that has not been exposed to
transition metals,39 DJ-1 used for the aggregation experiments was supplemented with 10
mM EDTA, dialyzed overnight against storage buffer containing 1 mM EDTA, then
dialysed again against storage buffer alone (referred to as ‘EDTA treated and Removed’
in Fig. 5b.) Aggregation of 100 M DJ-1 was monitored by measuring the optical density
of the sample at 400 nm every 30 min over 60 continuous hours with a BioTek Synergy 2
multi-mode microplate reader (BioTek Instruments, Inc.). Sample temperature was
controlled with the installed Gen5 software and data were collected at 30, 35, and 37C.
WT, M26I, M26L, and M26V DJ-1 were diluted to a volume of 180 L with degassed
storage buffer and placed in a 96-well plate (Costar 3595). 50 µL of light mineral oil
(Fisher Scientific) was layered over the sample to prevent evaporation, the 96-well plate
was sealed with optically clear polystyrene seals (VWR International), and the samples
were allowed to equilibrate for 10 min prior to the start of the assay.
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7.2.6 Fluorometry of DJ-1 Tryptophan Mutants
Human DJ-1 lacks a Trp, making it necessary to introduce a Trp by site-directed
mutagenesis. To identify minimally disruptive locations for introduction of a Trp residue
into DJ-1, sequence alignments of various proteins in the DJ-1/PfpI superfamily that
contain Trp residues were used. Proteins in this alignment were 40-46% identical to
human DJ-1, maximizing the chances for identifying well-tolerated locations for Trp
substitution. Leu101 and Tyr141 were identified as candidate sites for mutation that also
corresponded to areas of DJ-1 with markedly different responses to the M26I mutation in
HDX. All mutations were verified by DNA sequencing. Hexahistidine-tagged
recombinant proteins were expressed using pET15b in BL21(DE3) E. coli and purified as
previously described.16, 23 Due to solubility problems, M26I/L101W DJ-1 cells were
induced with 0.2 mM IPTG followed by incubation at 20C overnight with shaking.
Additionally, chloramphenicol (Fisher Scientific) was added to a final concentration of
100 g/mL two hrs before cells were harvested to enhance the recovery of soluble
protein.40, 41
Intrinsic tryptophan fluorescence emission spectra were collected at 37°C using a Cary
Eclipse fluorescence spectrophotometer (Varian) from 300-400 nm with excitation at 280
nm, and excitation and emission slit widths set to 5 nm. A recirculating thermostated
water bath (Varian) was used to control temperature. DJ-1 samples were diluted to 500
M in storage buffer, the cuvette was capped, and the solution was allowed to equilibrate
for 5 min. After correction for background scattering using a buffer control, the

249
fluorescence spectra of the samples were measured. All fluorescence intensities were
normalized to the concentration of their respective protein.

7.2.7 Chemical Cross-linking and Proteolysis of DJ-1
Disuccinimidyl suberate (DSS) (Thermo-Scientific) was aliquoted into 2 mg portions in a
Coy anaerobic chamber (Coy Lab Products) with plastic spatulas. All plastic material was
equilibrated in this environment for at least two weeks prior to use in order to minimize
metal or oxygen contamination prior to the experiment, which can reduce DSS crosslinking efficiency. DSS aliquots were then stored in desiccant at 4C until ready to use.
Wild-type and M26I DJ-1 were diluted to 100 M and subsequently dialyzed against
storage buffer lacking DTT. Each protein was divided into two 200 L aliquots where
one aliquot was incubated at room temperature (~22C) and the other at 37C. The
samples were incubated at their respective temperatures for ~ 2 hrs prior to the initiation
of cross-linking by addition of 100 mM DSS dissolved in DMSO to final concentrations
of 0, 2, 3, 4, or 5 mM. DMSO alone was added as a negative control. After 30 min, the
reaction was quenched with the addition of Tris-HCl, pH 7.5 to a final concentration of
38 mM and incubated for an additional 15 min at their respective temperatures. All
samples were then mixed with SDS-loading dye, heated to 95C for 5 min and analyzed
using SDS-PAGE with a 12% gel stained with colloidal Coomassie blue dye (Life
Technologies).
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Wild-type, M26I and M26L DJ-1 were diluted to 100 M and subsequently dialyzed
against PBS pH 7.4 (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, 5
mM EDTA). Each protein was incubated either at room temperature (~22C) or at 37C.
The samples incubated at their respective temperatures for 0-3 hr, and at selected time
points, a small aliquot was removed and either incubated with Bismaleimidoethane
(BMOE) (Thermo-Scientific) (final concentrations: 0, 0.1, or 0.5 mM) or DMSO
(negative control) for 45 min. After 45 min, the reaction was quenched with the addition
of DTT to a final concentration of 20 mM and incubated for an additional 15 min.
Samples were mixed with SDS-loading dye, heated to 100C for 5 min and analyzed
using SDS-PAGE with a 12% gel stained with colloidal Coomassie blue dye (Life
Technologies).

7.2.8 Limited protease digestion
Wild-type, M26I and M26L DJ-1 were diluted to 400 M in storage buffer. Trypsin,
dissolved in storage buffer, was added to the protein sample at a final concentration of
4.3 M. The samples were incubated in a water bath at 37C for 22.5 hrs. Aliquots were
removed at various time points, mixed with SDS-loading dye, and heated to 100C for 5
min to stop proteolysis. Digested samples were analyzed using SDS-PAGE with a 15%
gel and stained with colloidal Coomassie blue (Life Technologies).
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7.2.9 Thermal stability determination and far-UV circular dichroism (CD)
spectroscopy
The melting temperatures of DJ-1 proteins were determined using differential scanning
fluorimetry as previously described.24, 42 The secondary structural content of the proteins
was determined using far-UV CD spectroscopy following a previously reported
protocol24 with minor modifications. CD spectra were measured for 13 M proteins in 10
mM potassium phosphate pH 7.2, 2.5 mM DTT using a Jasco J-815 CD Spectrometer
(Jasco, Inc.). Sample temperature was controlled with a Julabo AWC100 (Julabo USA,
Inc.) recirculating water cooler and far-UV CD spectra were collected at 25 and 37C.
Protein concentration in the cuvette was determined using Scopes’ method43 and used to
calculate the mean residue molar ellipticity according to the formula below:24

[Θ(𝜆)] =

𝜃𝑜𝑏𝑠 (𝜆)
[EQ. 3]
10𝑛𝑐𝑙

where Θ(λ) is the mean residue molar ellipticity as a function of wavelength (deg cm2
dmol-1 residue-1), θobs(λ) is the measured ellipticity as a function of wavelength (nm), n is
the number of residues in the protein, c is the concentration of the protein (M), and l is
the path length of the cuvette (cm).
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7.2.10 Crystal growth, data collection and processing, and structure determination for
M26V DJ-1
M26V DJ-1 was crystallized using the sitting drop vapor diffusion method by mixing 2.4
µL of protein at 1.3 mM and 1.8 µL of reservoir solution (100 mM Tris-HCl pH 9, 200
mM sodium acetate trihydrate, 25 % PEG 4000 and 3 mM DTT), followed by
equilibration against 1 mL of the reservoir solution. Bipyramidal crystals of M26V DJ-1
in space group P3121 appeared in 2-4 days at room temperature. Crystals were
cryoprotected by serial transfer through the reservoir solution supplemented with
gradually increasing amounts of ethylene glycol until a final concentration of 25% (v/v)
was reached. The cryoprotected crystals were removed from the cryoprotectant in nylon
loops and mounted in a nitrogen cryostream for data collection.
X-ray diffraction data were collected to 1.45 Å resolution from a single crystal at 110 K
at the University of Nebraska-Lincoln Macromolecular Structural Core Facility using a
MicroMax-007 copper rotating anode source (Rigaku) operating at 40 kV and 20 mA
with Osmic Blue confocal optics, and a Raxis IV++ detector (Rigaku). In situ annealing44
of all crystals was done by blocking the cold nitrogen stream for ~3 sec, which reduces
mosaicity and improves data scaling statistics. All data were indexed, scaled, and merged
using HKL200045 with final data statistics in Table 1.
Phases for M26V DJ-1 were determined by molecular replacement (MR) using the
structure of human DJ-1 (PDB: 1P5F, 99% sequence identity46) as a search model in
Phaser47 in the CCP4 suite.48 Manual adjustments to the initial top MR solution were
made by inspection of 2mFO-DFC and mFO-DFC electron density maps in COOT.49 The
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resulting model was refined in Refmac5 against a maximum likelihood amplitudebased target function with geometric and anisotropic atomic displacement parameter
(ADP) restraints and including riding hydrogens. A test set of 5% randomly chosen
reflections were used for the calculation of the Rfree51 value. The stereochemical, side
chain rotameric, and packing quality of the final model was validated using COOT49 and
the MolProbity server52. All residues except Cys106 were in favored regions of the
Ramachandran plot, which is commonly observed in DJ-1 crystal structures. Final data
and model statistics are provided in Table 1.

Table 1: Data Collection and Refinement Statistics
Data Collection
Sample
M26V DJ-1
X-ray source
Rotating Cu Anode
X-ray wavelength (Å)
1.54
Space group
P3121
Cell dimensions a, b, c (Å)
75.04, 75.04, 75.27
90, 90, 120
, β,  (degrees)
a
Resolution (Å)
64.99-1.45 (1.49-1.45)
Rmergeb
0.062 (0.523)
<I>/<σ(I)>
56.6 (5.0)
Completeness (%)
99.7 (97.0)
Redundancy
20.4 (18.2)
Refinement
Program
Refmac5
Resolution (Å)
64.99-1.45
No. of reflections
41569
Rwork (%)c
0.110 (0.344)
d
Rfree (%)
0.135 (0.375)
Rall (%)e
0.111
No. of protein residues
189
No. of water atoms
309
No. of heteroatoms (ligand EDO)
4
Beq factors (Å2)
Protein
18.07
Water
38.07
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Heteroatoms
r.m.s. deviations
Bond lengths (Å)
Bond angles (degrees)

30.50
0.013
1.63

a

Values in parentheses are for highest resolution shell

b

Rmerge is calculated according to Equation 4,

𝑖
𝑖
R merge =  ∑ℎ𝑘𝑙 ∑𝑖|𝐼ℎ𝑘𝑙
−  〈𝐼ℎ𝑘𝑙 〉|/∑ℎ𝑘𝑙 ∑𝑖 𝐼ℎ𝑘𝑙
[EQ. 4]

where i is the ith observation of a reflection with index h, k, l, and angle brackets
indicate the average over all i observations.
c

Rwork is calculated according to Equation 5,
𝑂
𝐶
𝑂
R work =  ∑|𝐹ℎ𝑘𝑙
−  𝐹ℎ𝑘𝑙
|/∑ 𝐹ℎ𝑘𝑙
[EQ. 5]
ℎ𝑘𝑙

ℎ𝑘𝑙

𝐶
𝑂
where 𝐹ℎ𝑘𝑙
is the calculated structure factor amplitude with index h, k, l, and 𝐹ℎ𝑘𝑙
is the
observed structure factor amplitude with index h, k, l.
d

𝑂
Rfree is calculated as Rwork, where the 𝐹ℎ𝑘𝑙
values are taken from a test set comprising
5% of the data that were excluded from the refinement.

e

𝑂
Rall is calculates as Rwork, where the 𝐹ℎ𝑘𝑙
include all measured data (including the Rfree
test set).

7.3 Results
7.3.1 M26I and wild-type DJ-1 have similar picosecond-nanosecond dynamics at 35˚C
Consistent with previous NMR and X-ray crystallographic results, the solution structures
of wild-type and M26I DJ-1 are comparable based on their highly similar two
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1

15

dimensional (2D) H- N heteronuclear single quantum coherence (HSQC) NMR
spectra collected at 35°C (Figure 1).16, 17 This temperature was chosen because we sought
to characterize DJ-1 near physiological temperature, however experiments at 37C
resulted in aggregation of M26I DJ-1 (see below). The similar structures but divergent
cellular stabilities of wild-type and M26I DJ-1 suggest the hypothesis that the M26I
mutation may alter the conformational dynamics of DJ-1.
We characterized the picosecond-nanosecond (ps-ns) time-scale dynamics of DJ-1 using
NMR by measuring the R1 and R2 relaxation rates as well as Nuclear Overhauser Effect
(NOE) ratios at 500 MHz and 35C (Figure 2). The R2/R1, and NOE ratios were similar
for wild-type and M26I DJ-1 at 35C (Table 2, Figure 3). NOE ratios are bound by 0 and
1, with lower values indicating areas of increased motion in the backbone of a protein.17
The averaged NOE ratios at 35C for both wild-type (0.78  0.10) and M26I DJ-1 (0.77 
0.087) are lower than previously reported values at 27C (0.9  0.09),17 consistent with
greater protein motion at higher temperature.
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Figure 1: Wild-type and M26I DJ-1 have similar 2D 1H-15N HSQCs at 35°C. The 2D
1

H-15N HSQC spectrum for wild-type (WT, black) is overlaid with the spectrum for M26I

DJ-1 (red). M26I DJ-1 resonances mostly overlap with those observed for WT DJ-1, as
was previously shown by Malgieri and Eliezer.17
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Figure 2: Example fitting for T1, T2 relaxation curves of select residues in wild-type
and M26I DJ-1 at 35°C. (A, C) Wild-type (WT) and M26I T1 relaxation fits for ten
randomly chosen amino acids. (B, D) WT and M26I T2 relaxation fits for the same amino
acids as in (A). (A-D)

Table 2.
WT DJ-1

M26I DJ-1

NOE

0.779  0.0997

0.770  0.0871

R1

1.158  0.1398

1.219  0.288

R2

19.303  2.309

18.821  1.727

Model Free Input
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16.877  2.643

15.911  2.271

S2

0.912  0.0788

0.934  0.0544

S2f

0.876  0.0492

---

S2s

0.916  0.0724

0.934  0.0544

te

1313.9  714.923

622.75  656.975

Rex

3.188  1.688

1.356  1.917

SSE

1.977  2.742

1.545  2.238

R2/R1
Model Free Output

Values in the table are averages  SD
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Figure 3: The R2/R1 and NOE ratios are similar for WT and M26I DJ-1 at 35°C. (A)
The ratio of relaxation rates (R2/R1) is plotted for every observed backbone amide
resonance in both wild-type (WT, black) and M26I (red) DJ-1. The R2/R1 ratio is similar
for both proteins at 35°C. (B) WT (black) and M26I (red) NOE ratios. Four NOE ratio
values for M26I DJ-1 are not bound by 0 and 1, and they are Met133, Ser161, Val169,
and Val186. This is likely due to inadequate equilibration of NOE saturation for these
few residues.
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Lipari-Szabo model free analysis was performed using the measured R1, R2, and NOE
ratios, generating generalized order parameters (S2) that describe the extent of motion of
each assigned amide N-H pair using a “vector in a cone” description. S2 is bound by 0
and 1, where lower values indicate areas of increased mobility of the backbone peptide
groups.30, 53 The S2 values for wild-type and M26I DJ-1 at 35C are similar (Figure 4),
with average values of 0.91  0.079 and 0.93  0.054, respectively (Table 2). We note
that these values are high, indicating that DJ-1 is fairly rigid on the ps-ns timescale.
These calculated S2 values are robust to changes in the selection of residues used for
initial diffusion tensor calculation and different random number seeds, indicating good
convergence in the calculations and low sensitivity to initial parameters.

7.3.2 The M26I mutation increases longer time-scale dynamics at 35C
Slower timescale (minutes to hours) dynamics of DJ-1 were investigated using NMRdetected hydrogen/deuterium exchange (HDX). Because enhanced protein mobility will
increase the solvent accessibility of backbone amide groups, NMR-detected HDX is a
sensitive and site-specific probe of dynamics that occur on longer timescales than those
characterized using NMR relaxation-based methods.
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Figure 4: Wild-type and M26I DJ-1 behave similarly on a fast time-scale at 35C.
The general order parameter (S2) for wild-type (WT, black) and M26I DJ-1 (red) at 35°C
obtained from FAST ModelFree are plotted per residue. Picosecond-nanosecond motions
for both proteins are nearly identical at 35C. The regions without a reported value
indicate amino acids that could not be analyzed in FAST ModelFree, primarily due to
unobserved or overlapping resonances in the NMR spectra. A schematic of the secondary
structure of DJ-1 is shown below for reference (rectangles=-sheet, arrows=-helix.)

HDX reveals that the hydrophobic core of M26I DJ-1 is substantially less protected (and
hence more dynamic) than that of wild-type DJ-1, while both proteins have comparable
HDX rates for solvent exposed residues. HDX rates measured at 35˚C were converted to
protection factors (log10PF)33, 34 (Figure 5a, Figure 6) and were then mapped onto the
crystal structure of dimeric DJ-1 (Figure 5b). Despite being structurally similar to the
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wild-type protein, M26I DJ-1 experiences greater conformational fluctuations than
wild-type DJ-1, particular for residues 15-35, 45-55, 110-120, 130-135, 140-190. The
elevated exchange in the core of M26I DJ-1 is particularly noteworthy, as it indicates that
the mutant protein transiently samples conformations that deviate markedly from the
crystal structure and exposes the hydrophobic core to solvent. This is highlighted by
inspection of difference log10PF factors, which clearly show that the hydrophobic core of
DJ-1 is less protected (and hence more solvent exposed) in M26I DJ-1 (Fig. 5c). Because
the hydrophobic core of DJ-1 spans both monomers in the dimer, the elevated exchange
in the core of M26I DJ-1 could involve transient dimer opening, although M26I is highly
dimeric in other studies,16, 17, 19, 20 suggesting that dissociation into monomers is less
likely.
Tryptophan (Trp) fluorescence spectroscopy was used as an additional probe of the
influence of the M26I mutation on the flexibility of M26I DJ-1. The quantum yield of
Trp is sensitive to its local environment, and thus Trp can serve as a reporter of sitespecific environmental changes resulting from mutation of residue 26. Human DJ-1
contains no Trp residues, therefore we introduced Trp at two locations of the protein
(residues Tyr141 and Leu101) that exhibited strongly differing HDX behavior in
response to the M26I mutation (Fig. 5c). Both the Y141W and L101W mutations have
small effects on the thermal stability and secondary structure of DJ-1, indicating that
these mutations do not significantly perturb the DJ-1 structure (Figure 7). Tyr141 is
located in a region of DJ-1 with low log10PF and whose HDX exchange rate is insensitive
to the M26I mutation (log10PFWT=2.09 vs. log10PFM26I= 2.08). Consistent with the HDX
results, the fluorescence quantum yield of Y141W is similar in wild-type and M26I DJ-1
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(Figure 8). In contrast, the L101W substitution is located at a position that becomes
mobile as a result of the M26I mutation, exhibiting a HDX log10PF decrease from 4.35 in
wild-type to 1.75 in M26I DJ-1. Consistent with the HDX results, the fluorescence
emission of M26I/L101W DJ-1 is markedly lower than that of L101W alone, indicating
that Trp101 fluorescence in the M26I mutant is partially quenched due to a dynamically
driven increase in solvent exposure (Figure 8).
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Figure 5: HDX-detected dynamics are dramatically changed for M26I DJ-1 at
35C.
(A) Calculated log10 HDX protection factors (Log10PF) for wild-type (WT, black) and
M26I (red) DJ-1. Lower Log10PF values correspond to backbone amide hydrogen atoms
that exchange more readily with solvent deuterons. (B) Log10PF values from (A) have
been mapped onto the structure of wild-type (WT, left) and M26I (right) DJ-1 dimer. All
residues for which a Log10PF could not be assigned are shown in grey. M26I DJ-1 is
more dynamic than WT DJ-1, particularly in the hydrophobic core of the protein. (C)
Difference Log10PF (M26I Log10PF – WT Log10PF) mapped on to the dimer of M26I DJ1. Red indicates areas that are more dynamic for M26I DJ-1, while green indicates areas
that are more dynamic for WT DJ-1. Areas that are similar between the two proteins are
grey. The enhanced exposure of the hydrophobic core of M26I DJ-1 to solvent is evident.

266

Figure 6: Example fitting for HDX curves of select residues in WT and M26I DJ-1.
(A, C) Fitted decay curves for ten amino acids in wild-type (WT) and M26I DJ-1 HDX,
spanning a range of different log10PF values. (B, D) Expanded view of the boxed region
in (A) and (C), respectively. For WT HDX, Leu185 (open squares) the data could not be
adequately fitted due to chemical exchange (see L185 in (A)).

7.3.3 Thiol cross-linking and proteolysis indicate that M26I DJ-1 is more flexible than
wild-type DJ-1 at 37°C
We have recently described the use of thiol cross-linking to probe DJ-1 flexibility.24 DJ-1
contains three free thiols per monomer, only one of which (Cys53) is highly solvent
accessible (Figure 9a). Cys53 is ~3.5 Å from its symmetry mate in the DJ-1 dimer.
Consequently the Cys53 pair is readily cross-linked, while the other cysteines (Cys106
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and Cys46) are not. However, conformational fluctuations in DJ-1 can transiently
expose the other cysteines and make them available for reaction, increasing the number
of cross-linked DJ-1 species that can be observed in SDS-PAGE.24 Therefore, thiol crosslinking is a sensitive probe of large-scale conformational plasticity in DJ-1.

Figure 7: Tryptophan mutations have modest effects on secondary structure and
thermal stability of DJ-1 at 37°C. (A) Circular dichroism (CD) spectra were collected at
37°C for wild-type (WT) (black), M26I (blue), L101W (green), M26I/L101W (magenta),
Y141W (orange), and M26I/Y141W DJ-1 (purple). These proteins show no significant
differences in the mean residue molar ellipicity ([]) as a function of wavelength,
indicating that the Trp mutations are not highly disruptive to DJ-1 structure. (B) Thermal
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stability for all proteins in (A) was determined by the thermofluor assay. Consistent
with the CD spectroscopy data (A), only minor changes are observed. The melting
temperature (°C) is plotted for all proteins (n=5, plotted as avg  SD.)

Figure 8: Tryptophan fluorescence emission spectra reveal site-specific differences
in M26I DJ-1 solvent exposure. Tryptophan emission spectra for L101W (),
M26I/L101W (), Y141W (), and M26I/Y141W () obtained at 37°C. The M26I
mutation results in quenching of L101W DJ-1 fluorescence, indicating Trp101 is more
solvent exposed in M26I DJ-1. Leu101 is in a dynamic area of DJ-1 that is sensitive to
the M26I substitution in HDX (Log10PF WTL101=4.35, Log10PF M26IL101=1.75.) In
contrast, no differences are observed in the spectra for Y141W and M26I/Y141W DJ-1.
Tyr141 is in a dynamic region of DJ-1 that is not sensitive to the M26I mutation
(Log10PF WTY141=2.09, Log10PF M26IY141=2.08.)
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Figure 9: Thiol cross-linking and limited proteolysis show that M26I DJ-1 is more
dynamic than wild-type DJ-1 at physiological temperature. (A) Left: Cysteine crosslinking with BMOE for wild-type (WT), and M26I DJ-1 at 22 and 37C resolved by
SDS-PAGE. M26I DJ-1 forms a faster migrating, more extensively cross-linked dimeric
species at 37°C that is absent at 22 °C and for WT DJ-1. Monomer and dimer DJ-1 bands
are indicated. Right: Location of all six cysteine residues on dimeric DJ-1. (B) Limited
proteolysis time course with trypsin for wild-type (WT) and M26I DJ-1 at 37C. M26I
DJ-1 is more vulnerable to proteolysis, which is apparent by comparing the 8 and 22.5 hr
lanes.
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DJ-1 was cross-linked using the homobifunctional thiol cross-linker BMOE both at
21C and at 37C. In SDS-PAGE, a dominant dimer band at ~50 kDa is observed for
both wild-type and M26I DJ-1 at both temperatures (Figure 9a). However, M26I DJ-1
also exists as a faster-migrating dimeric cross-linked species (~37 kDa) at 37C that is
not observed at 21C and is never observed in wild-type DJ-1 (Figure 9a). This faster
migrating species is likely a multiply cross-linked dimer. Therefore, increased flexibility
of M26I DJ-1 allows it to transiently sample conformations at 37C that expose the more
buried Cys46 and Cys106 residues, making them available for additional cross-linking. In
contrast, cross-linking with the amine-reactive DSS (Figure 10) shows little difference
between wild-type and M26I DJ-1 at room temperature and at 37C. This is consistent
with the larger number of DSS-cross-linked species that can be formed between multiple
solvent-exposed locations.
Limited proteolysis with trypsin was used to further characterize DJ-1 flexibility on
longer timescales. An increase in DJ-1 flexibility would be expected to result in more
extensive digestion by the protease. M26I DJ-1 has an accelerated rate of cleavage by
trypsin at 37C, with a digestion pattern at 8 hours (Figure 9b) that is comparable to that
of wild-type protein at 22.5 hrs. In contrast, no loss of either protein was observed at
22C over the same time-course. This proteolysis result is consistent with the HDX, Trp
fluorescence, and cross-linking experiments, all of which demonstrate that longer
timescale dynamics of M26I are enhanced at 37C compared to wild-type DJ-1.
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Figure 10: Cross-linking behavior of DJ-1 proteins. (A) Primary amine cross-linking
with DSS for wild-type (WT, left) and M26I (right) DJ-1 resolved by SDS-PAGE. Crosslinking was performed at 1:20, 1:30, 1:40, and 1:50 (DJ-1:DSS) at both 22 and 37°C.
Samples in lanes 1 and 2 for both gels are the input and protein + DMSO controls. There
is no difference in DSS cross-linking between WT and M26I DJ-1 at either temperature.
(B) BMOE cross-linking for M26L DJ-1 is similar to that of wild-type DJ-1 (Figure 9a.),
consistent with this mutation being non-disruptive.

7.3.4 M26I DJ-1 is unstable at physiological temperature
Prior studies reported that M26I DJ-1 is more prone to aggregation in vitro, although a
structural explanation for this aberrant behavior has been elusive. We monitored the
aggregation of recombinant M26I in vitro by measuring its scattering of 400 nm light as a
function of temperature (Figure 11a). Both wild-type and M26I DJ-1 remained soluble
from 15 to 30C. Aggregation of M26I DJ-1 was apparent at 35°C and exacerbated at
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37C, with a lag phase of approximately 20 hrs (Figure 11a). In contrast, wild-type
DJ-1 was not observed to aggregate at these temperatures (Figure 11a). The onset of
aggregation for M26I at physiological temperature provides an appealing explanation for
the reduced stability of the protein in cells (grown at 37C)3, 22 and the apparent stability
of the recombinant protein, which is typically handled at lower temperatures.16, 17
The exposure of DJ-1 to transition metals such as Ni2+ and Fe3+ has been reported to
enhance its instability.39 As all proteins used in this study were purified by Ni2+-NTA
chromatography, we tested the influence of trace metal contamination by treating the
samples with a large excess of EDTA followed by dialysis. Consistent with the prior
report, the chelation and removal of trace metal diminishes M26I DJ-1 aggregation,
although M26I is still unstable and aggregates at 35-37°C (Figure 11b).
The crystal structure of M26I DJ-1 shows that the mutation creates both a small cavity
within the hydrophobic core and a steric conflict with a neighboring Ile31.16 The steric
clash with Ile31 is the most obvious structural change resulting from the M26I mutation,
but it is minor (0.7 Å displacement). To determine whether the clash at Ile31 in M26I DJ1 is responsible for the increase in flexibility that drives aggregation of the protein, we
created both the M26L and M26V mutations (Figure 12, Table 1). The M26L substitution
eliminates the β-branched sidechain at position 26 and alleviates the clash with Ile31.16
Many close homologues of DJ-1 natively have a Leu at position 26, indicating that this
substitution is well-tolerated and preserves DJ-1 function. M26L DJ-1 does not aggregate
at 37C (Figure 11) and is less dynamic as determined by thiol crosslinking (Figure 10).
This demonstrates the importance of the steric conflict between I26 and Ile31 that leads
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to M26I DJ-1 instability. The destabilizing effect of β-branched sidechains at residue
26 was confirmed by the extensive aggregation observed for the M26V mutant at 3537°C (Figure 11), which, like M26I, places a hydrophobic -branched amino acid at this
position. The crystal structure of M26V DJ-1 shows that the mutation is highly
conservative, with a C-RMSD of 0.14 Å with M26I DJ-1 (Figure 12). The most
significant structural change is the displacement of Ile31 resulting from a clash with the
C1 atom of Val26, similar to M26I DJ-1 (Figure 12).
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Figure 11: M26I DJ-1 is aggregation-prone at physiological temperature in vitro.
(A) Aggregation of wild-type (WT), M26I, M26L, and M26V at 30, 35, and 37°C. There
is no observable aggregation for wild-type and M26L DJ-1 at any of these temperatures
(baseline). In contrast, M26I and M26V DJ-1 aggregate extensively at 35 and 37°C
(labeled). (B) Aggregation was performed as in (A), but the samples were treated with 10
mM EDTA and dialyzed to remove any trace metal contamination from the proteins
before the start of the experiment. M26I and M26V DJ-1 still aggregate at 35 and 37°C
(labeled), although to a lesser extent than in (A.) (A-B) All samples are in triplicate
(plotted as avg  SD.)

Figure 12: The M26I and M26V mutations cause similar steric conflicts with Ile31.
(A, B) The local environment surrounding residue 26 are shown for wild-type (dark grey),
M26L (blue), and either M26I (red) (A) or M26V (gold) (B). Ile31 and residue 26 are
labeled.
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7.4 Discussion
This study demonstrates that the structurally conservative parkinsonian M26I mutation in
DJ-1 causes an increase in slow protein conformational dynamics near physiological
temperature that destabilizes the protein. M26I DJ-1 provides an attractive system in
which to explore the connection between protein dynamics and disease, as X-ray
crystallography and NMR spectroscopy both indicate a high structural similarity between
M26I DJ-1 and the wild-type protein despite being a disease-causing mutation.16, 17
Therefore, the observed dynamical changes in M26I DJ-1 are not confounded by large
structural changes in the protein. Consistent with the structurally conservative character
of the mutation, M26I does not alter fast timescale (ps-ns) backbone dynamics. However,
this parkinsonian mutation does enhance slower motions detected by HDX as well as by
tryptophan fluorescence, chemical cross-linking, and limited proteolysis. These slower
motions destabilize M26I DJ-1 and, ultimately, cause parkinsonism.
Considered together, our data suggest a model involving a slow transient opening of the
M26I DJ-1 dimer that increases solvent exposure of its hydrophobic core, especially near
physiological temperature. Difference log10PF values for HDX show a more exchangeactive core in M26I DJ-1, and greater H/D exchange at the edges of the central β-sheet
(Figure 5c) are consistent with “fraying” of this central sheet at its edges. Some prior
studies have reported modestly reduced secondary structural content for M26I DJ-1,17, 19
which would be consistent with a transient loss of interstrand hydrogen bonds in these
regions. Supporting this interpretation, the Trp fluorescence and thiol cross-linking data
both suggest that largely buried regions of the structure become more solvent-exposed in
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M26I at 37°C. In particular, the appearance of a distinct BMOE-cross-linked dimer
species for M26I at 37°C that is not observed at lower temperature or in the wild-type
protein indicates that increased solvent exposure of buried portions of M26I DJ-1 is a
temperature-dependent phenomenon.
The exposure of hydrophobic areas of DJ-1 near physiological temperature is the likely
cause of the enhanced aggregation that we and others have observed in M26I DJ-1. We
find that mutant DJ-1 aggregation is only apparent (over the 60 hour timescale) at 3537°C, indicating that M26I acts as a temperature-sensitive loss of stability mutant. In
addition, M26I DJ-1 aggregation is distinct from thermal denaturation, as the melting
temperature for M26I DJ-1 has been measured to be 52-63°C using various techniques.16,
17, 19, 54

It is important to emphasize that DJ-1 aggregation in vitro would likely manifest

as protein degradation in vivo, and thus would account for the reduced level of M26I DJ1 observed in cells grown at 37°C. The strong coupling between elevated temperature and
M26I DJ-1 instability suggests that the greater flexibility of M26I mutant “softens” DJ-1
and leads to loss of stability at physiological temperature where the wild-type protein is
still stable and functional. Attractively, the onset of dynamically-driven instability in
M26I DJ-1 at physiological temperature resolved conflicting reports of this mutant’s
stability in cells (at 37°C) and in vitro (at room temperature).
The dynamical changes in DJ-1 resulting from the M26I mutation are initiated by the
steric conflict between Ile26 and Ile3116 that causes a ~0.7 Å displacement of Ile31 in
M26I DJ-1. This clash is relieved by the engineered M26L mutant, which also abrogates
protein aggregation, indicating that the Ile26-Ile31 clash is an important contributor to
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16, 55

DJ-1 destabilization.

The damaging effects of -branched amino acids at residue

26 in DJ-1 is confirmed by the M26V mutation, which restores this clash and
consequently causes aggressive aggregation of the protein. Our data indicates that the
minor, local structural change caused by the introduction of a -branched amino acid at
residue 26 causes large-scale, global changes in DJ-1 slow conformational dynamics that
result in protein instability. We also note that trace transition metals in the DJ-1 purified
in this work seem to enhance aggregation, consistent with a prior finding.39 This is
intriguing, as iron (another transition metal) levels are elevated in parkinsonian nigral
tissue 56 and may influence DJ-1 stability. The basis of this effect is a direction for future
work.
M26I DJ-1 is a rare case where principally dynamical, rather than structural, changes in a
protein can be directly connected with instability and disease. However, other examples
where protein dynamics have been connected to pathological dysfunction include the
deletion of a single amino acid (F508) in the Cystic fibrosis transmembrane conductance
regulator (CFTR) protein, which causes areas of inherent disorder and flexibility resulting
in disease.57, 58 An additional example is copper-zinc superoxide dismutase (Cu-Zn SOD),
where mutations associated with heritable forms of amylotropic lateral sclerosis (ALS)
cause changes in protein dynamics.59 DJ-1, which is an easily handled protein amenable
to multiple biophysical approaches, makes an attractive model system in which to further
explore the connection between disturbed protein dynamics and disease. We propose the
aberrant protein dynamics may be a more common contributor to disease than currently
appreciated.
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More generally, our results indicate that routine in vitro characterization of proteins
lower than physiological temperature provides an inaccurate view of their behavior. This
has been well established in the extreme case of X-ray crystallography of cryo-cooled
samples, where proteins are characterized at ~-170°C. In these cases, significant
alterations to the degree and correlation of sidechain disorder that effect functionally
relevant dynamics has been described.60 The present study indicates that even a modest
~15°C difference between room temperature and physiological temperature (for humans)
is enough to conceal important aspects of protein conformational behavior. As the
characterization of protein dynamics becomes more widespread and routine, these results
indicate that samples should be studied at their physiologically relevant temperatures
wherever possible.
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Chapter 8
15

N CEST Data and Traditional Model-Free Analysis Capture Fast

Internal Dynamics of DJ-1
8.1 Introduction
NMR spectroscopy is a powerful tool for the study of protein structures and dynamics in
the solution state. Over the years, many NMR methods have been developed to observe
protein dynamics for a range of timescales.1 In which, fast timescale dynamics have been
traditionally studied using 1H-15N HSQC R1, R2, and heteronuclear NOE experiments
with the Carr-Purcell-Meiboom-Gill (CPMG) relaxation dispersion approach.2 The T1, T2
and NOE data obtained from these experiments are routinely used to characterize subnano to millisecond protein dynamics with modelfree formalism.3, 4 The CPMG approach
has also been extended to the study of conformational exchange due to its sensitivity to
chemical shift differences between ground and excited states.5 However, CPMG
relaxation dispersion fails for proteins undergoing slow conformational exchange or for
lowly populated excited states.6
Recent advances employing saturation transfer, such as chemical exchange saturation
transfer (CEST) and dark-state exchange saturation transfer (DEST), have enabled the
detection of these previously invisible protein states.6, 7 Several studies have already
reported the use of CEST to study the invisible conformers of slowly exchanging proteins
on the millisecond to second timescale.8-12 Additionally, the fitting of CEST profiles have
been shown to reliably extract R1 and R2 parameters that can be used for modelfree
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analysis of fast timescale dynamics (ps to ns). Thus, the simultaneous measurement of
both fast and slow timescale dynamics is possible with the CEST experiment. The
extraction of the R1 and R2 parameters is particularly advantageous due to the fact that
CEST and CPMG experiments can be acquired in a similar amount of experimental
time.12 To date, however, no study has combined CEST-derived R1 and R2 parameters
with 1H-15N NOE data to establish the picosecond to nanosecond dynamics of a protein.
Instead, leaner versions of modelfree have been applied without the NOE data.9
The NOE is a sensitive measure of the high frequency motions as it reports directly on
the structure of the protein and is strongly associated with its correlation time (

c).

13

Therefore, the heteronuclear NOE experiment has been essential to traditional dynamics
analyses in conjunction with R1 and R2 values. The importance of the NOE is
strengthened by the fact that, at the expense of precise R1 measurements, only precise
NOE and R2 values are necessary to calculate a reliable S2.14 Additionally, the NOE is
more sensitive than the R1 parameter for capturing internal dynamics.10 The significance
of the NOE to the understanding of fast protein dynamics is considerable and we present
further evidence to substantiate the use of NOE data for modelfree analysis using 15NCEST experiments.

8.2 Material and Methods
NMR was used to investigate the dynamics of three DJ-1 oxidation states of Cys106
corresponding to a reduced form (DJ-1 Cys106-H), a sulfinic acid form (DJ-1 Cys106SO2) and a sulfonic acid form (DJ-1 Cys106-SO3). The reduced DJ-1 Cys106 was
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oxidized to a cysteine sulfinic acid by adding hydrogen peroxide at a molar ratio of
1:7 and incubating on ice for 45 minutes. Similarly, the Cys106 sulfonic acid was
prepared by adding hydrogen peroxide at a molar ratio of 1:100 and incubation at room
temperature for 2.5 hours. Following incubation, the protein was subjected to a buffer
exchange to remove excess hydrogen peroxide. All NMR experiments were collected at
37 or 35oC on a 700 MHz Bruker Avance III spectrometer equipped with a 5 mm QCI-P
probe with cryogenically cooled carbon and proton channels. 15N CEST experiments
were performed as previously described6 with B1 field strengths of 12.5 and 25 Hz. The
external field was scanned across the range of 100 to 140 ppm at a step size of 50 Hz
(35oC) or 25 Hz (37oC). An interscan delay of 1.5s was employed and 15N saturation was
applied for 0.5s. For each experiment a total of 4 transients were collected per 2D plane
resulting in a total experiment time of approximately 7 hours. Processing was
accomplished with NMRPipe15 and CEST profiles were fit with ChemEx (Figure 1).6
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Figure 1. Representative CEST profiles for 3 residues in DJ-1 Cys16-H at 35oC. The
profiles show the proper fitting of the dip in intensity and the lack of a noticeable minor
state conformation. Residues were chosen based on position in the primary sequence to
highlight the consistence of the fitting of the profiles.
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Figure 2. A plot of the CEST derived R1 and R2 parameters for DJ-1 Cys106-H at 35oC.
The cartoon5 represents the secondary structure of DJ-1 with helices in red, strands in
green, and loops and disordered regions in blue.

The fitting of the CEST profiles by ChemEx produces R1 and R2 relaxation parameters as
standard output and is explained in detail in Vallurupalli et al., JACS (2012).6 The R1, R2,
NOE, and S2 errors reported in Tables 1 and 2 were calculated as the standard error of the
mean. Heteronuclear NOE experiments were performed as previously described16 and
processed in NMRPipe. FAST-ModelFree analysis was done identical to our previous
study to ensure a proper comparison of the methods.16
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8.3 Results and Discussion
The fast protein dynamics of reduced DJ-1 have been previously determined using
traditional spin relaxation derived R1 and R2 values and 1H-15N NOE data.16 DJ-1 was
found to be fairly rigid in solution at 35˚C, with most order parameters (S2) approaching
the maximum theoretical limit (S2 = 1). Importantly, the previous dynamics finding from
these traditional relaxation experiments was reproduced with the R1 and R2 values
obtained from fitting of 15N CEST profiles and from 1H-15N NOE data (Table 1, Figure
2). Per residue CEST profiles were reliably fit simultaneously for both external fields,
although only one field was necessary (Figure 1). Unfortunately, the fitting of the CEST
profiles did not reveal the presence of a minor state or chemical exchange, but this
finding did not negatively affect the quality of the derived relaxation parameters. Our
results further establish the robustness of the 15N CEST experiment and justify its
adoption as an alternative to traditional relaxation experiments. The observed consistency
between two distinct sets of R1, R2 and S2 values substantiates previous claims that CEST
data is equivalent to traditional spin relaxation experiments.9 The calculated RMSDs
values (Table 3) comparing the CEST and traditional R1 and R2 values are within the
observed standard deviations for the data sets (Tables 1 and 2). An NOE RMSD of 0.13
was obtained when we compared our original 1H-15N NOE data16 with an NOE data set
recollected with the CEST experiments. Again, the NOE RMSD is within the observed
experimental error and standard deviations (Tables 1 and 2).
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Table 1. Average R1, R2, NOE, and S2 values from DJ-1 Cys106-H at 35oC.
Exp. Type

Protein

Observed
R1 a

R1
Errorb

Traditional
(35oC)

DJ-1,
Cys106H

0.78
(0.10)

0.06

CEST
(35oC)

DJ-1,
Cys106H

0.72

0.06

a

(0.21)

Observed
R2 a

R2
Errorb

19.30
(2.30)

0.7

19.33

2.1

Observed
NOEa

NOE
Errorb

Calculated
S2a

S2
Error
b

(3.50)

0.79
(0.11)

0.15

0.79

0.11

0.92

0.02

(0.10)

(0.15)

0.88

0.07

(0.12)

Standard deviations are in parenthesis. bThe reported errors are the standard error of the mean.

Table 2. Average R1, R2, NOE, and S2 values from different physiological states of
DJ-1.
Exp.
Type

Protein

Observed
R1 a

R1
Errorb

Observed
R2 a

R2
Errorb

Observed
NOE a

NOE
Error

Calculated
S2a

S2
Errorb

CEST
(37oC)

DJ-1,
Cys106-H

0.72
(0.22)

0.06

19.50
(3.46)

2.1

0.79
(0.16)

0.11

0.86 (0.15)

0.07

DJ-1,
Cys106SO2

0.78
(0.13)

0.08

20.65
(2.66)

1.3

0.80
(0.16)

0.14

0.92 (0.13)

0.04

DJ-1,
Cys106SO3

0.71
(0.21)

0.06

18.47
(4.96)

1.0

0.64
(0.42)

0.10

0.76 (0.22)

0.04

a

Standard deviations are in parenthesis. bThe reported errors are the standard error of the mean.

Table 3. RMSD values comparing traditionally collected and CEST datasets
for DJ-1 Cys106-H at 35oC.

Traditional vs
CEST

R1

R2

S2

0.18

1.95

0.02
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Figure 3. A delta plot of the R1, R2, and generalized order parameters comparing
traditionally collected data versus CEST derived data for DJ-1 Cys106-H at 35oC. The
cartoon5 represents the secondary structure of DJ-1 with helices in red, strands in green,
and loops and disordered regions in blue.
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The per residue delta plots of the R1, R2 and S values shown in Figure 3 further
illustrates the consistency between the two methods. The low variability in the R2 delta
plot indicates that the CEST profile linewidths were robust in the reporting of the true R2
values and that there was an absence of chemical exchange. Only a slight overall
difference of the methods was observed based on an S2 RMSD of 0.02. This is despite the
fact that the prior dynamics measurements were carried out on different NMR
spectrometers at different field strengths (i.e., 500 MHz vs. 700 MHz). The largest
variations in the observed ΔS2 values were primarily located in loop regions, which are
expected to be more sensitive to subtle temperature and solvent differences. A few
residues with large ΔS2 were removed from the comparison since the ΔS2 error was likely
a result of peak overlap and not representative of the overall quality of the CEST data. It
is again important to note that these datasets were collected several years apart on
different protein samples, on different spectrometers, and by different spectroscopists.
Therefore, although the reproducibility between the two datasets is not on par with prior
results,9 our comparison does represent a more realistic scenario and a more accurate
representation of the true uncertainty. Importantly, the final results of the modelfree
analyses from both the CEST and CPMG datasets led to the same conclusions regarding
the overall dynamic properties of DJ-1.
Leveraging the 15N-CEST experiment, several naturally occurring oxidation states of DJ1 were studied (Cys106-H, -SO2, -SO3) to identify if there were any differences in their
dynamic properties. At physiological temperature (37oC), none of the three forms of DJ-1
exhibited a minor state conformer based on analysis of the CEST profiles. The CESTderived R1 and R2 parameters for each of the DJ-1 states were further analyzed to identify
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any ps-ns timescale dynamics that may differ between the three states. Interestingly,
there were only minor differences in the R1 and R2 relaxation parameters between the
three states in addition to being comparable to our previous results (Tables 1 and 2). 1H15

N NOE experiments were subsequently performed to further explore the dynamic

properties of the three DJ-1 states. A drastic change was readily apparent in DJ-1
Cys106-SO3, where the average NOE is lower, and the NOE standard deviation is much
larger compared to the two other DJ-1 states (Table 2). The CEST derived R1 and R2
parameters and the heteronuclear NOE values were then used with FAST-ModelFree17-19
to determine the per residue order parameters. The dynamic properties for the first two
DJ-1 states are quite similar to our previously published results for the reduced form of
DJ-1, where the protein exhibits minimal motion on the ps-ns time scale. Conversely, DJ1 Cys106-SO3 exhibits a significant increase in dynamics based on an overall lower S2
value of 0.76 ± 0.22. Importantly, it appears that the main contributor to the increase in
dynamics for DJ-1 Cys106-SO3 is a reduction in the average NOE from approximately
0.80 to 0.64 ± 0.42. Further, it is well known that NOE data is essential for the accurate
analysis of protein dynamics since the NOE is very sensitive to fast internal dynamics
(e.g.,

e),

as previously defined in Kay et al. (1989).10 In addition, the large standard

deviation in the NOEs for DJ-1 Cys106-SO3 is also indicative of a substantial decrease in
structural stability. This is consistent with the observation that DJ-1 Cys106-SO3 was less
stable than the other two forms of the protein. DJ-1 Cys106-SO3 would aggregate and
precipitate out of solution after approximately two days at 37oC. Conversely, the reduced
and sulfinic forms of DJ-1 were indefinitely stable.
To gain insight on the impact of the NOEs on the per residue order parameters, the NOE
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data from DJ-1 Cys106-SO3 was combined with the R1 and R2 data from DJ-1
Cys106-SO2. DJ-1 Cys106-SO2 is arguably the most rigid form of DJ-1 since it has the
highest average order parameter of 0.92 ± 0.13. Moreover, DJ-1 Cys106-SO2 has the
lowest R1 and R2 standard deviations of 0.13 and 2.66, respectively. Any changes in the
order parameters calculated by combining the DJ-1 Cys106-SO2 R1 and R2 data with the
DJ-1 Cys106-SO3 NOE data will highlight the impact of the more dynamic NOEs on the
calculated order parameters. Figure 4 shows the ΔS2 obtained from comparing the DJ-1
Cys106-H and Cys106-SO3 NOE data. It is readily apparent that the more dynamic NOEs
contribute significantly to the per residue order parameters as approximately 10 residues
order parameters decreased by -0.25 or more. These differences are noteworthy because
they may change the classification of a residue from “ordered” to “disordered”.
Interestingly, a majority of the ΔS2 values are near zero, which indicates essentially
identical dynamics between the two states. Not surprisingly, only the residues with a
significant difference in NOE values were substantially affected. It is likely that these DJ1 residues in the Cys106-SO3 form have sub-ns internal motions, which make them
sensitive to the 1H-15N NOE experiment. These findings are significant because exclusion
of any NOE data would have hidden the true dynamics of these particular DJ-1 residues.
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Figure 4. A delta plot of the generalized order parameters comparing DJ-1 Cys106-H and
DJ-1 Cys106-SO3 NOE data. Data points below zero indicate an increase in internal
motion due to the DJ-1 Cys106-SO3 NOE value.

8.4 Conclusion
The purpose of this study was to further evaluate the robustness of the 15N CEST
experiments as an alternative method to determine the fast protein dynamics of three
physiological states of DJ-1 while combining CEST derived R1 and R2 parameters with
traditional NOE values. Initial results confirmed that this new method was comparable to
traditional dynamics analyses as our results correspond well with previous findings. We
have also reaffirmed the importance of the heteronuclear NOE to a dynamics analysis.
Extremely low NOE values are strong indicators of protein disorder or unfolding and, in
this study, were the only experimental evidence for this phenomenon in DJ-1 since the R1
and R2 parameters were similar for the three DJ-1 states. To our knowledge, this is the
first study that combines 15N CEST data with a traditional model-free analysis of a
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biological system and also confirms the necessity of NOE data for exploring fast
protein dynamics.
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Chapter 9
Summary and Future Directions
9.1 Summary
This dissertation has covered a wide variety of research projects revolving around the
sequence, structure, function, and dynamics of proteins. Using both conventional and
novel biophysical and bioinformatics approaches, we have made important contributions
in the expansive field of structural biology. Structures for therapeutic and putative protein
targets have been elucidated and advancements in evolutionary analysis have been
discovered. Furthermore, we have reaffirmed the crucial role of NMR in the study of
proteins. NMR has and will continue to be a significant instrument for probing proteins in
environments closest to their most natural and physiological state.
Beginning with Chapter 2, a novel approach to the evolutionary analysis of distant
proteins was introduced. By simply using comparisons of active site structures we
quickly and efficiently mapped the functional evolution of proteins regardless of their
sequence or structure similarity. This method was first proven on the pyridoxal 5’phosphate (PLP) enzyme family, which began their divergence in the last common
ancestor. Altogether, the PLP family has approximately 10% sequence identity within
four structurally independent fold-types. Thus, conventional sequence based studies for
the evolutionary analyses of this family have been narrowly focused on small subsets of
functionally similar PLP enzymes. The application of CPASS, however, enabled the
entirety of the family to be studied simultaneously and presented on a single phylogenetic
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network. Within the generated network was a perfect clustering of the enzymes by
fold-type, enzymatic function, and organism classification. Our bioinformatics
investigation of the functional evolution of PLP-enzymes represents the first time ever
that a single phylogentic tree was constructed that contained the four PLP fold-types.
Consequently, our phylogentic tree captures the step-wise evolution of function for the
entire PLP enzyme family.
The success of the PLP active site evolutionary study led to a similar but greatly
expanded project aimed at all of the ligand-bound proteins in the PDB. Approximately
40,000 unique active sites exist in the PDB, which is significantly larger than the PLP set
used previously (~200). To reduce the overall size of the data and improve visualization
of the end results, the unique active sites were first grouped according to the identity of
the bound ligand. A statistical tool known as Principal Component Analysis (PCA) was
applied to each ligand defined group to identify a representative structure. This proved to
be an effective approach to reducing the number of active sites to 10% of the total
(~4000) while maintaining essential information since a representative structure was
easily identified from the PCA scores plot for each ligand defined group. The resulting
phylogenetic tree based on a CPASS similarity scoring matrix for the 4000 representative
ligand binding sites resulted in a near-perfect functional clustering of the active sites
based on EC function. Importantly, the phylogenetic tree enables the functional
evolution at the residue level to be visualized for the entirety of protein functions present
in the RCSB PDB. This is a major achievement and advancement in our understanding of
the evolution of protein function since it represents the first time the entire RCSB PDB
has been functionally mapped according to active site structure similarity.
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Obtaining a protein structure is fundamental to our understanding of the biological
function of a protein; and its possible role in human disease; and as a either a therapeutic
target or a new therapy. Accordingly NMR was used to investigate the structure of the
Citropin 1.1 peptide and its analogs, which are potential novel antimicrobial therapies;
the structure and dynamics of the S. aureus protein primase CTD, which is a potential
novel therapeutic target for the development of next generation antibiotics; the dynamics
of the human protein DJ-1 and its mutants, which is an important therapeutic target for
Parkinson’s disease; and the structure and potential function for the functionally
uncharacterized R. palustris protein RPA3313. The NMR structures of the Citropin 1.1
peptide and its analogs were presented in Chapter 4. We found that the cationic residues
at the N-terminus of the peptide formed essential hydrogen bonds and electrostatic
interactions that synergistically worked to promote antimicrobial activity. Importantly,
our structural analysis of the Citropin 1.1 peptides clearly demonstrated that the peptides
adopt a single helical structure and forms a head to tail dimer in the presence of
membrane-mimic. Thus, our results correct a mistake propagated in the literature that
Citropin 1.1 peptides are a monomer composed of two separate helical regions.
Moreover, we discovered an equilibrium between disordered monomer and helical dimer
structures that was directly correlated with antimicrobial activity. Fluorescence and
microscopy experiments indicated that the peptides mechanism of action involved
disrupting the bacterial membrane through a “carpet model”. Our results identified
sequence and structural features of the Citropin 1.1 peptide that are critical for
antimicrobial activity. Furthermore, our results provide support for the peptides’
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mechanism of antimicrobial activity. This information is essential to evolve the
Citropin 1.1 peptide into a drug-like candidate and to develop a new antibiotic.
Chapters 5 and 6 presented the NMR structure determination of the R. palustris RPA3313
protein and the S. aureus primase C-terminal domain (SaP-CTD), respectively. In both
instances, the NMR solution structures provided critical evidence to possible protein
function, protein-protein interaction sites, and putative ligand binding sites. RPA3313
was observed to adopt a novel fold and was found to interact with the ribosome in R.
palustris. Thus, the RPA3313 NMR structure extended our knowledge of protein
conformational space through the identification of a new protein fold. Significantly, the
RPA3313 structure can be extended to homologs of RPA3313, since the protein family
was structurally uncharacterized prior to our study. While the structure of RPA3313 was
used to infer a potential function, the NMR solution structure of SaP-CTD was used to
identify potential ligands and ligand binding sites. This information is essentially to
assessing the potential therapeutic utility of SaP-CTD as a drug discovery target. The
NMR structure for SaP-CTD indicates that the protein is composed of two subdomains.
Importantly, the relative orientations of the two subdomains (open or closed
conformation) are correlated with helicase binding. SaP-CTD adopts the closed
conformation, which does not bind helicase. NMR dynamics experiments indicated that
the two subdomains of SaP-CTD moved independently of one another with a binding site
located between the two subdomains. An in silico virtual screen and subsequent NMR
titration experiment found significant binders which could stabilize the two subdomains
in the closed conformation and prevent proper protein function. In essence, our structural
and dynamics analysis of SaP-CTD identified a potential novel ligand binding site, a set
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of potential ligands and, importantly, a potential novel mechanism of inhibiting the
primase and helicase interaction by capitalizing on the dynamic properties of primase.
The relative flexibility between the two SaP-CTD subdomains allows the protein to
readily adopt the open conformation and bind primase. Conversely, a ligand that binds
between the two subdomains and locks the protein in the closed conformation may be a
valuable antibiotic. In both projects, the NMR determined structures proved to be
essential to the understanding of the proteins’ biological functions and therapeutic utility.
The importance of NMR to the study protein dynamics was further demonstrated in our
analysis of DJ-1 presented in Chapters 7 and 8. Human protein DJ-1 is a ubiquitously
expressed homodimer, however, its molecular activity is largely unknown. M26I DJ-1 is
an inheritable mutant that has been implicated in Parkinson’s disease; and adopts a fold
structurally identical to the wild-type protein. The “benign” mutation does not alter the
tertiary structure or disrupt dimer formation, yet it still leads to protein instability and
disease. NMR relaxation studies revealed that the wild-type and M26I DJ-1 proteins are
both rigid in solution. A hydrogen-deuterium exchange experiment discovered that the
hydrophobic core of M26I DJ-1 was transiently exposed to solvent, which enabled it to
subsequently aggregate, which, in turn, leads to a loss of function, and, presumably, is a
cause of Parkinson’s disease. Thus, the NMR dynamics has provided an important insight
into a potential molecular mechanism associated with Parkinson’s disease. This important
finding further illustrates that changes in dynamics, rather than structure, may also be
connect to protein instability and the diseased state of the protein.
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DJ-1 dynamic properties were also investigated as a result of changes in the protein’s
oxidative state. It was found that over-oxidized DJ-1 was extremely unstable in solution
and began to unfold and aggregate at physiological temperature. This raised the
possibility that DJ-1 may be regulated by its oxidation state and may serve as a cellular
sensor for oxidative stress. Concurrently, improvements in the NMR experimental
methods for probing protein dynamics were accomplished while investigating the
dynamics of the oxidative states of DJ-1. Chemical exchange saturation transfer (CEST)
experiments can be used to visualize the transient, invisible states of proteins in solution.
Although no invisible state of DJ-1 was found, the fitting of the CEST profiles produced
relaxation parameters of the fast timescale dynamics that were consistent with our
previous findings. This observation demonstrated that the dynamics at multiple
timescales can be studied simultaneously and expand the capabilities of NMR
spectroscopy. This was particularly important in the case of DJ-1 because the CEST
experiments were collected significantly faster than the traditional methods that required
individual set of experiments to measure R1, R2 and NOEs. Rapid data collection was
critical because different forms of DJ-1 had limited long-term stability.

9.2 Future Directions
Improvements to CPASS in the future should be aimed at increasing the utility of the
software toward the functional annotation of proteins as well as increasing its usefulness
as an evolutionary tool. Each day more active sites are deposited in the PDB, and it will
become necessary to re-evaluate the active site representative tree. Although it is unlikely
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that new representative active sites will need to be chosen, it is very likely that new
functions are added or that improved annotation tools are developed. I firmly believe in
the tenet, “If its not broken, don’t fix it”. CPASS is proven in its ability to annotate and
evolutionarily relate active sites. Future efforts should be aimed at increasing the
portability of the software and expanding its capabilities rather than modifications to the
scoring function. Merging CPASS with an existing, popular software tool will
undoubtedly increase its overall use. In parallel, the development of a process or pipeline
to dock ligands in silico to both known and putative binding sites prior to CPASS
analysis is necessary. This improvement would not only increase the use of CPASS, but
could also significantly decrease experimental time in the determination of protein
function.
NMR will always maintain a significant role in the field of structural biology. For
decades NMR has been used to solve the structures of proteins in the solution state.
Improvements in the hardware and software of spectrometers; as well as in the
preparation of the samples has significantly expanded the range of proteins that can be
studied. However, the future of the field involves studying membrane proteins and their
structures in membrane mimics. Significant development is still required to study
membrane proteins by NMR. New isotopic labeling schemes, pulse programs, and data
collection methods will all be needed to study membrane proteins. Although the task
seems insurmountable, the ability to elucidate the structure of a protein in the solution
state is valuable, as it closely resembles the physiological state of the protein.
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NMR is one of the few techniques that are capable of studying the dynamics of
proteins. Already discussed in this dissertation is the possibility that dynamics may play a
more significant role in disease than previously considered. That being said, future
developments are of the utmost importance. The extraction of even more information
from the data rich NMR spectra will provide key clues into the dynamics of invisible or
transient conformers. Additionally, it should be possible to collect distance restraints on
the invisible states by using a paramagnetic ion or spin label in combination with a
saturation transfer experiment. The distance restraints could then be used to refine the
invisible state structure, which would be a significant accomplishment. Lastly, these
structures would provide researchers with a superior target for drug design and
development.

